Compound
L-glutamine
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells.
Studied for
26 endpoints · 47 findings · 28 papers · 17 null
- CD4/CD8 ratioraisesEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.
- All-cause mortalityno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Hospital length of staylowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Infectious complication rateno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Interleukin-6 concentrationlowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
Structure
An optically active form of glutamine having L-configuration.
Loading the model…
- Class
- Organic compound
- Formula
- C5H10N2O3
- Mass
- 146.146 g/mol
- Charge
- 0
- InChIKey
- ZDXPYRJPNDTMRX-VKHMYHEASA-N
- SMILES
- NC(=O)CC[C@H](N)C(=O)O
- Look it up
- ChEBIPubChemBy InChIKey
Identity from ChEBI, geometry from PubChem. Not evidence.
What the evidence says
How to read these marks47 findings · 26 endpoints · 28 papers · 17 null · by evidence strength
- Evidence strength
- Strong
- Moderate
- Limited
- Very limited
- Insufficient
| Endpoint | Lowered26 findings, 17 endpoints | No detected effect17 findings, 10 endpoints | Raised3 findings, 3 endpoints | Other1 finding, 1 endpoint |
|---|---|---|---|---|
| CD4/CD8 ratio | ||||
| All-cause mortality | ||||
| Hospital length of stay | ||||
| Infectious complication rate | ||||
| Interleukin-6 concentration | ||||
| C-reactive protein concentration | ||||
| Tumour necrosis factor alpha concentration | ||||
| Fasting blood glucose | ||||
| Intensive care unit length of stay | ||||
| Numeric rating scale (NRS) pain intensity | ||||
| Stool frequency | ||||
| Alanine aminotransferase | ||||
| Aspartate aminotransferase | ||||
| Plasma citrulline concentration | ||||
| Serum leptin | ||||
| Total cholesterol (TC) | ||||
| Urinary lactulose/mannitol ratio | ||||
| Wound infection incidence | ||||
| Is transported by SLC7A8 | ||||
| Malondialdehyde (circulating) | ||||
| Superoxide dismutase activity | ||||
| Measured, and no finding detected an effect | ||||
| Glycated haemoglobin (HbA1c) | ||||
| Serum creatine kinase activity | ||||
| Time to exhaustion | ||||
| Necrotising enterocolitis incidence | ||||
| Serum creatinine concentration | ||||
What moved
30 findings
Increases CD4/CD8 ratio
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Finding“Analysis suggested Gln enriched nutrition support could effectively increase postoperative CD3+ T-cell (MD: 3.71; 95% CI: 2.57–4.85; P < 0.05) and CD4/CD8 ratio (MD: 0.27; 95% CI: 0.12–0.42; P < 0.05) of GI cancer patients.”
Quoted verbatim from Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Participants
- 322
- Population
- Surgical patients with gastrointestinal tumour given glutamine-enriched enteral or parenteral nutrition support, glutamine the only difference between arms per the review inclusion criteria; postoperative measurement; 5 pooled trials
Effect 0.27 mean difference, 95% CI 0.12 to 0.42
Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.2015PMID:25591570Permalink
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“Meta-analysis showed that glutamine supplementation significantly decreased significantly serum levels of FPG [SMD: - 0.73, 95% CI - 1.35, - 0.11, I2: 84.1%] and CRP [SMD: - 0.58, 95% CI - 0.1, - 0.17, I2: 0%].”
Quoted verbatim from Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- participants in randomized clinical trials of glutamine supplementation
Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis.2021PMID:33865313Permalink
Decreases fasting blood glucose
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Meta-analysis showed that glutamine supplementation significantly decreased significantly serum levels of FPG [SMD: - 0.73, 95% CI - 1.35, - 0.11, I2: 84.1%] and CRP [SMD: - 0.58, 95% CI - 0.1, - 0.17, I2: 0%].”
Quoted verbatim from Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- participants in randomized clinical trials of glutamine supplementation
Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis.2021PMID:33865313Permalink
Decreases tumour necrosis factor alpha concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“Compared with placebo, glutamine (MD −25.2; 95% CrI [−32.62, −17.95]) and probiotics (MD −12.55; 95% CrI [−15.19, −9.92]) significantly reduced TNF-α levels in CRC patients.”
Quoted verbatim from Comparative Effects of Different Nutritional Supplements on Inflammation, Nutritional Status, and Clinical Outcomes in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis.. - Study
- meta-analysis
- Population
- colorectal cancer (CRC) patients; network meta-analysis estimate for glutamine versus placebo
Effect -25.2 mean difference, 95% CI -32.62 to -17.95
Comparative Effects of Different Nutritional Supplements on Inflammation, Nutritional Status, and Clinical Outcomes in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis.2023PMID:37375676Permalink
Decreases interleukin-6 concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“The results indicated that Gln supplementation effectively reduced IL-6 levels (SMD = −1.23, 95% CI: −1.68 to −0.78, P < 0.00001; Figure 17).”
Quoted verbatim from Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
Effect -1.23 standardised mean difference, 95% CI -1.68 to -0.78
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.2022PMID:35774540Permalink
Decreases intensive care unit length of stay
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The pooled results indicated that Gln supplementation was associated with a significantly shorter ICU hospital stay (SMD = −0.93, 95% CI: −1.83 to −0.04, P = 0.04; Figure 6).”
Quoted verbatim from Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
Effect -0.93 standardised mean difference, 95% CI -1.83 to -0.04
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.2022PMID:35774540Permalink
Show the remaining 24
Decreases tumour necrosis factor alpha concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“The combined results showed that nutritional supplementation with Gln was effective in reducing TNF-α levels (SMD = −2.47, 95% CI: −3.27 to −1.66, P < 0.00001; Figure 19).”
Quoted verbatim from Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
Effect -2.47 standardised mean difference, 95% CI -3.27 to -1.66
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.2022PMID:35774540Permalink
Decreases hospital length of stay
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×3“The pooled results showed that Gln supplementation significantly reduced the total length of hospital stay (MD = −3.41, 95% CI: −4.93 to −1.88, P < 0.0001; Figure 7).”
Quoted verbatim from Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
Effect -3.41 mean difference, 95% CI -4.93 to -1.88
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.2022PMID:35774540Permalink
Decreases stool frequency
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Glutamine also (i) reduced daily bowel movement frequency (p<0.0001), (ii) improved stool form on the Bristol Stool Scale (p<0.0001), and (iii) normalized intestinal hyperpermeability (where hyperpermeability is defined as an elevated urinary lactulose/mannitol ratio > 0.07) (p<0.0001).”
Quoted verbatim from Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.. - Study
- RCT
- Participants
- 106
- Duration
- 8 weeks
- Dose
- glutamine powder 5 g orally three times daily for 8 weeks
- Population
- adults with post-infectious diarrhoea-predominant IBS (IBS-D) and intestinal hyperpermeability
Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.2019PMID:30108163Permalink
Decreases numeric rating scale (NRS) pain intensity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“NRS scores were significantly lower in group G than in group P at weeks 4, 5 and 6 (p=0.049, p=0.019, p=0.032, respectively; Fig. 3B).”
Quoted verbatim from L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.. - Study
- RCT
- Participants
- 40
- Dose
- 10 g orally three times a day throughout the chemoradiotherapy course
- Population
- Patients with untreated squamous cell carcinoma of the nasopharynx, oropharynx, hypopharynx or larynx receiving weekly cisplatin and docetaxel with 66-70 Gy radiation in both arms; strongest daily pain on a 0-10 NRS, reported at weeks 4, 5 and 6
L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.2015PMID:25351453Industry fundedPermalink
Decreases aspartate aminotransferase
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“The meta-analysis results showed that Gln supplementation was more effective in reducing AST level (MD = −21.45, 95% CI: −34.74 to −8.16, P = 0.002; Figure 7).”
Quoted verbatim from Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
Effect -21.45 mean difference, 95% CI -34.74 to -8.16
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.2022PMID:35774540Permalink
Decreases alanine aminotransferase
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“We selected a random-effects model, and the pooled estimates suggested that Gln supplementation significantly reduced ALT level (MD = −13.73, 95% CI: −16.40 to −11.07, P < 0.00001; Figure 11).”
Quoted verbatim from Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
Effect -13.73 mean difference, 95% CI -16.4 to -11.07
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.2022PMID:35774540Permalink
Decreases hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“However, enteral GLN therapy was related to a reduction of hospital LOS (MD, -2.85; 95% CI, -5.27 to -0.43; p = 0.02).”
Quoted verbatim from Glutamine enteral therapy for critically ill adult patients: An updated meta-analysis of randomized controlled trials and trial sequential analysis.. - Study
- meta-analysis
- Population
- Adult critically ill patients receiving enteral glutamine supplementation (meta-analysis of 18 RCTs).
Glutamine enteral therapy for critically ill adult patients: An updated meta-analysis of randomized controlled trials and trial sequential analysis.2024PMID:38041938Permalink
Decreases wound infection incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Moreover, glutamine supplement reduced wound infection (risk ratios [RR] = 0.38, 95% CI 0.21 to 0.69, I2 = 0%, 3 trials), but not nonwound infection (RR = 0.88, 95% CI 0.73 to 1.05, I2 = 39.6%, 9 trials).”
Quoted verbatim from Glutamine Supplementation on Burn Patients: A Systematic Review and Meta-analysis.. - Study
- meta-analysis
- Population
- Burn patients receiving glutamine supplementation (meta-analysis of 3 trials); route not stated.
Glutamine Supplementation on Burn Patients: A Systematic Review and Meta-analysis.2024PMID:38243579Permalink
Decreases serum leptin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Serum levels of leptin, interleukin-6, cholesterol, and oxidized low-density lipoprotein, as well as the ratio of oxidized low-density lipoprotein to high-density lipoprotein, were significantly decreased in the intervention group compared to the control group after exhaustive exercise (P < 0.05).”
Quoted verbatim from Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.. - Study
- RCT
- Duration
- 14 days
- Dose
- 0.3 g glutamine per kilogram body weight per day, oral, for 14 days, with 25 g sugar in 250 mL water
- Population
- Healthy young males (n=30, 15 per group) given oral glutamine 0.3 g/kg/day for 14 days then performing one session of exhaustive exercise, vs isocaloric sugar-water control
Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.2022PMID:34844156Permalink
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Serum levels of leptin, interleukin-6, cholesterol, and oxidized low-density lipoprotein, as well as the ratio of oxidized low-density lipoprotein to high-density lipoprotein, were significantly decreased in the intervention group compared to the control group after exhaustive exercise (P < 0.05).”
Quoted verbatim from Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.. - Study
- RCT
- Duration
- 14 days
- Dose
- 0.3 g glutamine per kilogram body weight per day, oral, for 14 days, with 25 g sugar in 250 mL water
- Population
- Healthy young males (n=30, 15 per group) given oral glutamine 0.3 g/kg/day for 14 days then performing one session of exhaustive exercise, vs isocaloric sugar-water control
Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.2022PMID:34844156Permalink
Decreases urinary lactulose/mannitol ratio
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The levels of diamine oxidase (DAO), lactulose/mannitol (L/M), β2-microglobulin, lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBD) and cardiac troponin l (cTnl) in the B+G group were significantly lower than those in the B group (p < 0.05 or 0.01).”
Quoted verbatim from Glutamine relieves the hypermetabolic response and reduces organ damage in severe burn patients: A multicenter, randomized controlled clinical trial.. - Study
- RCT
- Population
- Adult burn patients with TBSA 30-70% (multicenter RCT); B+G (burn+glutamine) arm vs B (burn control) arm, measured on the 7th and/or 14th day after treatment (specific timepoint not stated for this comparison)
Glutamine relieves the hypermetabolic response and reduces organ damage in severe burn patients: A multicenter, randomized controlled clinical trial.2022PMID:34973853Permalink
Decreases infectious complication rate
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Glutamine supplementation was also associated with a lower rate of infectious complications (RR, 0.81; 95% CI, 0.64-1.00) and a shorter hospital stay (-2.6 days; 95% CI, -4.5 to -0.7).”
Quoted verbatim from Glutamine supplementation in serious illness: a systematic review of the evidence.. - Study
- meta-analysis
- Population
- surgical and critically ill adult patients (pooled meta-analysis of 14 randomised trials, various glutamine doses and routes)
Effect 0.81 risk ratio, 95% CI 0.64 to 1
Glutamine supplementation in serious illness: a systematic review of the evidence.2002PMID:12352035Permalink
Decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Use of glutamine compared with an isonitrogenous control led to a reduction in length of hospital stay (mean stay -5.65 days, 95% confidence interval (CI) -8.09 to -3.22) and reduced mortality (pooled risk ratio (RR) 0.25, 95% CI 0.08 to 0.78).”
Quoted verbatim from Immunonutrition as an adjuvant therapy for burns.. - Study
- meta-analysis
- Population
- patients with severe burn injury; glutamine (7 of 16 included RCTs) versus isonitrogenous control diet
Effect 0.25 risk ratio, 95% CI 0.08 to 0.78
Immunonutrition as an adjuvant therapy for burns.2014PMID:25536183Permalink
Decreases interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“Serum levels of leptin, interleukin-6, cholesterol, and oxidized low-density lipoprotein, as well as the ratio of oxidized low-density lipoprotein to high-density lipoprotein, were significantly decreased in the intervention group compared to the control group after exhaustive exercise (P < 0.05).”
Quoted verbatim from Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.. - Study
- RCT
- Duration
- 14 days
- Dose
- 0.3 g glutamine per kilogram body weight per day, oral, for 14 days, with 25 g sugar in 250 mL water
- Population
- Healthy young males (n=30, 15 per group) given oral glutamine 0.3 g/kg/day for 14 days then performing one session of exhaustive exercise, vs isocaloric sugar-water control
Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.2022PMID:34844156Permalink
Increases plasma citrulline concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“In plasma (Table 5), both citrulline and proline levels were significantly higher in glutamine-supplemented rats than in controls.”
Quoted verbatim from Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.. - Study
- animal · not in humans
- Dose
- glutamine in drinking water 7 consecutive days a month for 10 months, 20% of dietary protein (about 0.8 g/rat/day)
- Population
- Very old (27-month) female Wistar rats given intermittent oral glutamine for 10 months versus water-only controls
Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.2014PMID:25389959Permalink
Decreases infectious complication rate
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“The results showed a significant decrease in the infectious complication rates of patients undergoing abdominal surgery receiving GLN-PN (risk ratio [RR], 0.48; 95% confidence interval [CI], 0.32 to 0.72; P = 0.0004).”
Quoted verbatim from The impact of perioperative glutamine-supplemented parenteral nutrition on outcomes of patients undergoing abdominal surgery: a meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- patients undergoing abdominal surgery receiving glutamine-supplemented parenteral nutrition
The impact of perioperative glutamine-supplemented parenteral nutrition on outcomes of patients undergoing abdominal surgery: a meta-analysis of randomized clinical trials.2013PMID:23635587Permalink
Decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Glutamine supplemented nutrition can be associated with a reduction in mortality in hospital, complications due to gram-negative bacteremia in burn patients.”
Quoted verbatim from A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn.. - Study
- meta-analysis
- Population
- Adult burn patients receiving glutamine supplementation, intention-to-treat analysis (meta-analysis of 4 RCTs, 155 patients); route not stated.
A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn.2013PMID:23313017Permalink
Decreases hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Glutamine supplementation was also associated with a lower rate of infectious complications (RR, 0.81; 95% CI, 0.64-1.00) and a shorter hospital stay (-2.6 days; 95% CI, -4.5 to -0.7).”
Quoted verbatim from Glutamine supplementation in serious illness: a systematic review of the evidence.. - Study
- meta-analysis
- Population
- surgical and critically ill adult patients (pooled meta-analysis of 14 randomised trials, various glutamine doses and routes)
Effect -2.6 mean difference, 95% CI -4.5 to -0.7
Glutamine supplementation in serious illness: a systematic review of the evidence.2002PMID:12352035Permalink
Decreases hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Use of glutamine compared with an isonitrogenous control led to a reduction in length of hospital stay (mean stay -5.65 days, 95% confidence interval (CI) -8.09 to -3.22) and reduced mortality (pooled risk ratio (RR) 0.25, 95% CI 0.08 to 0.78).”
Quoted verbatim from Immunonutrition as an adjuvant therapy for burns.. - Study
- meta-analysis
- Population
- patients with severe burn injury; glutamine (7 of 16 included RCTs) versus isonitrogenous control diet
Effect -5.65 mean difference, 95% CI -8.09 to -3.22
Immunonutrition as an adjuvant therapy for burns.2014PMID:25536183Permalink
Is transported by SLC7A8
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“LAT2 has a critical role in regulating Gln efflux from skeletal muscle.”
Quoted verbatim from Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis.. - Study
- animal · not in humans
- Population
- LAT2 knockout (LAT2KO) mice, skeletal muscle, fasting
Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis.2025PMID:40546137Permalink
Decreases malondialdehyde (circulating)
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“Serum concentrations of malondialdehyde, nitric oxide synthase and nitric oxide were significantly higher in PCOS group (P < 0.01) compared with the control group, and significantly decreased to the comparative levels of control group with supplementation of 0.5 g/kg glutamine (P < 0.01).”
Quoted verbatim from The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.. - Study
- animal · not in humans
- Dose
- 0.5 g/kg, intraperitoneal, twice on the morning after the last DHEA injection
- Population
- Female Sprague-Dawley rats, DHEA-induced PCOS model, 0.5 g/kg glutamine dose
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.2020PMID:32386521Permalink
Increases superoxide dismutase activity
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“Concentrations of superoxide dismutase were significantly lower in all the PCOS groups (P < 0.01) compared to the control group, and increased significantly with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
Quoted verbatim from The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.. - Study
- animal · not in humans
- Dose
- 0.5 g/kg, intraperitoneal, twice on the morning after the last DHEA injection
- Population
- Female Sprague-Dawley rats, DHEA-induced PCOS model, 0.5 g/kg glutamine dose
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.2020PMID:32386521Permalink
Decreases C-reactive protein concentration
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Findingreplicated ×1“All the detected inflammation factors [C-reactive protein, interleukin (IL)-6, IL-18, tumor necrosis factor] showed significantly higher in all the PCOS groups compared to the control group (P < 0.01), and were significantly decreased with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
Quoted verbatim from The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.. - Study
- animal · not in humans
- Dose
- 0.5 g/kg, intraperitoneal, twice on the morning after the last DHEA injection
- Population
- Female Sprague-Dawley rats, DHEA-induced PCOS model, 0.5 g/kg glutamine dose
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.2020PMID:32386521Permalink
Decreases interleukin-6 concentration
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Findingreplicated ×2“All the detected inflammation factors [C-reactive protein, interleukin (IL)-6, IL-18, tumor necrosis factor] showed significantly higher in all the PCOS groups compared to the control group (P < 0.01), and were significantly decreased with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
Quoted verbatim from The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.. - Study
- animal · not in humans
- Dose
- 0.5 g/kg, intraperitoneal, twice on the morning after the last DHEA injection
- Population
- Female Sprague-Dawley rats, DHEA-induced PCOS model, 0.5 g/kg glutamine dose
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.2020PMID:32386521Permalink
What did not
17 findings
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×4“The mortality rate was insignificantly different between glutamine group and placebo group (22.7% vs. 36.4% respectively, p-value = 0.509) as presented in Table 4 and.”
Quoted verbatim from Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients' Survival: A Randomized Controlled Trial.. - Study
- RCT
- Participants
- 44
- Dose
- 20 gm/100 mL intravenous N(2)-L-Alanyl-L-Glutamine Dipeptide (Dipeptiven) on the day 1-2 regimen every 2 weeks
- Population
- Stage II and III colon cancer patients, both arms receiving identical mFOLFOX-6 chemotherapy, randomised to intravenous L-alanyl L-glutamine dipeptide or placebo; mortality over the trial follow-up
Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients' Survival: A Randomized Controlled Trial.2022PMID:35334570Permalink
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×4“The pooled data indicated that enteral Gln did not decrease the overall mortality (RR = 0.37; 95% CI: 0.06 − 2.37; p = 0.300), with significant heterogeneity (I 2 = 61%).”
Quoted verbatim from Enteral glutamine supplements for patients with severe burns: A systematic review and meta-analysis.. - Study
- meta-analysis
- Participants
- 1,271
- Population
- Adults with severe burns (second- or third-degree burns over 20% or more TBSA, or 15% or more with inhalation injury) given enteral glutamine; primary endpoint; 3 pooled trials
Effect 0.37 risk ratio, 95% CI 0.06 to 2.37
Enteral glutamine supplements for patients with severe burns: A systematic review and meta-analysis.2024PMID:37460347Permalink
No detected effect on glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Fasting glycemia and glycated hemoglobin A1c values before and after 60 days of supplementation with EGln or maltodextrin indicated prediabetes, but no significant differences were observed between the EGln and placebo groups.”
Quoted verbatim from Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 30
- Duration
- 2 months
- Dose
- 12.4 g oral effervescent glutamine daily
- Population
- community-dwelling older adults aged over 60 from three daycare centres in Brazil; safety/tolerability endpoint, not the trial's primary outcome
Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.2024PMID:38808890Permalink
No detected effect on time to exhaustion
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“There were no statistical differences regarding time to exhaustion between Hypoxia group (27.6 ± 5.46), Hypoxia + Carbohydrate group (29.2 ± 6.49), and Hypoxia + Glutamine group (23.66 ± 4.95).”
Quoted verbatim from Effects of Carbohydrate and Glutamine Supplementation on Oral Mucosa Immunity after Strenuous Exercise at High Altitude: A Double-Blind Randomized Trial.. - Study
- crossover
- Duration
- 6 days
- Dose
- 20 g/day glutamine for six days before the test day, plus 8% maltodextrin 200 mL every 20 min during exercise and recovery on test day
- Population
- physically active healthy male volunteers running at 70% VO2peak on a treadmill under simulated altitude (4500 m); comparator (Hypoxia + Carbohydrate) also received the same carbohydrate supplementation as the glutamine arm
Effects of Carbohydrate and Glutamine Supplementation on Oral Mucosa Immunity after Strenuous Exercise at High Altitude: A Double-Blind Randomized Trial.2017PMID:28671626Permalink
No detected effect on infectious complication rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“GLN supplementation did not affect overall morbidity (RR = 0.84, 95% CI 0.51 to 1.36; p = 0.473) and infectious morbidity (RR = 0.64; 95% CI = 0.38 to 1.07; p = 0.087).”
Quoted verbatim from Effect of glutamine dipeptide supplementation on primary outcomes for elective major surgery: systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- patients undergoing major elective abdominal operations
Effect of glutamine dipeptide supplementation on primary outcomes for elective major surgery: systematic review and meta-analysis.2015PMID:25584966Permalink
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×4“Mortality showed no significant difference between glutamine group and control group.”
Quoted verbatim from The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- critically ill patients
The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials.2014PMID:24401636Permalink
Show the remaining 11
No detected effect on infectious complication rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“When the four studies in which the researchers reported infectious complications were aggregated, enteral GLN supplementation was not associated with a reduction in infectious complications (RR 0.93, 95 % CI 0.79–1.10, p =0.39; heterogeneity I2 = 0 %) (Fig..”
Quoted verbatim from Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.. - Study
- meta-analysis
- Participants
- 776
- Population
- Adult critically ill ICU patients given enteral glutamine against an isonitrogenous control; secondary endpoint (primary was hospital mortality); 4 pooled trials; infection defined by each source trial
Effect 0.93 risk ratio, 95% CI 0.79 to 1.1
Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.2015PMID:26283217Permalink
No detected effect on serum creatine kinase activity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Consistent with muscle mass, markers of myofibrillar protein breakdown (3 methyl-histidine/creatinine ratio in urine) and serum CPK were not affected by Gln treatment compared with placebo (Table 2).”
Quoted verbatim from Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.. - Study
- crossover
- Dose
- 0.5 g/kg/d oral glutamine once daily for 4 months versus maltodextrin placebo of equal weight, 1-month washout
- Population
- 30 ambulant boys aged 2 to 10 years with Duchenne muscular dystrophy, 5 on corticosteroids; change over the 4-month glutamine phase versus the 4-month placebo phase
Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.2009PMID:19421321Permalink
No detected effect on hospital length of stay
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×1“The length of hospital stay was reported in 14 trials, in which a total of 2,777 patients were enrolled; however, the patient length of stay was not affected by glutamine supplementation.”
Quoted verbatim from The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Participants
- 2,777
- Population
- critically ill patients
The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials.2014PMID:24401636Permalink
No detected effect on necrotising enterocolitis incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“We found that glutamine supplementation does not have a statistically significant effect on the incidence of systemic infection (typical relative risk 1.02 (95% confidence interval 0.92 to 1.13); typical risk difference 0.01 (95% confidence interval -0.03 to 0.05)), necrotising enterocolitis (typical relative risk 1.02 (95% confidence interval 0.79 to 1.33); typical risk difference 0.00 (95% confidence interval -0.02 to 0.03)), days to full enteral nutrition (weighted mean difference -1.1 days (95% confidence interval -3.4 to 1.2)), or duration of hospital stay (weighted mean difference 0.65 days (95% confidence interval -2.9 to 4.2)).”
Quoted verbatim from Glutamine supplementation to prevent morbidity and mortality in preterm infants.. - Study
- meta-analysis
- Population
- very low birth weight preterm infants (pooled meta-analysis of six randomised trials, enteral and parenteral)
Effect 1.02 risk ratio, 95% CI 0.79 to 1.33
Glutamine supplementation to prevent morbidity and mortality in preterm infants.2005PMID:15674878Permalink
No detected effect on infectious complication rate
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“We observed no significant effect of glutamine supplementation on overall mortality (RR, 0.65, 95% CI, 0.33-1.28; p = 0.21), infectious complications (RR, 0.83; 95% CI, 0.63-1.09; p = 0.18), or other secondary outcomes.”
Quoted verbatim from The Efficacy of Glutamine Supplementation in Severe Adult Burn Patients: A Systematic Review With Trial Sequential Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe adult burn patients receiving glutamine supplementation, enteral or IV route pooled (meta-analysis of 10 RCTs).
The Efficacy of Glutamine Supplementation in Severe Adult Burn Patients: A Systematic Review With Trial Sequential Meta-Analysis.2023PMID:37114912Permalink
No detected effect on all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×4“We observed no significant effect of glutamine supplementation on overall mortality (RR, 0.65, 95% CI, 0.33-1.28; p = 0.21), infectious complications (RR, 0.83; 95% CI, 0.63-1.09; p = 0.18), or other secondary outcomes.”
Quoted verbatim from The Efficacy of Glutamine Supplementation in Severe Adult Burn Patients: A Systematic Review With Trial Sequential Meta-Analysis.. - Study
- meta-analysis
- Population
- Severe adult burn patients receiving glutamine supplementation, enteral or IV route pooled (meta-analysis of 10 RCTs).
The Efficacy of Glutamine Supplementation in Severe Adult Burn Patients: A Systematic Review With Trial Sequential Meta-Analysis.2023PMID:37114912Permalink
No detected effect on all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×4“Hospital mortality was not significantly different between the glutamine group and the control group.”
Quoted verbatim from Glutamine on critical-ill patients: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Adult critically ill patients receiving glutamine supplementation (meta-analysis of 47 RCTs); route not stated.
Glutamine on critical-ill patients: a systematic review and meta-analysis.2021PMID:33222464Permalink
No detected effect on serum creatinine concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Plasma creatinine and urea were similar in very old rats supplemented or not with glutamine (Table 3).”
Quoted verbatim from Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.. - Study
- animal · not in humans
- Dose
- glutamine in drinking water 7 consecutive days a month for 10 months, 20% of dietary protein (about 0.8 g/rat/day)
- Population
- Very old (27-month) female Wistar rats given intermittent oral glutamine for 10 months versus water-only controls
Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.2014PMID:25389959Permalink
No detected effect on hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“We found that glutamine supplementation does not have a statistically significant effect on the incidence of systemic infection (typical relative risk 1.02 (95% confidence interval 0.92 to 1.13); typical risk difference 0.01 (95% confidence interval -0.03 to 0.05)), necrotising enterocolitis (typical relative risk 1.02 (95% confidence interval 0.79 to 1.33); typical risk difference 0.00 (95% confidence interval -0.02 to 0.03)), days to full enteral nutrition (weighted mean difference -1.1 days (95% confidence interval -3.4 to 1.2)), or duration of hospital stay (weighted mean difference 0.65 days (95% confidence interval -2.9 to 4.2)).”
Quoted verbatim from Glutamine supplementation to prevent morbidity and mortality in preterm infants.. - Study
- meta-analysis
- Population
- very low birth weight preterm infants (pooled meta-analysis of six randomised trials, enteral and parenteral)
Effect 0.65 mean difference, 95% CI -2.9 to 4.2
Glutamine supplementation to prevent morbidity and mortality in preterm infants.2005PMID:15674878Permalink
No detected effect on aspartate aminotransferase
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.FindingNull result“Likewise ALT and AST were not modified by glutamine supplementation (Table 3).”
Quoted verbatim from Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.. - Study
- animal · not in humans
- Dose
- glutamine in drinking water 7 consecutive days a month for 10 months, 20% of dietary protein (about 0.8 g/rat/day)
- Population
- Very old (27-month) female Wistar rats given intermittent oral glutamine for 10 months versus water-only controls
Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.2014PMID:25389959Permalink
No detected effect on alanine aminotransferase
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.FindingNull result“Likewise ALT and AST were not modified by glutamine supplementation (Table 3).”
Quoted verbatim from Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.. - Study
- animal · not in humans
- Dose
- glutamine in drinking water 7 consecutive days a month for 10 months, 20% of dietary protein (about 0.8 g/rat/day)
- Population
- Very old (27-month) female Wistar rats given intermittent oral glutamine for 10 months versus water-only controls
Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.2014PMID:25389959Permalink
What it touches on the way
Mechanistic reach
40 entities
40 entities reached.
0 reported hops40 assembled from the scaffold
- SLC1A5ProteinUNIPROT:Q15758transported byInferred only920 paths44 endpoints
- SLC38A2ProteinUNIPROT:Q96QD8transported byInferred only353 paths179 endpoints
- SLC7A5ProteinUNIPROT:Q01650transported byInferred only161 paths7 endpoints
- CADProteinUNIPROT:P27708substrate ofInferred only108 paths27 endpoints
- SLC3A2ProteinUNIPROT:P08195transported byInferred only96 paths12 endpoints
- SLC38A1ProteinUNIPROT:Q9H2H9transported byInferred only72 paths36 endpoints
- QARS1ProteinUNIPROT:P47897substrate ofInferred only70 paths34 endpoints
- ASNSProteinUNIPROT:P08243substrate ofInferred only58 paths29 endpoints
- SLC38A10ProteinUNIPROT:Q9HBR0transported byInferred only56 paths55 endpoints
- GLSProteinUNIPROT:O94925substrate ofInferred only54 paths27 endpoints
- GFPT1ProteinUNIPROT:Q06210substrate ofInferred only54 paths27 endpoints
- SLC7A8ProteinUNIPROT:Q9UHI5transported byInferred only54 paths18 endpoints
Show the remaining 28
- GLS2ProteinUNIPROT:Q9UI32substrate ofInferred only48 paths24 endpoints
- SLC7A6ProteinUNIPROT:Q92536transported byInferred only47 paths2 endpoints
- SLC7A9ProteinUNIPROT:P82251transported byInferred only45 paths9 endpoints
- CTPS1ProteinUNIPROT:P17812substrate ofInferred only42 paths21 endpoints
- SLC43A1ProteinUNIPROT:O75387transported byInferred only33 paths33 endpoints
- GLULProteinUNIPROT:P15104substrate ofInferred only33 paths33 endpoints
- SLC7A7ProteinUNIPROT:Q9UM01transported byInferred only32 paths16 endpoints
- SLC38A5ProteinUNIPROT:Q8WUX1transported byInferred only28 paths14 endpoints
- PFASProteinUNIPROT:O15067substrate ofInferred only24 paths12 endpoints
- PPATProteinUNIPROT:Q06203substrate ofInferred only22 paths11 endpoints
- GMPSProteinUNIPROT:P49915substrate ofInferred only18 paths9 endpoints
- KYAT1ProteinUNIPROT:Q16773substrate ofInferred only18 paths9 endpoints
- NADSYN1ProteinUNIPROT:Q6IA69substrate ofInferred only16 paths8 endpoints
- SLC6A19ProteinUNIPROT:Q695T7transported byInferred only14 paths6 endpoints
- GFPT2ProteinUNIPROT:O94808substrate ofInferred only12 paths6 endpoints
- SLC1A4ProteinUNIPROT:P43007transported byInferred only12 paths12 endpoints
- GLYATL1ProteinUNIPROT:Q969I3substrate ofInferred only11 paths11 endpoints
- AADATProteinUNIPROT:Q8N5Z0substrate ofInferred only10 paths10 endpoints
- CTPS2ProteinUNIPROT:Q9NRF8substrate ofInferred only8 paths4 endpoints
- KYAT3ProteinUNIPROT:Q6YP21substrate ofInferred only6 paths6 endpoints
- SLC3A1ProteinUNIPROT:Q07837transported byInferred only5 paths1 endpoint
- SLC36A1ProteinUNIPROT:Q7Z2H8transported byInferred only4 paths2 endpoints
- SLC38A4ProteinUNIPROT:Q969I6transported byInferred only4 paths2 endpoints
- SLC6A17ProteinUNIPROT:Q9H1V8transported byInferred only4 paths4 endpoints
- SLC6A14ProteinUNIPROT:Q9UN76transported byInferred only4 paths2 endpoints
- SLC38A3ProteinUNIPROT:Q99624transported byInferred only2 paths1 endpoint
- QRSL1ProteinUNIPROT:Q9H0R6substrate ofInferred only2 paths2 endpoints
- SLC6A15ProteinUNIPROT:Q9H2J7transported byInferred only2 paths1 endpoint
What the reference databases state
Regulatory determinations
LiverTox likelihood score ELiverTox
LiverTox Likelihood Score E — despite extensive use, no evidence that the agent has caused liver injury. Chapter: "L-Glutamine". Source: LiverTox Master List (NBK571102).
The document·Public Domain (NLM/NIH)·Transcribed, not assessed
Statements
182 statements
182 statements · 2 reference databases · Subject: L-glutamine · Sources: Human-GEM, Rhea
- L-glutamine is converted to 2-oxoglutaramateCompoundRhea RHEA:61260Inferred only
- 2-oxoglutaramate is converted to L-glutamineCompoundRhea RHEA:61260Inferred only
- L-glutamine is converted to carbamoyl phosphateCompoundHuman-GEM MAR04034Inferred only
- L-glutamine is converted to carbamoyl phosphateCompoundRhea RHEA:18633Inferred only
- carbamoyl phosphate is converted to L-glutamineCompoundRhea RHEA:18633Inferred only
- L-glutamine is a substrate of AADATProteinHuman-GEM MAR04197Inferred only
- L-glutamine is a substrate of ASNSProteinRhea RHEA:12228Inferred only
- L-glutamine is a substrate of ASNSProteinHuman-GEM MAR03903Inferred only
- L-glutamine is a substrate of CADProteinRhea RHEA:18633Inferred only
- L-glutamine is a substrate of CADProteinHuman-GEM MAR09802Inferred only
- L-glutamine is a substrate of CADProteinRhea RHEA:15889Inferred only
- L-glutamine is a substrate of CADProteinHuman-GEM MAR04034Inferred only
Show the remaining 170
- L-glutamine is a substrate of CTPS1ProteinHuman-GEM MAR04194Inferred only
- L-glutamine is a substrate of CTPS1ProteinRhea RHEA:26426Inferred only
- L-glutamine is a substrate of CTPS2ProteinHuman-GEM MAR04194Inferred only
- L-glutamine is a substrate of CTPS2ProteinRhea RHEA:26426Inferred only
- L-glutamine is a substrate of GATBProteinRhea RHEA:17521Inferred only
- L-glutamine is a substrate of GATCProteinRhea RHEA:17521Inferred only
- L-glutamine is a substrate of GFPT1ProteinRhea RHEA:13237Inferred only
- L-glutamine is a substrate of GFPT1ProteinHuman-GEM MAR04300Inferred only
- L-glutamine is a substrate of GFPT2ProteinRhea RHEA:13237Inferred only
- L-glutamine is a substrate of GFPT2ProteinHuman-GEM MAR04300Inferred only
- L-glutamine is a substrate of GLSProteinHuman-GEM MAR03892Inferred only
- L-glutamine is a substrate of GLSProteinRhea RHEA:15889Inferred only
- L-glutamine is a substrate of GLS2ProteinRhea RHEA:15889Inferred only
- L-glutamine is a substrate of GLS2ProteinHuman-GEM MAR09802Inferred only
- L-glutamine is a substrate of GLULProteinRhea RHEA:16169Inferred only
- L-glutamine is a substrate of GLYATL1ProteinRhea RHEA:18469Inferred only
- L-glutamine is a substrate of GLYATL1BProteinRhea RHEA:18469Inferred only
- L-glutamine is a substrate of GMPSProteinRhea RHEA:11680Inferred only
- L-glutamine is a substrate of GMPSProteinHuman-GEM MAR04046Inferred only
- L-glutamine is a substrate of KYAT1ProteinHuman-GEM MAR04196Inferred only
- L-glutamine is a substrate of KYAT1ProteinRhea RHEA:17593Inferred only
- L-glutamine is a substrate of KYAT3ProteinHuman-GEM MAR04197Inferred only
- L-glutamine is a substrate of NADSYN1ProteinRhea RHEA:24384Inferred only
- L-glutamine is a substrate of NADSYN1ProteinHuman-GEM MAR04260Inferred only
- L-glutamine is a substrate of PFASProteinHuman-GEM MAR04808Inferred only
- L-glutamine is a substrate of PFASProteinRhea RHEA:17129Inferred only
- L-glutamine is a substrate of PPATProteinRhea RHEA:14905Inferred only
- L-glutamine is a substrate of PPATProteinHuman-GEM MAR04406Inferred only
- L-glutamine is a substrate of QARS1ProteinHuman-GEM MAR05136Inferred only
- L-glutamine is a substrate of QARS1ProteinRhea RHEA:20121Inferred only
- L-glutamine is a substrate of QRSL1ProteinRhea RHEA:17521Inferred only
- L-glutamine is transported by BEST2ProteinRhea RHEA:73419Inferred only
- L-glutamine is transported by SLC1A4ProteinHuman-GEM MAR05709Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70863Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05624Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70867Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70875Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05627Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70879Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05629Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05634Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05784Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05754Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05709Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05619Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70883Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05618Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05308Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70855Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70887Inferred only
- L-glutamine is transported by SLC1A5ProteinHuman-GEM MAR05603Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70871Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:75307Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70891Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:70859Inferred only
- L-glutamine is transported by SLC1A5ProteinRhea RHEA:84327Inferred only
- L-glutamine is transported by SLC36A1ProteinHuman-GEM MAR05052Inferred only
- L-glutamine is transported by SLC36A1ProteinHuman-GEM MAR05078Inferred only
- L-glutamine is transported by SLC38A1ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC38A1ProteinHuman-GEM MAR05308Inferred only
- L-glutamine is transported by SLC38A10ProteinRhea RHEA:73419Inferred only
- L-glutamine is transported by SLC38A2ProteinHuman-GEM MAR05308Inferred only
- L-glutamine is transported by SLC38A2ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC38A3ProteinHuman-GEM MAR06380Inferred only
- L-glutamine is transported by SLC38A3ProteinRhea RHEA:71127Inferred only
- L-glutamine is transported by SLC38A4ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC38A4ProteinHuman-GEM MAR05308Inferred only
- L-glutamine is transported by SLC38A5ProteinRhea RHEA:71127Inferred only
- L-glutamine is transported by SLC38A5ProteinHuman-GEM MAR06380Inferred only
- L-glutamine is transported by SLC38A6ProteinRhea RHEA:73419Inferred only
- L-glutamine is transported by SLC38A7ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC38A8ProteinRhea RHEA:73419Inferred only
- L-glutamine is transported by SLC38A9ProteinRhea RHEA:73419Inferred only
- L-glutamine is transported by SLC3A1ProteinHuman-GEM MAR05925Inferred only
- L-glutamine is transported by SLC3A1ProteinHuman-GEM MAR05973Inferred only
- L-glutamine is transported by SLC3A1ProteinHuman-GEM MAR05909Inferred only
- L-glutamine is transported by SLC3A1ProteinHuman-GEM MAR05941Inferred only
- L-glutamine is transported by SLC3A1ProteinHuman-GEM MAR05957Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR05487Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR07643Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR06897Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR05473Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR05078Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR05492Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR05497Inferred only
- L-glutamine is transported by SLC3A2ProteinHuman-GEM MAR08733Inferred only
- L-glutamine is transported by SLC43A1ProteinHuman-GEM MAR05078Inferred only
- L-glutamine is transported by SLC6A14ProteinHuman-GEM MAR06896Inferred only
- L-glutamine is transported by SLC6A14ProteinRhea RHEA:71283Inferred only
- L-glutamine is transported by SLC6A15ProteinHuman-GEM MAR05308Inferred only
- L-glutamine is transported by SLC6A15ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC6A17ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC6A19ProteinRhea RHEA:68236Inferred only
- L-glutamine is transported by SLC6A19ProteinHuman-GEM MAR05308Inferred only
- L-glutamine is transported by SLC7A10ProteinHuman-GEM MAR05473Inferred only
- L-glutamine is transported by SLC7A10ProteinHuman-GEM MAR05487Inferred only
- L-glutamine is transported by SLC7A10ProteinHuman-GEM MAR08733Inferred only
- L-glutamine is transported by SLC7A10ProteinHuman-GEM MAR05497Inferred only
- L-glutamine is transported by SLC7A10ProteinHuman-GEM MAR07643Inferred only
- L-glutamine is transported by SLC7A10ProteinHuman-GEM MAR05492Inferred only
- L-glutamine is transported by SLC7A13ProteinRhea RHEA:76311Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05473Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05078Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05459Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05487Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05488Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05489Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05490Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05491Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05492Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05493Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05494Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05495Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05496Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05497Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05498Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05499Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05617Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05620Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05621Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05622Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05623Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05625Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05626Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05628Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05631Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05649Inferred only
- L-glutamine is transported by SLC7A5ProteinHuman-GEM MAR05664Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05679Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05739Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05709Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05784Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05694Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05814Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05837Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05838Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05839Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05840Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05841Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05724Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05909Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05664Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05925Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05631Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05941Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05630Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05957Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05629Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05973Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05628Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05626Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05625Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05624Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR06897Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05623Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05621Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05620Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05619Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05603Inferred only
- L-glutamine is transported by SLC7A6ProteinHuman-GEM MAR05588Inferred only
- L-glutamine is transported by SLC7A6ProteinRhea RHEA:70835Inferred only
- L-glutamine is transported by SLC7A7ProteinHuman-GEM MAR05078Inferred only
- L-glutamine is transported by SLC7A7ProteinHuman-GEM MAR06897Inferred only
- L-glutamine is transported by SLC7A8ProteinRhea RHEA:71027Inferred only
- L-glutamine is transported by SLC7A8ProteinHuman-GEM MAR05078Inferred only
- L-glutamine is transported by SLC7A9ProteinHuman-GEM MAR05909Inferred only
- L-glutamine is transported by SLC7A9ProteinHuman-GEM MAR05925Inferred only
- L-glutamine is transported by SLC7A9ProteinHuman-GEM MAR05941Inferred only
- L-glutamine is transported by SLC7A9ProteinHuman-GEM MAR05957Inferred only
- L-glutamine is transported by SLC7A9ProteinHuman-GEM MAR05973Inferred only
Reactions
226 reactions
L-alanine+L-arginine+L-asparagine+L-aspartate+CHEBI:1307929+a cholesterol ester+a cardiolipin+MAM01602c+L-cysteine+MAM01721n+MAM01722n+L-glutamate(1-)+L-glutamine+glycine+CHEBI:15971+L-isoleucine+L-leucine+MAM02392c+CHEBI:18019+L-methionine+L-phenylalanine+phosphatidic acid+1-phosphatidyl-1D-myo-inositol+CHEBI:17203+MAM02847c+L-seryl residue+a sphingomyelin+CHEBI:16857+L-tryptophan+CHEBI:17895+L-valine+MAM03161cMAM03970c
Reaction pageBlockedBalance undeterminablecytosol, endoplasmic reticulum, nucleus
Human-GEM MAR00021CC BY 4.0Reference data
Reaction pageLeft to rightBalancedcytosol, mitochondrial matrix
Human-GEM MAR01381CC BY 4.0Reference data
ATP+L-glutamate(1-)+ammoniumADP+L-glutamine+phosphate(3-)
Catalysed by GLUL
Reaction pageLeft to rightBalancedEC 6.3.1.2cytosol
Human-GEM MAR03890CC BY 4.0Reference data
L-glutamine+waterL-glutamate(1-)+proton+ammonium
Catalysed by GLS
Reaction pageLeft to rightBalancedEC 3.5.1.2, 3.5.1.38mitochondrial matrix
Human-GEM MAR03892CC BY 4.0Reference data
L-aspartate+ATP+L-glutamine+waterAMP+L-asparagine+L-glutamate(1-)+proton+diphosphate(3-)
Catalysed by ASNS
Reaction pageLeft to rightBalancedEC 6.3.5.4cytosol
Human-GEM MAR03903CC BY 4.0Reference data
2ATP+L-glutamine+water+hydrogencarbonate2ADP+carbamoyl phosphate+L-glutamate(1-)+2proton+phosphate(3-)
Catalysed by CAD
Reaction pageLeft to rightBalancedEC 6.3.5.5cytosol
Human-GEM MAR04034CC BY 4.0Reference data
ATP+L-glutamine+water+XMPAMP+L-glutamate(1-)+GMP+2proton+diphosphate(3-)
Catalysed by GMPS
Reaction pageLeft to rightBalancedEC 6.3.5.2cytosol
Human-GEM MAR04046CC BY 4.0Reference data
ATP+L-glutamine+water+UTPADP+CHEBI:17677+L-glutamate(1-)+2proton+phosphate(3-)
Reaction pageLeft to rightBalancedEC 6.3.4.2cytosol
Human-GEM MAR04194CC BY 4.0Reference data
L-glutamine+pyruvate2-oxoglutaramate+L-alanine
Catalysed by KYAT1
Reaction pageLeft to rightBalancedEC 2.6.1.15, 2.6.1.63cytosol
Human-GEM MAR04196CC BY 4.0Reference data
L-glutamine+pyruvate2-oxoglutaramate+L-alanine
Reaction pageLeft to rightBalancedEC 2.6.1.15, 2.6.1.63mitochondrial matrix
Human-GEM MAR04197CC BY 4.0Reference data
ATP+deamido-NAD(+)+L-glutamine+waterAMP+L-glutamate(1-)+proton+NAD(+)+diphosphate(3-)
Catalysed by NADSYN1
Reaction pageLeft to rightBalancedEC 6.3.5.1cytosol
Human-GEM MAR04260CC BY 4.0Reference data
keto-D-fructose 6-phosphate+L-glutaminealpha-D-glucosamine 6-phosphate+L-glutamate(1-)
Reaction pageLeft to rightBalancedEC 2.6.1.16cytosol
Human-GEM MAR04300CC BY 4.0Reference data
On the label
Labelled products
1,552 products
Source: NIH DSLD · Ingredient: L-glutamine · 1,552 products · Declared amount per serving: 1.5–33,333 mg (734 products) · Showing 1,000 of 1,552
991 labels state an amount9 do not
- 1MDGutMD1,500 mgper 3 Capsule(s)DSLD:246745
- 1MDGutMD1,500 mgper 3 Capsule(s)DSLD:274800
- 1MD NutritionGutMD1,850 mgper 3 Capsule(s)DSLD:309809
- 1st PhormGI Advantage750 mgper 4 Capsule(s)DSLD:242777
- 1st PhormGlutamine5 Gram(s)per 5 Gram(s)DSLD:242796
- 1st PhormIntra-Formance Lemon Lime2,500 mgper 31.8 Gram(s)DSLD:242858
- 1st PhormIntra-Formance Orange2,500 mgper 31.8 Gram(s)DSLD:242859
- 20S20 NutritionSuper Immune Support200 mgper 2 Capsule(s)DSLD:286853
- AB American BiologicsUltra Brain Power125 mgper 3 Capsule(s)DSLD:203653
- AB American BiologicsUltra Hepa Trope II200 mgper 4 Capsule(s)DSLD:203820
- AB American BiologicsUltra Minerals For Life200 mgper 1 Capsule(s)DSLD:20374
- About TimeL-Glutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:213814
Show the remaining 1,540
- Absorb HealthAdvanced Digestion Support300 mgper 3 Capsule(s)DSLD:215702
- Absorb HealthL-Glutamine1,000 mgper 0.5 Gram(s)DSLD:215852
- Adaptogen ResearchGI Renew1.5 Gram(s)per 8 Gram(s)DSLD:247015
- Adaptogen ResearchL-Glutamine5 Gram(s)per 5.85 Gram(s)DSLD:307153
- AdvoCareArginine Extreme Citrus200 mgper 13 Gram(s)DSLD:265495
- AdvoCareCatalyst1,200 mgper 3 Capsule(s)DSLD:265036
- AdvoCareMNS E1,600 mgper 1 Packet(s)DSLD:177964
- Akasha NaturalsUltraCleanse Plus100 mgper 42 Gram(s)DSLD:313121
- Alani NuBCAA Berry500 mgper 7.9 Gram(s)DSLD:247871
- Alani NuBCAA Hawaiian Shaved Ice500 mgper 8.2 Gram(s)DSLD:321216
- Alani NuBCAA Sour Gummies500 mgper 7.9 Gram(s)DSLD:321217
- Alani NuBCAA Sour Peach Rings500 mgper 8.1 Gram(s)DSLD:321218
- Allergy Research GroupBrainStorm125 mgper 1 Tablet(s)DSLD:233202
- Allergy Research GroupBrainStorm125 mgper 1 Tablet(s)DSLD:258045
- Allergy Research GroupFast & Be Clear1 Gram(s)per 20 Gram(s)DSLD:233522
- Allergy Research GroupFast & Be Clear500 mgper 40 Gram(s)DSLD:258091
- Allergy Research GroupGastroCort II750 mgper 3 Capsule(s)DSLD:233174
- Allergy Research GroupL-Glutamine4.7 Gram(s)per 1 tspDSLD:233226
- Allergy Research GroupL-Glutamine 500 mg1 Gram(s)per 1 Capsule(s)DSLD:233194
- Allergy Research GroupL-Glutamine 800 mg1.6 Gram(s)per 1 Capsule(s)DSLD:317593
- Allergy Research GroupPerm A Vite Powder2 Gram(s)per 6.3 Gram(s)DSLD:233232
- ALLMAXA:Cuts Amino-Charged Energy Drink Sweet Tea250 mgper 7 Gram(s)DSLD:265269
- ALLMAXAmino: Cuts Amino-Charged Energy Drink Grape250 mgper 7 Gram(s)DSLD:296130
- ALLMAXGlutaminefree-form5 Gram(s)per 5 Gram(s)DSLD:261923
- ALLMAXVitastack Orange100 mgper 8.3 Gram(s)DSLD:264245
- Amazing MuscleL-Glutamine 1000 mg1,000 mgper 1 Capsule(s)DSLD:251849
- Amazing MuscleL-Glutamine 500 mgL-Glutamine Note: free form500 mgper 1 Capsule(s)DSLD:251174
- Amazing MuscleL-Glutamine 500 mgL-Glutamine Note: free form500 mgper 1 Capsule(s)DSLD:251848
- Amazing MuscleL-Glutamine Unflavored5,000 mgper 5 Gram(s)DSLD:251178
- Amazing MusclePre Rise Fruit Punch3 Gram(s)per 21 Gram(s)DSLD:251083
- AN Amazing Nutrition Amazing FormulasL-Glutamine1 Gram(s)per 1 Gram(s)DSLD:251952
- AN Amazing Nutrition Amazing FormulasL-Glutamine 1000 mg1,000 mgper 1 Capsule(s)DSLD:256035
- AN Amazing Nutrition Amazing FormulasL-Glutamine 1000 mg1,000 mgper 1 Capsule(s)DSLD:256036
- AN Amazing Nutrition Amazing FormulasL-Glutamine 500 mgL-Glutamine Note: free form500 mgper 1 Capsule(s)DSLD:251918
- AN Amazing Nutrition Amazing FormulasL-Glutamine 500 mgL-Glutamine Note: free-form500 mgper 1 Capsule(s)DSLD:251951
- Anabolic WarfareAnabolic Recovery Operation OJ2,500 mgper 17.6 Gram(s)DSLD:307045
- Anabolic WarfareAnabolic Recovery Tropical Tornado2,500 mgper 17.7 Gram(s)DSLD:307046
- ANSI Pro-Series100% Pure L-Glutamine 5000L-Glutamine Note: (FreeForm) (usp)5 gper 5 Gram(s)DSLD:21019
- ANSI Pro-Series100% Pure L-Glutamine 5000L-Glutamine Note: (FreeForm) (usp)5 gper 5 Gram(s)DSLD:21021
- Apollon NutritionChainsaw Blue Bomb5,000 mgper 12 Gram(s)DSLD:215752
- Apollon NutritionEnigma Passion Fruit5,000 mgper 21.6 Gram(s)DSLD:215758
- Apollon NutritionEnigma Pineapple5,000 mgper 22 Gram(s)DSLD:235587
- Arms Race Nutrition BasicsGlutamine Unflavoredfermented5,000 mgper 5 Gram(s)DSLD:308134
- Assault LabsWild Thing Tropical Tornado500 mgper 1 Scoop(s)DSLD:200542
- AST Sports ScienceAR-5 Juicy Grape3,000 mgper 15 Gram(s)DSLD:21388
- AST Sports ScienceAR-5 Lemon Ice3,000 mgper 15 Gram(s)DSLD:21395
- AST Sports ScienceMicronized GL3 L-GlutamineL-Glutamine Note: not less than 98.5%5 Gram(s)per 5 Gram(s)DSLD:250561
- athBCAA Cotton Candy Flavor2,500 mgper 1 Scoop(s)DSLD:288267
- athBCAA Green Apple Flavor2,500 mgper 9 Gram(s)DSLD:288264
- athBCAA Strawberry Kiwi Flavor2,500 mgper 9.8 Gram(s)DSLD:288272
- athPOST with added L-Glutamine Birthday Cake Flavor2,000 mgper 87.6 Gram(s)DSLD:288270
- athPOST with added L-Glutamine Cocoa Flavor2,000 mgper 91 Gram(s)DSLD:288262
- ATP ScienceVegan Essential Aminos Cola500 mgper 6 Gram(s)DSLD:241753
- ATP ScienceVegan Essential Aminos Raspberry500 mgper 6 Gram(s)DSLD:241760
- Axe & Sledge SupplementsGlutamine Unflavored5,000 mgper 5 Gram(s)DSLD:255019
- Barlean's PlatinumIntestinal Repair Mixed Berry Flavor500 mgper 6 Gram(s)DSLD:314168
- Basic VitaminsStress Formula with Iron20 mgper 1 Tablet(s)DSLD:250028
- Beast Sports NutritionGlutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:249540
- Best NaturalsL-Glutamine 1000 mg2 gram2,000 mgper 2 Tablet(s)DSLD:270633
- Best NaturalsL-Glutamine 500 mg500 mgper 2 Tablet(s)DSLD:269810
- Best NaturalsL-Glutamine Pure Powder5 Grams5,000 mgper 5 Gram(s)DSLD:270637
- Bio-Tech PharmacalGlutamine500 mgper 1 Capsule(s)DSLD:217446
- BioCareChildren's Mindlinx Complex1,000 mgper 2 Gram(s)DSLD:309733
- BioCareMindlinx Complex500 mgper 1 Capsule(s)DSLD:309751
- BioCarePermatrol750 mgper 3 Capsule(s)DSLD:309760
- BiochemGlutamine Pure 5 gL-Glutamine Note: free form5 Gram(s)per 5 Gram(s)DSLD:230855
- BioChem SportsUltimate L-Glutamine Muscle Support 1000L-Glutamine Note: (free form) (1 g)1,000 mgper 1 Tablet(s)DSLD:13216
- Bioclinic NaturalsDetoxiCleanse500 mgper 40 Gram(s)DSLD:20771
- Bioclinic NaturalsDetoxiCleanse500 mgper 40 Gram(s)DSLD:20930
- Bioclinic NaturalsRestorX1,000 mgper 32.4 Gram(s)DSLD:20770
- Bioclinic NaturalsRestorX1,000 mgper 32.4 Gram(s)DSLD:20931
- BIOHMMicrobiome Multi286 mgper 2 Capsule(s)DSLD:291956
- BiosteelAdvanced Recovery Formula Vanilla6,264 mgper 36 Gram(s)DSLD:30899
- BioSteelAdvanced Recovery Formula Chocolate6,264 mgper 36 Gram(s)DSLD:30953
- BioSteelBioSteel Hydration Mix Mixed Berry Flavor973 mgper 7 Gram(s)DSLD:273699
- BioSteelBioSteel Hydration Mix Rainbow Twist Flavor973 mgper 7 Gram(s)DSLD:273703
- BioSteelBioSteel Hydration Mix White Freeze Flavor973 mgper 7 Gram(s)DSLD:271048
- BioSteelBioSteel Sports Hydration Mix Blue Raspberry970 mgper 0.24 ozDSLD:273737
- BioSteelBioSteel Sports Hydration Mix Lemon-Lime970 mgper 0.24 ozDSLD:273736
- BioSteelBioSteel Sports Hydration Mix Mixed Berry970 mgper 0.24 ozDSLD:271055
- BioSteelBioSteel Sports Hydration Mix Orange970 mgper 0.24 ozDSLD:273726
- BioSteelBioSteel Sports Hydration Mixed Berry970 mgper 0.24 ozDSLD:273727
- BioSteelWhey Protein Isolate Chocolate3,937 mgper 32 Gram(s)DSLD:30990
- BioSteelWhey Protein Isolate Vanilla3,937 mgper 32 Gram(s)DSLD:30993
- Biotics Research CorporationL-GlutamineL-Glutamine Hydrochloride · Glutamine (Form: as L-Glutamine HCl Note: Nonhydrolyzed, naturally produced, free-form L-Amino Acid. )500 mgper 1 Capsule(s)DSLD:21918
- Biotics Research CorporationL-Glutamine Powder3 gper 1 tspDSLD:21934
- Biotics Research CorporationNuclezyme-Forte100 mgper 1 Capsule(s)DSLD:22115
- BIOVEAL-Glutamine 500 mg500 mgper 1 Vegetarian Capsule(s)DSLD:277892
- Blackstone LabsFormula 19 Black Currant4.5 Gram(s)per 34.42 Gram(s)DSLD:204939
- Blackstone LabsFormula 19 Black Currant9 Gram(s)per 68.85 Gram(s)DSLD:219481
- Bluebonnet100% Natural Dual-Action Protein Natural Chocolate500 mgper 34 Gram(s)DSLD:179935
- Bluebonnet100% Natural Dual-Action Protein Natural Chocolate500 mgper 34 Gram(s)DSLD:179938
- Bluebonnet100% Natural Dual-Action Protein Natural Chocolate500 mgper 34 Gram(s)DSLD:179941
- Bluebonnet100% Natural Dual-Action Protein Natural French Vanilla500 mgper 34 Gram(s)DSLD:179930
- Bluebonnet100% Natural Dual-Action Protein Natural French Vanilla500 mgper 34 Gram(s)DSLD:179933
- Bluebonnet100% Natural Dual-Action Protein Natural Original Flavor500 mgper 34 Gram(s)DSLD:179868
- Bluebonnet100% Natural Dual-Action Protein Natural Original Flavor500 mgper 34 Gram(s)DSLD:179881
- Bluebonnet100% Natural Dual-Action Protein Natural Original Flavor500 mgper 34 Gram(s)DSLD:179912
- BluebonnetBCAA & Glutamine Strawberry Kiwi Flavor1,000 mgper 12.5 Gram(s)DSLD:279907
- BluebonnetL-Glutamine 500 mgL-Glutamine Note: free-form500 mgper 1 Capsule(s)DSLD:176436
- BluebonnetL-Glutamine 500 mgFree-form500 mgper 1 Capsule(s)DSLD:279542
- BluebonnetL-Glutamine Powderfree-form5,000 mgper 5 Gram(s)DSLD:314806
- BluebonnetL-Glutamine Powderfree-form5 Gram(s)per 5 Gram(s)DSLD:314807
- BluebonnetL-Glutamine Powderfree-form5,000 mgper 5 Gram(s)DSLD:314808
- BluebonnetPower Thought125 mgper 2 Caplet(s)DSLD:179161
- BluebonnetPower Thought125 mgper 2 Caplet(s)DSLD:179176
- BluebonnetPower Thought125 mgper 2 Caplet(s)DSLD:179183
- BluebonnetWhey & Casein Protein Powder Chocolate Flavor500 mgper 34 Gram(s)DSLD:314907
- BluebonnetWhey & Casein Protein Powder Chocolate Flavor500 mgper 34 Gram(s)DSLD:317237
- BluebonnetWhey & Casein Protein Powder French Vanilla Flavor500 mgper 34 Gram(s)DSLD:268384
- BluebonnetWhey & Casein Protein Powder French Vanilla Flavor500 mgper 34 Gram(s)DSLD:317236
- BluebonnetWhey of Life Multi-Action Whey Protein Natural Chocolate Blitz FlavorGlutamine Peptides500 mgper 36 Gram(s)DSLD:3147
- Body EcologyImmune Power Shake2,000 mgper 29.1 Gram(s)DSLD:304387
- Body Fortress100% Pure Glutamine Powder 4.5 g4,500 g4.5 Gram(s)per 4.6 Gram(s)DSLD:310105
- Bodybuilding.com SignatureMicronized Glutamine5 Gram(s)per 5 Gram(s)DSLD:282411
- BodyHealthHealthy Sleep Ultra50 mgper 1 Capsule(s)DSLD:259268
- BodyTechBCAA + Glutamine UnflavoredL-Glutamine Note: free form amino acid2.5 Gram(s)per 6.9 Gram(s)DSLD:183485
- BodyTechBCAA + Glutamine UnflavoredL-Glutamine Note: free form amino acid2.5 Gram(s)per 6.9 Gram(s)DSLD:183487
- BodyTechCreatine & Glutamine With Beta-Alanine Unflavored3,000 mgper 10.2 Gram(s)DSLD:183806
- BodyTechCreatine + Glutamine with Beta-Alanine Fruit Punch3,000 mgper 11.5 Gram(s)DSLD:183838
- BodyTechCritical Aminos XT Blue Ice Pop2,500 mgper 7.8 Gram(s)DSLD:184597
- BodyTechCritical Aminos XT Fruit Punch2,500 mgper 10 Gram(s)DSLD:183762
- BodyTechCritical Aminos XT Grape2,500 mgper 7.1 Gram(s)DSLD:183639
- BodyTechCritical Aminos XT Pineapple2,500 mgper 7.4 Gram(s)DSLD:183663
- BodyTechCritical Aminos XT Sweet Tea2,500 mgper 7.3 Gram(s)DSLD:184033
- BodyTechCritical Aminos XT Watermelon2,500 mgper 10.1 Gram(s)DSLD:184323
- BodyTechGlutamineL-Glutamine Note: a free form amino acid500 mgper 1 Capsule(s)DSLD:184327
- BodyTechGlutamineL-Glutamine Note: a free form amino acid500 mgper 1 Capsule(s)DSLD:184333
- BodyTechGlutamine UnflavoredL-Glutamine Note: a free form amino acid4.5 Gram(s)per 4.5 Gram(s)DSLD:184076
- BodyTechGlutamine UnflavoredL-Glutamine Note: a free form amino acid4.5 Gram(s)per 4.5 Gram(s)DSLD:184078
- BodyTechGlutamine UnflavoredL-Glutamine Note: a free form amino acid4.5 Gram(s)per 4.5 Gram(s)DSLD:184487
- BodyTechGlutamine UnflavoredL-Glutamine Note: a free form amino acid4.5 Gram(s)per 4.5 Gram(s)DSLD:204455
- BPI SportsBest Aminos Fruit PunchOligopeptide-Enzymatic Technology Glycyl-Alanyl-Lysine-L-Glutamine1 Gram(s)per 10 Gram(s)DSLD:270403
- BPI SportsGluta Alkaline UnflavoredL-Glutamine · Glutamine (Form: as pH-Sorb(TM) Buffering Technology L-Glutamine, and Trans-Alanyl-Glutamine) Note: patent-pending1,500 mgper 1 Scoop(s)DSLD:25732
- BrainMDNeurolink400 mgper 2 Capsule(s)DSLD:206093
- Brenda Watson's Vital PlanetVital Gut Renew6,000 mgper 6.5 Gram(s)DSLD:249854
- BronsonL-Glutamine 500 mgL-Glutamine Note: free form500 mgper 1 Tablet(s)DSLD:258110
- BronsonL-Glutamine 500 mgL-Glutamine Note: free form500 mgper 1 Tablet(s)DSLD:259223
- BronsonL-Glutamine Powder 1000 mgFree-form1,000 mgper 1.25 Gram(s)DSLD:317324
- Bucked UpAll Bulk No Bloat Peach Lemonade Flavor2,500 mgper 12.32 Gram(s)DSLD:282481
- Bucked UpAll Bulk No Bloat Swole Whip Flavor2,500 mgper 11.8 Gram(s)DSLD:284938
- BulkSupplements.comL-Glutamine5,000 mgper 5000 mgDSLD:312153
- BulkSupplements.comL-Glutamine5,000 mgper 5000 mgDSLD:312154
- BulkSupplements.comL-Glutamine5,000 mgper 5000 mgDSLD:312155
- BulkSupplements.comL-Glutamine5,000 mgper 5000 mgDSLD:312156
- BulkSupplements.comL-Glutamine (750 mg)1,500 mgper 2 Capsule(s)DSLD:252743
- BulkSupplements.comL-Glutamine (750 mg)1,500 mgper 2 Capsule(s)DSLD:254439
- Burbank Glendale ChiropracticUltimate Health Complex50 mgper 2 Tablet(s)DSLD:22089
- Buried Treasure Liquid NutrientsNeuro Nectar300 mgper 30 mLDSLD:250726
- California Academy of HealthWhey Protein Gold Isolate Plus Natural Chocolate Flavor420 mgper 44 Gram(s)DSLD:191162
- California Academy of HealthWhey Protein Gold Isolate Plus Natural Vanilla Flavor460 mgper 6 TbspDSLD:197375
- California Gold NutritionL-Glutamine1000 mg1 Gram(s)per 2 Capsule(s)DSLD:274239
- California Gold Nutrition SPORTL-Glutaminefree-form5 Gram(s)per 5 Gram(s)DSLD:274235
- CaptavidaImmune + Gut Health400 mgper 2 Veggie Capsule(s)DSLD:314336
- Cardiovascular ResearchOmnicholine60 mgper 1 Capsule(s)DSLD:283444
- CarlsonGlutathione Booster50 mgper 2 Capsule(s)DSLD:304777
- CarlsonL-Glutamine 750 mg750 mgper 1 Capsule(s)DSLD:241816
- CarlsonL-Glutamine 750 mg750 mgper 1 Capsule(s)DSLD:241817
- CarlsonL-Glutamine PowderL-Glutamine Note: 3,000 mg3 Gram(s)per 3 Gram(s)DSLD:241811
- CarlsonL-Glutamine PowderL-Glutamine Note: 3,000 mg3 Gram(s)per 3 Gram(s)DSLD:241814
- CarlsonNutra-Support Immune50 mgper 2 Capsule(s)DSLD:265253
- CarlsonNutra-Support Immune50 mgper 2 Capsule(s)DSLD:266384
- CarlsonNutra-Support Prostate100 mgper 2 Softgel(s)DSLD:216239
- CarlsonNutra-Support Prostate100 mgper 2 Softgel(s)DSLD:216243
- CarlsonNutra-Support Prostate100 mgper 2 Softgel(s)DSLD:216247
- CarlsonUltimate Liver Support50 mgper 2 Capsule(s)DSLD:242005
- CarlsonUltimate Liver Support50 mgper 2 Capsule(s)DSLD:242011
- CellucorBCAA Sport Cherry Limeade2,000 mgper 11 Gram(s)DSLD:291623
- CellucorCOR-Performance Glutamine5 Gram(s)per 5 Gram(s)DSLD:291630
- CellucorWhey Sport Vanilla2 Gram(s)per 46.5 Gram(s)DSLD:309674
- CGM LabsOnce A Day Albumin Complex30 mgper 1 Chewable Tablet(s)DSLD:301440
- CHK NutritionGlutamine PowderL-Glutamine Note: L-Glutamine powder is 100% free form amino acid.5,000 mgper 1 Scoop(s)DSLD:174194
- CHK NutritionNatural Unflavored Plant Protein4,150 mgper 28 Gram(s)DSLD:228645
- Cognetix LabsProvasil45 mgper 1 Tablet(s)DSLD:239432
- Cognetix LabsProvasil45 mgper 1 Tablet(s)DSLD:274326
- CognizanceImmunity200 mgper 2 Capsule(s)DSLD:246520
- Cohala WellnessNeuro Boost+150 mgper 1 Capsule(s)DSLD:313337
- Colossal LabsMonster Muscle Up-Gainer Cookies & Cream1,000 mgper 391 Gram(s)DSLD:177400
- Combat NutraBattle Buddy Fruit Punch1,000 mgper 6.5 Gram(s)DSLD:249643
- Core NutritionalsABC Australian Gummy Snakes2.5 Gram(s)per 20 Gram(s)DSLD:297748
- Core NutritionalsABC Australian Orange Sherbert2.5 Gram(s)per 20 Gram(s)DSLD:218159
- Core NutritionalsABC Australian Orange Sherbert2.5 Gram(s)per 20 Gram(s)DSLD:297749
- Core NutritionalsABC Australian Raspberry Chews2.5 Gram(s)per 20.75 Gram(s)DSLD:297750
- Core NutritionalsABC Blood Orange2.5 Gram(s)per 21 Gram(s)DSLD:297751
- Core NutritionalsABC Blueberry Acai2.5 Gram(s)per 20.6 Gram(s)DSLD:297752
- Core NutritionalsABC Cherry Lemonade2.5 Gram(s)per 20 Gram(s)DSLD:182784
- Core NutritionalsABC Crystal Cosmo2.5 Gram(s)per 20 Gram(s)DSLD:182779
- Core NutritionalsABC Crystal Cosmo2.5 Gram(s)per 20 Gram(s)DSLD:297753
- Core NutritionalsABC Crystal Star Candy2.5 Gram(s)per 20 Gram(s)DSLD:182780
- Core NutritionalsABC Crystal Star Candy2.5 Gram(s)per 20 Gram(s)DSLD:297754
- Core NutritionalsABC Fuzzy Uncle Carl2.5 Gram(s)per 20.5 Gram(s)DSLD:297755
- Core NutritionalsABC Lemon Drop2.5 Gram(s)per 20 Gram(s)DSLD:218164
- Core NutritionalsABC Lemon Drop2.5 Gram(s)per 20 Gram(s)DSLD:297756
- Core NutritionalsABC Lemon Lime Sherbert2.5 Gram(s)per 21 Gram(s)DSLD:297757
- Core NutritionalsABC Lemon Lime Sherbert2.5 Gram(s)per 1 Packet(s)DSLD:298372
- Core NutritionalsABC Natural Cherry Lemonade2.5 Gram(s)per 23.8 Gram(s)DSLD:297832
- Core NutritionalsABC Natural Mixed Berry2.5 Gram(s)per 22.8 Gram(s)DSLD:297831
- Core NutritionalsABC Patriot Pop2.5 Gram(s)per 22 Gram(s)DSLD:297833
- Core NutritionalsABC Pina Colada2.5 Gram(s)per 21 Gram(s)DSLD:297834
- Core NutritionalsABC Pink Guava2.5 Gram(s)per 20.5 Gram(s)DSLD:297835
- Core NutritionalsABC Sweet Tea2.5 Gram(s)per 19.6 Gram(s)DSLD:218169
- Core NutritionalsABC Sweet Tea2.5 Gram(s)per 19.6 Gram(s)DSLD:297836
- Core NutritionalsABC White Grape2.5 Gram(s)per 20 Gram(s)DSLD:182833
- Core NutritionalsABC White Grape2.5 Gram(s)per 20 Gram(s)DSLD:269125
- Core NutritionalsABC White Pineapple Strawberry2.5 Gram(s)per 20 Gram(s)DSLD:182834
- Core NutritionalsABC White Pineapple Strawberry2.5 Gram(s)per 20 Gram(s)DSLD:297837
- Core NutritionalsGlutamine5,000 mgper 5000 mgDSLD:297987
- Country LifeL-Glutamine 1000 mgL-Glutamine Note: (free form) (1 g)1,000 mgper 1 Tablet(s)DSLD:201929
- Country LifeL-Glutamine Caps 500 mgL-Glutamine Note: free form500 mgper 1 Capsule(s)DSLD:201924
- CrazyBulkIbuta 677500 mgper 4 Capsule(s)DSLD:288560
- Custom Health CentersImmune200 mgper 2 Capsule(s)DSLD:272697
- Cutler NutritionCutler Essentials Glutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:310075
- CymbiotikaPure Hydration Lemon Citrus100 mgper 8 Gram(s)DSLD:304740
- CymbiotikaPure Hydration Lychee100 mgper 8 Gram(s)DSLD:304739
- CymbiotikaPure Hydration Watermelon100 mgper 8 Gram(s)DSLD:304293
- CytoSportL-Glutamine Unflavored5 gper 5 Gram(s)DSLD:14780
- CytoSportMonster Mass Chocolate2 Gram(s)per 150 Gram(s)DSLD:26009
- CytoSportMonster Mass Strawberries 'N Creme2 Gram(s)per 150 Gram(s)DSLD:31497
- CytoSportMonster Mass Vanilla Creme2 Gram(s)per 150 Gram(s)DSLD:30871
- CytoSportMonster Milk Brownie Batter5 gper 78 Gram(s)DSLD:12850
- CytoSportMonster Milk Caffeinated Mocha Latte5 gper 78 Gram(s)DSLD:12803
- CytoSportMonster Milk Cake Batter5 gper 78 Gram(s)DSLD:12707
- CytoSportMonster Milk Chocolate5 gper 78 Gram(s)DSLD:12798
- CytoSportMonster Milk Chocolate Chip Cookie Dough5 gper 78 Gram(s)DSLD:12852
- CytoSportMonster Milk Vanilla Creme5 gper 78 Gram(s)DSLD:12786
- Daily SpraysBrain5 mgper 0.47 mLDSLD:247561
- DaVinci Benefits LineDetox Benefits300 mgper 6 Capsule(s)DSLD:313204
- DaVinci LaboratoriesMultiphase Detox300 mgper 6 Capsule(s)DSLD:304019
- DaVinci LaboratoriesSpectra50 mgper 2 Tablet(s)DSLD:304038
- DaVinci LaboratoriesSpectra50 mgper 2 Tablet(s)DSLD:304039
- DaVinci LaboratoriesSpectra Man50 mgper 2 Tablet(s)DSLD:313253
- DaVinci LaboratoriesSpectra Man50 mgper 2 Tablet(s)DSLD:313254
- DaVinci LaboratoriesSpectra Multi Age50 mgper 6.85 Gram(s)DSLD:288108
- DaVinci LaboratoriesSpectra Woman50 mgper 2 Tablet(s)DSLD:305242
- DaVinci LaboratoriesUltimate Prenatal20 mgper 5 Tablet(s)DSLD:304055
- DaVinci Laboratories Of VermontEnergy-Plex150 mgper 1 Tablet(s)DSLD:22518
- DaVinci Laboratories Of VermontKre-Alkalyn Complex3,000 mgper 10 Gram(s)DSLD:22868
- DaVinci Laboratories Of VermontNeuro-DMG200 mgper 1 Tablet(s)DSLD:245119
- DaVinci Laboratories Of VermontSpectra Without Copper And Iron50 mgper 2 Tablet(s)DSLD:23690
- DCL-Glutamine 500500 mgper 1 Capsule(s)DSLD:244937
- DCL-Glutamine 500500 mgper 1 Capsule(s)DSLD:266826
- DCL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:245115
- DCL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:266983
- DCL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:266992
- DCL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:266994
- DCVision Gard30 mgper 1 Capsule(s)DSLD:266022
- DCVision Gard20 mgper 1 Capsule(s)DSLD:266807
- DCVision Maxx60 mgper 2 Capsule(s)DSLD:266024
- DCVision Maxx60 mgper 2 Capsule(s)DSLD:267237
- DCVision Maxx50 mgper 2 Capsule(s)DSLD:267238
- DCVision Maxx60 mgper 2 Capsule(s)DSLD:309926
- Designs for HealthAmino D Tox250 mgper 3 Capsule(s)DSLD:22317
- Designs for HealthAmino-D-Tox500 mgper 6 Capsule(s)DSLD:22258
- Designs for HealthAmino-D-Tox500 mgper 6 Capsule(s)DSLD:22665
- Designs for HealthGI-Revive1,500 mgper 7.5 Gram(s)DSLD:22840
- Designs for HealthGI-Revive1,500 mgper 7.5 Gram(s)DSLD:22995
- Designs for HealthGI-Revive1,500 mgper 7 Capsule(s)DSLD:23201
- Designs for HealthIB Synergy500 mgper 2 Capsule(s)DSLD:22649
- Designs for HealthL-Glutamine850 mgper 1 Capsule(s)DSLD:22458
- Designs for HealthL-Glutamine Powder3,000 mgper 3 Gram(s)DSLD:22653
- Designs for HealthL-Glutamine Powder3 Gram(s)per 3 Gram(s)DSLD:22654
- Designs for HealthNeurolink600 mgper 2 Capsule(s)DSLD:22478
- Designs for HealthPaleoMeal Natural Chocolate FlavorTotal Glutamine Value3.9 Gram(s)per 36 Gram(s)DSLD:23181
- Designs for HealthPaleoMeal Natural Chocolate FlavorTotal Glutamine Value3.9 Gram(s)per 36 Gram(s)DSLD:23409
- Designs for HealthPaleoMeal Natural Strawberry FlavorTotal Glutamine Value3.9 Gram(s)per 36 Gram(s)DSLD:23295
- Designs for HealthPaleoMeal Natural Vanilla Flavor UnsweetenedTotal Glutamine Value3.9 Gram(s)per 36 Gram(s)DSLD:23176
- Designs for HealthPaleoMeal Natural Vanilla Flavor UnsweetenedTotal Glutamine Value3.9 Gram(s)per 36 Gram(s)DSLD:23189
- Designs for HealthPaleoMeal-DF Natural Berry Flavor900 mgper 36 Gram(s)DSLD:23300
- Designs for HealthPediaFocus - DF Natural Vanilla Flavor250 mgper 18 Gram(s)DSLD:23510
- DNA Miracles IsotonixDigestive Enzymes333 mgper 3.3 Gram(s)DSLD:298834
- Doctor DanielleGut Assist with Aloe3,000 mgper 5.8 Gram(s)DSLD:231158
- Doctor's BestPure L-Glutamine Powder5 Gram(s)per 5 Gram(s)DSLD:302703
- Douglas Cooper Co.Brain SupportL-Glutamine Note: free form125 mgper 1 Veg Capsule(s)DSLD:239508
- Douglas Cooper Co.Healthy Blood Sugar BalanceL-Glutamine Note: free-form167 mgper 1 Veg Capsule(s)DSLD:247355
- Douglas LaboratoriesIntestamine3,750 mgper 6 Capsule(s)DSLD:237929
- Douglas LaboratoriesIntestamineL-Glutamine · Glutamine (Form: as L-Glutamine)5,000 mgper 6.3 Gram(s)DSLD:261201
- Douglas LaboratoriesL-Glutamine + FOS Powder2.5 Gram(s)per 1 tspDSLD:30650
- Douglas LaboratoriesL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:232441
- Douglas LaboratoriesL-Glutamine Powder4 gper 1 tspDSLD:10741
- Douglas LaboratoriesMetabolic Rejuvenation Week 4 Renew500 mgper 1 PackDSLD:261764
- Douglas LaboratoriesMorphos Stack250 mgper 3 Capsule(s)DSLD:10321
- Douglas LaboratoriesMuscle Protect with HMB Natural Orange Vanilla Flavor2 Gram(s)per 9.15 Gram(s)DSLD:232943
- Douglas LaboratoriesMyo-GenL-Glutamine · Glutamine (Form: as L-glutamine FCC)1,000 mgper 7 Gram(s)DSLD:10960
- Douglas LaboratoriesNeuroTone500 mgper 4 Tablet(s)DSLD:261489
- Douglas LaboratoriesUltra 5-HTP Formula100 mgper 2 Capsule(s)DSLD:10298
- Douglas LaboratoriesWeek Four: Renew500 mgper 1 Packet(s)DSLD:231039
- Dr. BergSleep Aid25 mgper 1 Capsule(s)DSLD:257286
- Dr. BergSleep Aid25 mgper 1 Capsule(s)DSLD:292038
- Dr. Clark Research Association Dr. Clark ZentrumGlutamine 500 mg500 mgper 1 Capsule(s)DSLD:223519
- Dr. Clark StoreGlutamine 500 mg500 mgper 1 Capsule(s)DSLD:219859
- Dr. DanielleGut Assist Berry Flavor3,000 mgper 5.6 Gram(s)DSLD:283747
- Dr. DanielleGut Assist Orange Flavor3,000 mgper 5.6 Gram(s)DSLD:284941
- Dr. Drew SinatraGut Soother Harvest Apple Pear FlavorGlutamine Note: from fermentation5 Gram(s)per 11 Gram(s)DSLD:178522
- Dr. Mercola Premium SupplementsAll Natural Pro-Optimal Whey Chocolate FlavorTotal Glutamine Value3.9 Gram(s)per 30 Gram(s)DSLD:24915
- Dr. Mercola Premium SupplementsAll Natural Pro-Optimal Whey Strawberry FlavorTotal Glutamine Value3.9 Gram(s)per 30 Gram(s)DSLD:24925
- Dr. Mercola Premium SupplementsAll Natural Pro-Optimal Whey Vanilla FlavorTotal Glutamine Value3.9 Gram(s)per 30 Gram(s)DSLD:24927
- Dr. Seth's Vitamin VibrationsPower GI5,000 mgper 12.81 Gram(s)DSLD:315821
- Dr. Seth's Vitamin VibrationsPower HGH6,000 mgper 15.5 Gram(s)DSLD:315824
- Dr. Seth's Vitamin VibrationsPower Liver Cleanse300 mgper 6 Capsule(s)DSLD:315828
- Drucker LabsintraMAX 2.0 Peach Mango Flavoramount not statedper 1 fl. Oz.DSLD:236722
- DY NutritionHit BCAA 4:1:1 + Glutamine Cherry5,000 mgper 15 Gram(s)DSLD:241727
- DY NutritionHit BCAA 4:1:1 + Glutamine Peach33,333 mgper 15 Gram(s)DSLD:241728
- DY NutritionHit BCAA 4:1:1 + Glutamine Strawberry33,333 mgper 15 Gram(s)DSLD:241730
- DY NutritionThe Glutamine UnflavouredL-Glutamine Note: free-form amino acid4,500 mgper 4.5 Gram(s)DSLD:241762
- Ecological FormulasCephalgesic100 mgper 1 Capsule(s)DSLD:22296
- Ecological FormulasL-Glutamine Crystalline Amino Acid 500 Milligrams500 mgper 1 Capsule(s)DSLD:22700
- EquateWhey Protein Supplement Vanilla1.5 Gram(s)per 49 Gram(s)DSLD:295923
- Evlution NutritionGlutamine10001,000 mgper 2 Veggie Capsule(s)DSLD:302112
- Evlution NutritionGlutamine5000 Unflavored5,000 mgper 5 Gram(s)DSLD:302113
- Evlution NutritionRecoverMode Blue Razfermented3,000 mgper 21 Gram(s)DSLD:302141
- Extreme Edge by BluebonnetBCAA & Glutamine Strawberry Kiwi Flavor1,000 mgper 12.5 Gram(s)DSLD:314978
- FINAFLEXMuscle Fiber Unflavored Powder5 Gram(s)per 7.5 Gram(s)DSLD:178098
- FN Formutech NutritionEndurance BCAA+ Melon2.5 Gram(s)per 14.47 Gram(s)DSLD:261044
- FN Formutech NutritionEndurance BCAA+ Orange2.5 Gram(s)per 14.47 Gram(s)DSLD:261045
- FN Formutech NutritionEndurance BCAA+ Sweet Tea2.5 Gram(s)per 15 Gram(s)DSLD:259061
- ForestLeafPower Mind150 mgper 2 Capsule(s)DSLD:229527
- FortifeyeFortifeye Fit Fruit Punch2,500 mgper 33 Gram(s)DSLD:229426
- FortifyFocus SupportL-Glutamine Hydrochloride150 mgper 1 Vegetable Capsule(s)DSLD:283915
- FuelSelfImmune Support200 mgper 2 Capsule(s)DSLD:298304
- G6 SportsReplenish Orange Mango5,293 mgper 55.3 Gram(s)DSLD:269005
- Gaspari NutritionGlutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:291999
- GAT SportJetMASS Strawberry Lemonade1 Gram(s)per 23.6 Gram(s)DSLD:276597
- GenesaTotal Amino SolutionL-Glutamine · Glutamine (Form: as L-Glutamine)120 mgper 3 Vegi-Capsule(s)DSLD:205996
- Genesis Today'sImmunity Blend. Blackberry Lemonade1,000 mgper 6 Gram(s)DSLD:255953
- Genestra BrandsAmino L-Glutamine500 mgper 1 Capsule(s)DSLD:203075
- Genestra BrandsAmino L-Glutamine500 mgper 1 Capsule(s)DSLD:265476
- Genestra BrandsAmino L-Glutamine Powder4.5 Gram(s)per 4.5 Gram(s)DSLD:228845
- Genestra BrandsFOS + L-Glutamine1,500 mgper 5 Capsule(s)DSLD:203087
- Genestra BrandsHMB Complex Natural Citrus Flavor7 Gram(s)per 33.6 Gram(s)DSLD:231724
- Genestra BrandsHMF Neuro Capsules250 mgper 1 Capsule(s)DSLD:265531
- Genestra BrandsHMF Neuro Powder500 mgper 1 Gram(s)DSLD:231439
- Genestra BrandsPEA GI Support100 mgper 3 Capsule(s)DSLD:267731
- GNCDaily Immune Support Powder Mix Mixed Berry3 Gram(s)per 5.15 Gram(s)DSLD:243053
- GNCL-Glutamine 1000 mg1,000 mgper 1 Caplet(s)DSLD:227853
- GNCMultivitamin50 mgper 2 Beige Caplet(s)DSLD:260119
- GNC Beyond RawRe-Built Mass Cookies & Cream100 mgper 246 Gram(s)DSLD:19494
- GNC Beyond RawRe-Built Mass Cookies & Cream100 mgper 246 Gram(s)DSLD:19504
- GNC Beyond RawRe-Built Mass Strawberry Milkshake100 mgper 246 Gram(s)DSLD:19483
- GNC Beyond RawRe-Grow Double ChocolateL-Glutamine, Micronized · Glutamine (Form: As Whey Protein Isolate, Micronized Whey Protein Concentrate, Whey Protein Concentrate, Micronized L-Glutamine, Milk Protein Concentrate, Milk Protein Isolate, Hydrolyzed Whey Peptides)10 gper 114 Gram(s)DSLD:12834
- GNC Beyond RawRe-Grow Vanilla Ice CreamL-Glutamine, Micronized · Glutamine (Form: As Whey Protein Isolate, Micronized Whey Protein Concentrate, Whey Protein Concentrate, Micronized L-Glutamine, Milk Protein Concentrate, Milk Protein Isolate, Hydrolyzed Whey Peptides)10 gper 114 Gram(s)DSLD:19499
- GNC Beyond Raw Chemistry LabsElectrolytes1 Gram(s)per 3.6 Gram(s)DSLD:183349
- GNC Mega MenMuscle Recovery & Support500 mgper 1 White Caplet(s)DSLD:315849
- GNC Mega MenOne Daily MultiL-Glutamine5 mgper 1 Caplet(s)DSLD:304647
- GNC Men'sL-Glutamine1,000 mgper 1 White Caplet(s)DSLD:191086
- GNC Pro PerformanceHybrid Creatine Complex Fruit Punch500 mgper 48.17 Gram(s)DSLD:25606
- GNC Pro PerformanceHybrid Creatine Complex Unflavored500 mgper 48.64 Gram(s)DSLD:27358
- GNC Pro PerformanceL-Glutamine 5000 mg5 Gram(s)per 5 Gram(s)DSLD:175392
- GNC Pro PerformanceL-Glutamine 5000 mg Unflavored5 Gram(s)per 5 Gram(s)DSLD:183524
- GNC Pro PerformanceL-Glutamine 5000 mg Unflavored5 Gram(s)per 5 Gram(s)DSLD:220100
- GNC Pro PerformanceL-Glutamine Powder5 gper 5 Gram(s)DSLD:2711
- GNC Pro PerformanceL-Glutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:259731
- GNC Pro PerformanceL-Glutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:261071
- GNC Pro PerformanceProtein Advance XR Chocolate Supreme5 Gram(s)per 20.35 Gram(s)DSLD:25624
- GNC Pro PerformanceProtein Advance XR Vanilla Cream5 Gram(s)per 20.1 Gram(s)DSLD:25694
- GNC Pro PerformanceRapidDrive Glutamine 5000 Fruit Punch5,000 mgper 6 Gram(s)DSLD:2724
- GNC Pro PerformanceRapidDrive Post-Workout Amino Complex Fruit Punch3,000 mgper 17 Gram(s)DSLD:2723
- GNC Pro PerformanceUltra Amino Complex Fruit Punch100 mgper 14.07 Gram(s)DSLD:16385
- GNC Pro PerformanceUltra Amino Complex Fruit Punch100 mgper 14.07 Gram(s)DSLD:207201
- GNC Pro PerformanceUltra Amino Complex Watermelon100 mgper 13.98 Gram(s)DSLD:25704
- GNC Pro Performance AMPAmplified Endurance Booster Blue Raspberry250 mgper 60 Gram(s)DSLD:18529
- GNC Pro Performance AMPAmplified Glutamine Complex3 Gram(s)per 4 Tablet(s)DSLD:18478
- GNC Probiotic SolutionsProbiotic Solutions Sport 25 Billion CFUs150 mgper 1 Capsule(s)DSLD:259595
- GNC Triple StrengthFish Oil Sport500 mgper 2 Softgel(s)DSLD:1651
- Gundry MDTotal Restore213 mgper 3 Capsule(s)DSLD:210836
- Gut ResponseStress Probiotic250 mgper 1 Caplet(s)DSLD:307901
- H!D Hallelujah DietBrain Health SupportL-Glutamine Note: free form250 mgper 2 Tablet(s)DSLD:240434
- HealFastPost-Op & Injury Recovery Support Formula600 mgper 4 Tablet(s)DSLD:176433
- HealFastPre-Op Healing Optimization Formula600 mgper 3 Tablet(s)DSLD:176426
- Health PlusTurmeric Digest Curcumin50 mgper 1 Capsule(s)DSLD:255923
- Healthy OriginsL-Glutamine5 Gram(s)per 5 Gram(s)DSLD:269369
- HerbadietL-GlutamineFree-Form500 mgper 1 Capsule(s)DSLD:257717
- HerbadietL-Glutamine1,000 mgper 2 Capsule(s)DSLD:293586
- HerbaMeFull Vitality300 mgper 2 Capsule(s)DSLD:291592
- Higher NatureGlutamine1,000 mgper 2 Capsule(s)DSLD:223456
- Higher NatureGlutamine1,000 mgper 2 Capsule(s)DSLD:275923
- Higher NatureGlutamine1,000 mgper 2 Capsule(s)DSLD:304538
- Higher NatureGlutamine Powder900 mgper 0.25 Teaspoon(s)DSLD:245621
- Higher NatureGlutamine Powder900 mgper 0.25 tspDSLD:275904
- Higher NatureGlutamine Powder900 mgper 0.25 Teaspoon(s)DSLD:304539
- Higher NatureLiver Support100 mgper 2 Tablet(s)DSLD:217204
- Higher NaturePositive Outlook500 mgper 2 Capsule(s)DSLD:217119
- Higher NaturePositive Outlook500 mgper 2 Capsule(s)DSLD:240549
- Higher NaturePositive Outlook500 mgper 2 Capsule(s)DSLD:245754
- Higher NaturePositive Outlook500 mgper 2 Capsule(s)DSLD:245757
- HoltraCeuticalsGut Feeling212.5 mgper 2 Capsule(s)DSLD:19445
- HoltraCeuticalsGut Feeling MaxL-Glutamine Note: USP2,500 mgper 52.06 Gram(s)DSLD:19452
- Home HealthPre-Natal Multi-Vitamin Multi-Mineral Supplement8 mgper 2 Tablet(s)DSLD:19369
- Huge NutritionBCAA Kiwi Bluebery5,000 mgper 19.3 Gram(s)DSLD:299798
- IF Intestinal FortitudeGLR-6800 mgper 4 Vegetarian Capsule(s)DSLD:229801
- ILN Iron Labs NutritionAC8 Fruit Punch Flavour1,000 mgper 8 Gram(s)DSLD:289160
- ILN Iron Labs NutritionAC8 Pre Workout Blue Raspberry Flavour1,000 mgper 8 Gram(s)DSLD:286922
- ILN Iron Labs NutritionArginine200 mgper 4 Capsule(s)DSLD:286929
- ILN Iron Labs NutritionArginine XXL200 mgper 4 Capsule(s)DSLD:286930
- ILN Iron Labs NutritionGlutamine3,000 mgper 1 Tablet(s)DSLD:286936
- ILN Iron Labs NutritionVX8 Blue Raspberry Flavour2,000 mgper 15.3 Gram(s)DSLD:286943
- Image Sports4D Pump Artic IceGlutamine Alpha-Ketoglutarate · Glutamine (Form: as glutamine alpha ketoglutarate, and trans-alanyl glutamine)500 mgper 11 Gram(s)DSLD:31225
- Image Sports4D Pump Red LemonadeGlutamine Alpha-Ketoglutarate · Glutamine (Form: as glutamine alpha ketoglutarate, and trans-alanyl glutamine)500 mgper 11 Gram(s)DSLD:31270
- Image SportsATP Fruit PunchMagnesium Glycyl Glutamine · Glutamine (Form: as as magnesium glycyl glutamine)amount not statedper 5.495 Gram(s)DSLD:18350
- IMSOALPHAAlpha Carb Fruit Punch1,000 mgper 33 Gram(s)DSLD:216984
- IMSOALPHABCAA Grape1,000 mgper 6.5 Gram(s)DSLD:256162
- IMSOALPHABCAA Lemon Lime1,000 mgper 6.5 Gram(s)DSLD:256180
- IMSOALPHABCAA Watermelon1,000 mgper 6.5 Gram(s)DSLD:256183
- IMSOALPHAPure Glutamine5,000 mgper 5 Gram(s)DSLD:217325
- Infinite LabsInfinite Mass Chocolate5 Gram(s)per 67 Gram(s)DSLD:31196
- Infinite LabsInfinite Mass Vanilla5 Gram(s)per 67 Gram(s)DSLD:31197
- InfoWars LifeGut Fusion2,000 mgper 9 Gram(s)DSLD:218844
- InfoWars LifeVitamin Mineral Fusion Fruit Punch Flavor100 mgper 8.02 Gram(s)DSLD:218950
- Innate Response FormulasClear Response Vanilla500 mgper 27 Gram(s)DSLD:177902
- Innate Response FormulasGI Response5,000 mgper 7.9 Gram(s)DSLD:308998
- INNOSUPPSNatural BCAA + EAA Mango Twistfermented2.5 Gram(s)per 12.9 Gram(s)DSLD:303193
- INNOSUPPSNatural BCAA Candy Applefermented2.5 Gram(s)per 14.4 Gram(s)DSLD:303192
- Innovus PharmaceuticalsPEVArx52 mgper 1 Capsule(s)DSLD:181987
- InstaflexMuscle Support500 mgper 3 Capsule(s)DSLD:2434
- Integrative TherapeuticsDetoxication Factors66 mgper 1 Capsule(s)DSLD:242307
- Integrative TherapeuticsDetoxication Factors66 mgper 1 Capsule(s)DSLD:242311
- Integrative TherapeuticsDetoxication Factors66 mgper 1 Capsule(s)DSLD:292740
- Integrative TherapeuticsDetoxication Factors66 mgper 1 Capsule(s)DSLD:292741
- Integrative TherapeuticsGlutamine Forte Lemon Lime Flavored5 Gram(s)per 6.7 Gram(s)DSLD:223190
- Integrative TherapeuticsGlutamine Forte Lemon Lime Flavored5 Gram(s)per 6.7 Gram(s)DSLD:269912
- Integrative TherapeuticsPermeability Factors500 mgper 1 Softgel(s)DSLD:265948
- Integrative TherapeuticsVitaline Neuro-Essentials250 mgper 2 Caplet(s)DSLD:24221
- Intelligent LabsAdult Multivitamin50 mgper 1 Tablet(s)DSLD:313150
- IsodiolBioactive Sleep Shot Dreamberry380 mgper 1.93 Fluid Ounce(s)DSLD:219608
- Jacked Factory Essential SeriesL-Glutamine 5000 mg Unflavored5,000 mgper 5 Gram(s)DSLD:257770
- Jarrow FormulasL-Glutamine 1000 mg1,000 mgper 1 Tablet(s)DSLD:307639
- Jarrow FormulasL-Glutamine 2 grams2 Gram(s)per 2 Gram(s)DSLD:307640
- Jarrow FormulasL-Glutamine 750 mg750 mgper 1 Capsule(s)DSLD:307638
- Jarrow FormulasNeuro Optimizer500 mgper 4 Capsule(s)DSLD:307705
- JayLab ProMind Matrix150 mgper 1 Capsule(s)DSLD:250469
- JYM Supplement SciencePost JYM BCAAs+ Recovery Matrix Blue Arctic Freeze3 Gram(s)per 21 Gram(s)DSLD:216080
- KagedGlutamine Unflavoredfermented5 Gram(s)per 5 Gram(s)DSLD:298712
- Kaged MuscleGlutamine UnflavoredL-Glutamine Note: fermented5 Gram(s)per 5 Gram(s)DSLD:202312
- Kaged MuscleGlutamine UnflavoredL-Glutamine Note: fermented5 Gram(s)per 5 Gram(s)DSLD:202314
- KALMagnesium 500 mg100 mgper 1 Tablet(s)DSLD:286787
- KaraMDVital Restore1,000 mgper 3 Veggie Capsule(s)DSLD:243837
- Kaya NaturalsImmune Support200 mgper 2 Veggie Capsule(s)DSLD:295370
- KirkmanAmino Support Powder290 mgper 1 tspDSLD:23882
- KirkmanEveryDay Multi-Vitamin40 mgper 2 Capsule(s)DSLD:24537
- KirkmanEveryDay Multi-Vitamin40 mgper 2 Capsule(s)DSLD:24552
- KirkmanEveryDay Multi-Vitamin W/O Vitamins A & D40 mgper 2 Capsule(s)DSLD:24554
- KirkmanGastro Support500 mgper 6 Capsule(s)DSLD:24578
- KirkmanL-Glutamine 250 mg250 mgper 1 Capsule(s)DSLD:297053
- Klean AthleteKlean Essential Aminos+HMB Natural Orange Cream Flavor2 Gram(s)per 9.15 Gram(s)DSLD:237098
- Lake Avenue NutritionL-Glutamine 1000 mgFree-Form, 1,000 mg1 Gram(s)per 1 Veggie Capsule(s)DSLD:272399
- Lake Avenue NutritionL-Glutamine 5,000 mgFree-Form, 5,000 mg5 Gram(s)per 5 Gram(s)DSLD:272391
- Lee Haney's Nutritional Support SystemsCompetitive Mass2,500 mgper 65 Gram(s)DSLD:12990
- LidtkeL-GlutamineL-Glutamine Note: (JP, USP, EP) (As certified by the manufacturer.)3,000 mgper 1 Level Teaspoon(s)DSLD:257197
- LidtkeL-Glutamine 550 mgL-Glutamine Note: (JP, USP, EP) (As certified by the manufacturer.)550 mgper 1 Capsule(s)DSLD:257269
- LidtkeL-Glutamine 550 mgJP, USP, EP, As certified by the manufacturer.550 mgper 1 Capsule(s)DSLD:261011
- Life Extension Wellness CodeAdvanced Whey Protein Isolate Vanilla Flavor3 Gram(s)per 23 Gram(s)DSLD:182615
- Life Extension Wellness CodeAdvanced Whey Protein Isolate Vanilla Flavor3 Gram(s)per 23 Gram(s)DSLD:232794
- LifeBiomeGut SootheGlutamine Note: from fermentation3 Gram(s)per 1 Stick Pack(s)DSLD:241042
- LifeBiomeGut SootheGlutamine Note: from fermentation3 Gram(s)per 1 Stick Pack(s)DSLD:241045
- Longevity PremierImmune 4.8 Billion CFU200 mgper 2 Vegetable Capsule(s)DSLD:277546
- Love Me NutritionEvery Breath You Take200 mgper 2 Veggie Capsule(s)DSLD:306597
- LuckyVitaminL-Glutamine 500 mgfree-form500 mgper 1 Veg Capsule(s)DSLD:283207
- LuckyVitaminL-Glutamine Pure Powderfree-form, 5,000 mg5 Gram(s)per 5 Gram(s)DSLD:283208
- LumidayLumiday Youth Rejuvenator Lavender Lemon Flavor2,000 mgper 13.1 Gram(s)DSLD:250023
- Magnum NutraceuticalsMagnum GPharmaceutical Grade Fermented5 Gram(s)per 5 Gram(s)DSLD:263135
- Market AmericaAdvanced Fiber Powder1,000 mgper 12.2 Gram(s)DSLD:30043
- Market AmericaVitaMind45 mgper 2 Tablet(s)DSLD:313428
- Martin Avenue PharmacyAmino Acids Formula15.3 mgper 1 Tablet(s)DSLD:18766
- Martin Avenue PharmacyIntestinal Health Support With L-Glutamine & N-Acetyl Glucosamine563 mgper 2 Capsule(s)DSLD:19454
- Martin Avenue PharmacyL-Glutamine 500 mg500 mgper 1 Tablet(s)DSLD:18910
- Martin Avenue PharmacyL-Glutamine Powder4,500 mgper 1 tspDSLD:18911
- Mason NaturalLiver Detox150 mgper 2 Tablet(s)DSLD:244692
- MeijerL-Glutamine 500 mg500 mgper 1 Tablet(s)DSLD:271864
- MET-RxMET-Rx Protein Plus Chocolate3 Gram(s)per 31 Gram(s)DSLD:241114
- MET-RxMET-Rx Protein Plus Vanilla3 Gram(s)per 28.5 Gram(s)DSLD:241121
- MET-Rx 180(0)Recovery Shake Chocolate750 mgper 42 Gram(s)DSLD:15765
- MET-Rx 180(0)Recovery Shake Vanilla750 mgper 42 Gram(s)DSLD:15757
- Metabolic MaintenanceAnxiety Control140 mgper 2 Capsule(s)DSLD:24731
- Metabolic MaintenanceAnxiety Control Plus140 mgper 2 Capsule(s)DSLD:273984
- Metabolic MaintenanceL-Glutamine500 mgper 1 Capsule(s)DSLD:24897
- Metabolic MaintenanceL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:274046
- Metabolic MaintenanceL-Glutamine Powder1,000 mgper 1 Gram(s)DSLD:24898
- Metabolic MaintenanceL-Glutamine Powder1,000 mgper 1 Gram(s)DSLD:24900
- Metabolic MaintenanceL-Glutamine Powder1,000 mgper 1 Scoop(s)DSLD:274052
- Metabolic MaintenanceL-Glutamine Powder1,000 mgper 1000 mgDSLD:274055
- Metabolic MaintenanceMetabolic Detox Complete Natural Chocolate1,000 mgper 50 Gram(s)DSLD:274837
- Metabolic MaintenanceMetabolic Detox Complete Natural Vanilla1,000 mgper 50 Gram(s)DSLD:274189
- MetagenicsGut Care for Kids Pineapple Flavour1 Gram(s)per 5 Gram(s)DSLD:305328
- MetagenicsUltraClear Macro500 mgper 10 Gram(s)DSLD:27827
- MetagenicsUltraClear Plus Natural Berry Flavor100 mgper 22 Gram(s)DSLD:265119
- MetagenicsUltraClear Plus pH Pineapple Banana Flavor100 mgper 11.5 Gram(s)DSLD:216620
- MetagenicsUltraClear Plus pH Vanilla Flavor100 mgper 11 Gram(s)DSLD:295874
- MetagenicsUltraClear Plus pineapple banana flavor100 mgper 42 Gram(s)DSLD:210111
- MetagenicsUltraClear Plus Vanilla Flavor100 mgper 10.5 Gram(s)DSLD:295875
- MetagenicsUltraClear Renew Natural Berry Flavor150 mgper 18 Gram(s)DSLD:295876
- MetagenicsUltraClear Renew Natural Chai Flavor150 mgper 36 Gram(s)DSLD:265595
- MetagenicsUltraClear Renew Vanilla Flavor150 mgper 9 Gram(s)DSLD:265519
- MHP Maximum Human PerformanceUp Your Mass XXXL 1350 Milk ChocolateAmino Acid Enhanced, Fast Acting & Sustained Release Protein Blendamount not statedper 347.5 Gram(s)DSLD:274372
- Micro IngredientsGlutamine Powder3 Gram(s)per 3 Gram(s)DSLD:256690
- MicroTech Professional FormulationsOral Chelate6.6 mgper 4 Capsule(s)DSLD:214862
- MillecorGlutamine5,000 mgper 5 Gram(s)DSLD:299268
- MMUSAMuscle Maker Strawberry50 mgper 5 mLDSLD:308330
- MMUSAMuscle Rescue Strawberry50 mgper 5 mLDSLD:308331
- MontiffPure L-GlutamineL-Glutamine Note: amino acid500 mgper 1 Capsule(s)DSLD:237049
- MontiffPure L-GlutamineL-Glutamine Note: amino acid250 Gram(s)per 0.5 tspDSLD:237053
- MontiffSuper Antioxidant20 mgper 1 Capsule(s)DSLD:237078
- MontiffSuper-Sportsamount not statedper 1 Capsule(s)DSLD:237087
- MontiffSuper-Sports 750 Milligramsamount not statedper 1 Capsule(s)DSLD:293563
- Moss NutritionGI Meal Select Chocolate1,750 mgper 18.3 Gram(s)DSLD:248001
- Moss NutritionL-Glutamine Powder5 Gram(s)per 5 Gram(s)DSLD:275533
- Mountain Meadow HerbsWeight Control Caps2,000 mgper 8 Capsule(s)DSLD:267505
- MRMBCAA+G Green Apple1,000 mgper 6.5 Gram(s)DSLD:178962
- MRMBCAA+G RELOAD LemonadeL-Glutamine Note: fermented2,000 mgper 13.8 Gram(s)DSLD:178976
- MRM NutritionBCAA+G 1000 Green Apple Flavoredfermented1,000 mgper 6.5 Gram(s)DSLD:305015
- MRM NutritionBCAA+G Lemonade FlavoredFermented1,000 mgper 6.5 Gram(s)DSLD:305017
- MRM NutritionL-Glutamine 1000fermented5,000 mgper 5 Gram(s)DSLD:305115
- MTN OPSBCAA Strawberry Dragonfruit3 Gram(s)per 12 Gram(s)DSLD:277540
- MTN OPSMagnum Chocolate Coconut Flavor1,500 mgper 38 Gram(s)DSLD:277543
- MTN OPSYeti Blue Raspberry400 mgper 14.7 Gram(s)DSLD:277898
- Muscle FeastFree Form Glutamine UnflavoredFree form6,000 mgper 6 Gram(s)DSLD:259916
- Muscle FeastFree Form Glutamine UnflavoredFree form6,000 mgper 6 Gram(s)DSLD:262375
- Musclegen Performance NutritionAnabolism1,300 mgper 1 Packet(s)DSLD:213507
- Musclegen Performance NutritionBCAA Watermelon1,000 mgper 6.5 Gram(s)DSLD:249692
- Musclegen Performance NutritionElite-Intra Atomic Fruit Blast1 Gram(s)per 18 Gram(s)DSLD:220775
- Musclegen Performance NutritionZ-TropinL-Glutamine Note: as free form300 mgper 2 Capsule(s)DSLD:213610
- MuscleGen Performance NutritionAnabolism1,300 mgper 1 Packet(s)DSLD:211546
- MusclePharm MP EssentialsGlutamine Powder Unflavored5 Gram(s)per 5 Gram(s)DSLD:265438
- MusclePharm MP EssentialsGlutamine Powder Unflavored5 Gram(s)per 5 Gram(s)DSLD:267285
- MuscleTechMass Tech Cookies and CreamCalcium Caseinate15 Gram(s)per 230 Gram(s)DSLD:267879
- MyoFXGlutamine FX5,000 mgper 5 Gram(s)DSLD:240249
- MyProteinL Glutamine Unflavored5 Gram(s)per 1 tspDSLD:206206
- NatrolNight800 mgper 1 Tablet(s)DSLD:203170
- NatrolNight800 mgper 1 Tablet(s)DSLD:257112
- NatrolNight800 mgper 1 Tablet(s)DSLD:274872
- NatrolSleep 'n Restore800 mgper 1 Tablet(s)DSLD:306536
- Natural ClinicianClinical Digestion300 mgper 1 Capsule(s)DSLD:18620
- Natural FactorsDetoxitech500 mgper 39.5 Gram(s)DSLD:220563
- Natural FactorsDetoxitech500 mgper 39.5 Gram(s)DSLD:282152
- Natural FactorsMicronized L-Glutamine 5000 mgmicronized L-Glutamine Note: pharmaceutical grade5 Gram(s)per 5 Gram(s)DSLD:282200
- Natural FactorsMicronized L-Glutamine 5000 mg Powdermicronized L-Glutamine Note: pharmaceutical grade5 Gram(s)per 5 Gram(s)DSLD:179187
- Natural FactorsRevitalX1,000 mgper 31 Gram(s)DSLD:220570
- Natural FactorsRevitalX1,000 mgper 31 Gram(s)DSLD:282151
- Natural FactorsRevitalX1,000 mgper 31 Gram(s)DSLD:282627
- Natural FactorsRevitalX Step 11,000 mgper 31 Gram(s)DSLD:220576
- Natural FactorsStep 2 Detoxitech500 mgper 39.5 Gram(s)DSLD:220578
- Natural Factors CurcuminRichMuscle Recovery & Growth CurcumizerL-Glutamine Note: micronized5 Gram(s)per 5.2 Gram(s)DSLD:220380
- Natural Factors CurcuminRichTheracurmin & L-GlutamineL-Glutamine Note: micronized5,000 mgper 5.2 Gram(s)DSLD:247486
- Natural Grocers by Vitamin CottageL-Glutamine 500 mg500 mgper 1 Vegetarian Capsule(s)DSLD:256745
- Natural Healthy ConceptsGut Concepts3 Gram(s)per 5.8 Gram(s)DSLD:230774
- Natural NutraL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:246977
- Natural NutraShow Me The Whey Natural Vanilla Flavor75 mgper 21 Gram(s)DSLD:247189
- Natural RhythmDigestive Calm Probiotic80 mgper 2 Delayed Release Vegetable Capsule(s)DSLD:271255
- Nature's SunshineFree Amino Acids140 mgper 2 Tablet(s)DSLD:255231
- Nature's SunshineL-Glutamine1,000 mgper 2 Capsule(s)DSLD:278140
- Nature's SunshineUltraBiome DTX Herbal Citrus Flavor2,500 mgper 1 Packet(s)DSLD:313184
- Nature's Sunshine IN.FORMPurify2,500 mgper 13 Gram(s)DSLD:208539
- Natures PlusDyno VitesL-Glutamine Note: free form amino acid25 mgper 2 Tablet(s)DSLD:227966
- NaturesPlusGH MALEFree-Form Amino Acid125 mgper 2 Capsule(s)DSLD:303941
- NaturesPlusGI Natural Total Digestive WellnessL-Glutamine Note: free form amino acid4,000 mgper 5.8 Gram(s)DSLD:249661
- NaturesPlusGI Natural Total Digestive WellnessL-glutamine Note: (free form amino acid) (Pharmaceutical grade)1,000 mgper 3 Bi-Layered Tablet(s)DSLD:249677
- NaturesPlusSource of Life Men with Saw Palmetto, Lycopene & Luteinfree form amino acid10 mgper 2 Tablet(s)DSLD:298465
- NaturesPlusSugar Controlfree form amino acid100 mgper 1 Capsule(s)DSLD:298769
- New SunAdvanced BrainL-Glutamine Note: free-form125 mgper 1 Vegetarian Capsule(s)DSLD:202878
- New SunAdvanced BrainL-Glutamine Note: free-form125 mgper 1 Veg Capsule(s)DSLD:244890
- NewtonEverettAminoForce62 mgper 1 Capsule(s)DSLD:292148
- NewtonEverettGlucoRexL-Glutamine Note: free-form167 mgper 1 Vegetarian Capsule(s)DSLD:213280
- NewtonEverettNoxadrene Extreme1,000 mgper 7 Tablet(s)DSLD:213154
- NewtonEverettProdrene Cinnamon Vanilla Flavor2,500 mgper 65 Gram(s)DSLD:213146
- NewtonEverettTestrogain RX-100500 mgper 3 Vegetarian Capsule(s)DSLD:292199
- NFHGI Repair SAP1,500 mgper 10 mLDSLD:273620
- NFHL-Glutamine SAP5 Gram(s)per 5 Gram(s)DSLD:273203
- Northbound NutritionHydroHolic Coconut Water Amino Acids Fishbowl Punch250 mgper 7.1 Gram(s)DSLD:200615
- Northbound NutritionHydroHolic Coconut Water Amino Acids Lemon Shake Up250 mgper 7.1 Gram(s)DSLD:200621
- Northbound NutritionHydroHolic Coconut Water Amino Acids Taffy Twist250 mgper 7.1 Gram(s)DSLD:200623
- NOWBrain Elevatefree-form125 mgper 1 Veg Capsule(s)DSLD:313623
- NOWBrain Elevatefree-form125 mgper 1 Veg Capsule(s)DSLD:315772
- NOWGlucose Metabolic Supportfree-form167 mgper 1 Veg Capsule(s)DSLD:314359
- NOWL-Glutamine 500 mgfree-form500 mgper 1 Veg Capsule(s)DSLD:314417
- NOW SportsBCAA Big 6 Natural GrapeL-Glutamine Note: 1,000 mg1 Gram(s)per 19 Gram(s)DSLD:314243
- NOW SportsElectro Endurance Natural Orange FlavorL-Glutamine Note: free-form1 Gram(s)per 45 Gram(s)DSLD:205226
- NOW SportsElectro Endurance Orange FlavorL-Glutamine Note: free-form1 gper 45 Gram(s)DSLD:13117
- NOW SportsL-Glutamine 1000 mgfree-form, 1,000 mg1 Gram(s)per 1 Veg. Capsule(s)DSLD:314473
- NOW SportsL-Glutamine 1000 mgfree-form, 1,000 mg1 Gram(s)per 1 Veg. Capsule(s)DSLD:314474
- NOW SportsL-Glutamine Powderfree-form, 5,000 mg5 Gram(s)per 5 Gram(s)DSLD:314477
- NOW SportsPro-GH Fruit Punch Flavor2 Gram(s)per 18 Gram(s)DSLD:210369
- NOW SportsR&R Rest and Repair300 mgper 3 Veg Capsule(s)DSLD:303939
- NugenixGH-Boost Tea-Berry Blast2,000 mgper 13 Gram(s)DSLD:252329
- NugenixNugenix GH-Boost Tea-Berry Blast2,000 mgper 12.5 Gram(s)DSLD:249996
- Number One NutritionElderberry+200 mgper 2 Capsule(s)DSLD:316437
- NuMedicaTotal Vegan Chocolate Delight500 mgper 44.3 Gram(s)DSLD:182568
- NuMedicaTotal Vegan Delicious Mocha500 mgper 44.5 Gram(s)DSLD:217594
- NuMedicaTotal Vegan Natural Vanilla500 mgper 42 Gram(s)DSLD:182582
- NusaPureL-Glutamine 1000 mgL-Glutamine Note: free form1,000 mgper 2 Veg Capsule(s)DSLD:274990
- Nutra SportBCAA Watermelon Flavor3 Gram(s)per 1 Scoop(s)DSLD:249641
- Nutra SportPerformance Protein Natural Vanilla Flavor75 mgper 21 Gram(s)DSLD:249468
- NutraBioCGT Max Tropical Fruit PunchL-Glutamine Note: (Kyowa Quality) (fermented)4 Gram(s)per 12.3 Gram(s)DSLD:248205
- NutraBioIntra Blast Blueberry LemonadeKyowa Quality, HPLC5 Gram(s)per 22.78 Gram(s)DSLD:309321
- NutraChampsNeura-Spark25 mgper 1 Capsule(s)DSLD:228944
- NutraKeyGlutamine 9000 mg9,000 mgper 9 Gram(s)DSLD:287405
- Nutrex ResearchAmino Drive Black Bruisin' Berry1,500 mgper 14 Gram(s)DSLD:29971
- Nutrex ResearchAmino Drive Black Gashin' Grape1,500 mgper 14.2 Gram(s)DSLD:29973
- Nutrex ResearchAmino Drive Black Malicious Melon1,500 mgper 13.7 Gram(s)DSLD:29975
- Nutrex ResearchGlutamine Drive Unflavored5 Gram(s)per 5 Gram(s)DSLD:176208
- Nutrex Research Black SeriesGlutamine Drive Unflavored5 Gram(s)per 5 Gram(s)DSLD:176210
- Nutrex Research Black SeriesGlutamine Drive Unflavored5 Gram(s)per 5 Gram(s)DSLD:203784
- Nutri-WestComplete Gluco-D30 mgper 1 Tablet(s)DSLD:27601
- Nutri-WestComplete Glutathione15 mgper 1 Tablet(s)DSLD:27612
- Nutri-WestDSF-Herbal15 mgper 1 Tablet(s)DSLD:27685
- Nutri-WestL-Glutamine Plus500 mgper 1 Tablet(s)DSLD:28011
- Nutri-WestRNA-DNA Plus25 mgper 1 Tablet(s)DSLD:28235
- Nutri-WestTotal Brain10 mgper 1 Tablet(s)DSLD:28326
- Nutri-WestTotal Leaky Gut150 mgper 1 Tablet(s)DSLD:28641
- Nutri-WestTotal Systemic D-Tox33.33 mgper 1 Capsule(s)DSLD:29063
- Nutri-WestTotal TM15 mgper 1 Tablet(s)DSLD:215146
- Nutri-WestTotal Trim15 mgper 1 Tablet(s)DSLD:29071
- Nutri-WestTotal Upper GI50 mgper 1 Tablet(s)DSLD:28711
- NutriCleanAdvanced Fiber Powder1 Gram(s)per 11.4 Gram(s)DSLD:298750
- NutriCleanAdvanced Fiber Powder1 Gram(s)per 11.4 Gram(s)DSLD:298753
- NutriCologyBrainAid125 mgper 1 Tablet(s)DSLD:235524
- NutriCologyBrainAid125 mgper 1 Tablet(s)DSLD:258518
- NutriCologyDetox & Nourish500 mgper 40 Gram(s)DSLD:258534
- NutriCologyDetox & Nourish500 mgper 40 Gram(s)DSLD:258538
- NutriCologyDietEz1 Gram(s)per 2 Gram(s)DSLD:235644
- NutriCologyL-Glutamine1 Gram(s)per 1 Capsule(s)DSLD:235296
- NutriCologyL-Glutamine4.7 Gram(s)per 4.7 Gram(s)DSLD:258601
- NutriCologyL-Glutamine 800 mg1.6 Gram(s)per 1 Capsule(s)DSLD:235394
- NutriCologyPerm A vite Powder2 Gram(s)per 6.3 Gram(s)DSLD:234755
- NutriCologySuper Immuno Complex28 mgper 1 Packet(s)DSLD:183928
- NutricostL-Glutamine 5 g Blue Raspberry5,000 mgper 7 Gram(s)DSLD:308240
- NutricostL-Glutamine 5 g Fruit Punch5 Gram(s)per 7 Gram(s)DSLD:308241
- NutricostL-Glutamine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:306318
- NutricostL-Glutamine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:308238
- NutricostL-Glutamine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:308239
- NutricostL-Glutamine 800 mg800 mgper 1 Capsule(s)DSLD:306319
- Nutricost PerformanceIntra Blue Raspberry1,000 mgper 22 Gram(s)DSLD:311733
- Nutricost PerformanceIntra Peach Mango1,000 mgper 21 Gram(s)DSLD:311734
- Nutricost PerformanceIntra Pink Lemonade1,000 mgper 22 Gram(s)DSLD:306235
- Nutrients for HealthCognidyne150 mgper 1 Capsule(s)DSLD:229508
- NutriFlairImmune Support200 mgper 2 Vegetable Capsule(s)DSLD:268834
- NutriRiseSuper Immunity Complete Complex300 mgper 3 Capsule(s)DSLD:257165
- NutriSuppzEmergency Immune Support200 mgper 2 Veggie Capsule(s)DSLD:268876
- Nutrition EssentialsNeuro Clarity150 mgper 2 Capsule(s)DSLD:271766
- okitaGut Powder2,500 mgper 5 Gram(s)DSLD:309218
- OL Olympian LabsCalm120 mgper 3 Capsule(s)DSLD:259748
- ON Optimum NutritionBanana500 mgper 334 Gram(s)DSLD:268890
- ON Optimum NutritionChocolate500 mgper 334 Gram(s)DSLD:268887
- ON Optimum NutritionGlutamine 1000 Caps1 Gram(s)per 1 Capsule(s)DSLD:25920
- ON Optimum NutritionGlutamine 1000 Caps1 Gram(s)per 1 Capsule(s)DSLD:29077
- ON Optimum NutritionGlutamine Powder Unflavored5 gper 5 Gram(s)DSLD:17583
- ON Optimum NutritionGlutamine Powder Unflavored5 gper 5 Gram(s)DSLD:17585
- ON Optimum NutritionGlutamine Powder Unflavored5 Gram(s)per 5.15 Gram(s)DSLD:218626
- ON Optimum NutritionGlutamine Powder Unflavored5 Gram(s)per 5.15 Gram(s)DSLD:270344
- ON Optimum NutritionPre-Load Creatine Complex Fruit Punch2 gper 1 Scoop(s)DSLD:13927
- ON Optimum NutritionPro BCAA & 5 g Glutamine Support Fruit Punch5 Gram(s)per 19.5 Gram(s)DSLD:240086
- ON Optimum NutritionSerious Mass Strawberry500 mgper 167 Gram(s)DSLD:270153
- ON Optimum NutritionStrawberry500 mgper 334 Gram(s)DSLD:268889
- ON Optimum NutritionVanilla500 mgper 334 Gram(s)DSLD:268888
- OneBodeBuildMagnesium Glycyl Glutamine Chelate · Glutamine (Form: as magnesium glycyl glutamine chelate)950 mgper 5 Capsule(s)DSLD:12764
- Optimal AlphaAlpha Vegan Natural Chocolate3,475 mgper 34 Gram(s)DSLD:218313
- Optimal AlphaAlpha Vegan Natural Vanilla3,475 mgper 34 Gram(s)DSLD:218307
- Optimum NutritionAfter Max Chocolate Sunday5 gper 97 Gram(s)DSLD:17573
- Optimum NutritionAfter Max Vanilla Ice Cream5 gper 95 Gram(s)DSLD:17574
- Optimum NutritionSerious Mass Banana500 mgper 336 Gram(s)DSLD:268268
- Optimum NutritionSerious Mass Banana500 mgper 334 Gram(s)DSLD:308432
- Optimum NutritionSerious Mass Chocolate500 mgper 336 Gram(s)DSLD:260023
- Optimum NutritionSerious Mass Chocolate Peanut Butter500 mgper 168 Gram(s)DSLD:270149
- Optimum NutritionSerious Mass Strawberry500 mgper 168 Gram(s)DSLD:270140
- Optimum NutritionSerious Mass Vanilla500 mgper 168 Gram(s)DSLD:270138
- Optimum Nutrition Glutamine Caps 1 Gram1 Gram(s)per 2 Capsule(s)DSLD:258969
- Ormus MineralsGastric - Gut Supportamount not statedper 2 Capsule(s)DSLD:269138
- Orphic NutritionImmune Booster200 mgper 2 Capsule(s)DSLD:285528
- Ortho Molecular ProductsCore SupportL-Glutamine Note: USP150 mgper 39 Gram(s)DSLD:175667
- Ortho Molecular ProductsCore Support ChocolateL-Glutamine Note: USP150 mgper 37 Gram(s)DSLD:177778
- Ortho Molecular ProductsCore Support ChocolateUSP150 mgper 37 Gram(s)DSLD:294165
- Ortho Molecular ProductsCore Support ChocolateUSP150 mgper 35.3 Gram(s)DSLD:313461
- Ortho Molecular ProductsCore Support French VanillaL-Glutamine Note: USP150 mgper 35 Gram(s)DSLD:177704
- Ortho Molecular ProductsCore Support French VanillaUSP150 mgper 37.5 Gram(s)DSLD:294157
- Ortho Molecular ProductsCore Support French VanillaUSP150 mgper 33.8 Gram(s)DSLD:313460
- Ortho Molecular ProductsGlutaShield ChocolateL-Glutamine Note: USP4 Gram(s)per 1 Scoop(s)DSLD:175468
- Ortho Molecular ProductsGlutaShield VanillaL-Glutamine Note: USP4 Gram(s)per 1 Scoop(s)DSLD:175478
- Ortho Molecular ProductsInflammaCORE Banana CremeL-Glutamine Note: USP2.5 Gram(s)per 50.5 Gram(s)DSLD:177605
- Ortho Molecular ProductsInflammaCORE Chocolate MintUSP2.5 Gram(s)per 52.8 Gram(s)DSLD:275960
- Ortho Molecular ProductsInflammaCORE Natural CherryL-Glutamine Note: USP2.5 Gram(s)per 52.4 Gram(s)DSLD:177597
- Ortho Molecular ProductsInflammaCORE Orange SplashL-Glutamine Note: USP2.5 Gram(s)per 50.6 Gram(s)DSLD:177602
- Ortho Molecular ProductsInflammaCORE StrawberryUSP2.5 Gram(s)per 51.8 Gram(s)DSLD:275961
- Ortho Molecular ProductsInflammaCORE Vanilla ChaiUSP2.5 Gram(s)per 50.5 Gram(s)DSLD:275389
- Ortho Molecular ProductsInflammaCORE Vanilla ChaiUSP2.5 Gram(s)per 45.8 Gram(s)DSLD:313465
- Ortho Molecular ProductsMucosagenL-Glutamine Note: USP750 mgper 2 Capsule(s)DSLD:174488
- Ortho Molecular ProductsMucosagenL-Glutamine Note: USP750 mgper 2 Capsule(s)DSLD:174498
- PacificHealth LaboratoriesEndurox R4 Chocolate420 mgper 74 Gram(s)DSLD:18394
- PacificHealth LaboratoriesEndurox R4 Chocolate420 mgper 74 Gram(s)DSLD:18413
- PacificHealth LaboratoriesEndurox R4 Fruit Punch420 mgper 75 Gram(s)DSLD:18383
- PacificHealth LaboratoriesEndurox R4 Fruit Punch420 mgper 75 Gram(s)DSLD:18411
- PacificHealth LaboratoriesEndurox R4 Lemon Lime420 mgper 75 Gram(s)DSLD:18414
- PacificHealth LaboratoriesEndurox R4 Tangy Orange420 mgper 75 Gram(s)DSLD:18390
- PacificHealth LaboratoriesEndurox R4 Tangy Orange420 mgper 75 Gram(s)DSLD:18406
- PacificHealth LaboratoriesEndurox R4 Vanilla420 mgper 74 Gram(s)DSLD:18410
- Pathway To HealingImmunity Support125 mgper 2 Capsule(s)DSLD:31564
- Patient One 1 MediNutritionalsGastroOne Natural Orange Flavor3 Gram(s)per 5.94 Gram(s)DSLD:276254
- PerqueEndura / PAK Guard CapsulesL-Glutamine Note: free form1,500 mgper 3 Capsule(s)DSLD:18726
- PerqueEndura / PAK Guard CapsulesL-Glutamine Note: free form1,500 mgper 3 Capsule(s)DSLD:18727
- PerqueEndura/PAK GuardL-Glutamine Note: free form1,500 mgper 3 Capsule(s)DSLD:240726
- PerqueEndura/PAK GuardL-Glutamine Note: free form1,500 mmgper 3 Capsule(s)DSLD:240740
- PEScienceTruGlutamineFermented5 Gram(s)per 5 Gram(s)DSLD:297635
- PharmaxHLC MindLinx Capsules250 mgper 1 Capsule(s)DSLD:267668
- PharmaxHLC MindLinx Powder500 mgper 1 Gram(s)DSLD:238913
- PharmaxProbiotics with Nutrients400 mgper 1 Capsule(s)DSLD:288286
- Pharmaxa LabsProvasil45 mgper 1 Tablet(s)DSLD:306938
- Physician DesignedCopper Balance25 mgper 1 Capsule(s)DSLD:249562
- Physician DesignedMTHFR Renew25 mgper 2 Capsule(s)DSLD:249575
- PL Progressive LaboratoriesOne Step Unflavored125 mgper 32 Gram(s)DSLD:299206
- Power BlendzRecovery5,000 mgper 6.5 Gram(s)DSLD:263917
- Premier Research LabsPremier Glutamine500 mgper 1 Capsule(s)DSLD:269257
- Primal PharmBCAA Fruit Punch1,000 mgper 6.5 Gram(s)DSLD:276393
- Primal PharmBCAA Honeydew Watermelon1,000 mgper 6.5 Gram(s)DSLD:277565
- Primal PharmIMMUNE200 mgper 2 Vegetable Capsule(s)DSLD:276403
- Priority One Nutritional SupplementsL.G.S.500 mgper 2 Capsule(s)DSLD:277388
- Priority One Nutritional SupplementsSIBO-Rebuild750 mgper 3 Vegetarian Capsule(s)DSLD:310781
- pro:play Hydrationpro:play Hydration lemon Lime1,890 mgper 5.7 Gram(s)DSLD:240433
- Progressive Professional from Progressive LaboratoriesAmino Blend28 mgper 3 Capsule(s)DSLD:261202
- Progressive Professional from Progressive LaboratoriesGlutezyme190 mgper 1 Vegetable Capsule(s)DSLD:261225
- Progressive Professional from Progressive LaboratoriesL-Glutamine 1000 mg1,000 mgper 2 Capsule(s)DSLD:261878
- Progressive Professional from Progressive LaboratoriesL-Glutamine Powder5 Gram(s)per 5 Gram(s)DSLD:299197
- Progressive Professional from Progressive LaboratoriesOne Step Chocolate Flavor125 mgper 39 Gram(s)DSLD:299243
- Progressive Professional from Progressive LaboratoriesProbiotic MPF50 mgper 1 Capsule(s)DSLD:263138
- Progressive Professional from Progressive LaboratoriesVanadium Complex100 mgper 3 Vegetable Capsule(s)DSLD:263272
- Promuscle ProductsAmino 8:1:1+L-Glutamine Blue Raz Flavour18.2 Gram(s)per 1 Scoop(s)DSLD:211366
- Protocol For Life BalanceL-Glutamine Pure Powder5 Gram(s)per 1 Rounded Teaspoon(s)DSLD:258682
- PS ProSuppsGlutamine 3004,500 mgper 4.5 Gram(s)DSLD:218194
- PureL-Glutamine970 mgper 2 Capsule(s)DSLD:248695
- Pure AdvantagePure Glutamine Peptides5 Gram(s)per 5 Gram(s)DSLD:231506
- Pure EncapsulationsAmino RepleteL-Glutamine Note: free-form439 mgper 9 Gram(s)DSLD:184274
- Pure EncapsulationsAmino Repletefree-form439 mgper 4 Gram(s)DSLD:293886
- Pure EncapsulationsAmino-NRL-Glutamine Note: free-form338 mgper 3 Capsule(s)DSLD:245985
- Pure EncapsulationsAmino-NRFree-form338 mgper 3 Capsule(s)DSLD:293887
- Pure EncapsulationsAthletic Pure PackL-Glutamine Note: free-form1,000 mgper 9 Capsule(s)DSLD:182730
- Pure EncapsulationsAthletic Pure Packfree-form850 mgper 1 Packet(s)DSLD:299029
- Pure EncapsulationsDaily Pure Pack Healthy Gutfree-form850 mgper 3 Capsule(s)DSLD:293950
- Pure EncapsulationsDetox Pure PackL-Glutamine Note: free-form225 mgper 1 Packet(s)DSLD:246080
- Pure EncapsulationsEpi-Integrity PowderL-Glutamine Note: free form2.4 Gram(s)per 5.7 Gram(s)DSLD:277671
- Pure EncapsulationsG.I. FortifyL-Glutamine Note: free-form1 Gram(s)per 8.9 Gram(s)DSLD:184942
- Pure EncapsulationsG.I. Fortify (Capsules)L-Glutamine Note: free-form500 mgper 3 Capsule(s)DSLD:246102
- Pure EncapsulationsG.I. IntegrityL-Glutamine Note: free-form1,000 mgper 2 Capsule(s)DSLD:182925
- Pure EncapsulationsG.I. IntegrityL-Glutamine Note: free-form1,000 mgper 2 Capsule(s)DSLD:184924
- Pure EncapsulationsL-Glutamine 1,000 mgL-Glutamine Note: free-form1,000 mgper 1 Capsule(s)DSLD:182980
- Pure EncapsulationsL-Glutamine 1,000 mgL-Glutamine Note: free-form1,000 mgper 1 Capsule(s)DSLD:184513
- Pure EncapsulationsL-Glutamine 500 mgFree-Form500 mgper 1 Capsule(s)DSLD:293995
- Pure EncapsulationsL-Glutamine 850 mgFree-Form500 mgper 1 Capsule(s)DSLD:295520
- Pure EncapsulationsL-Glutamine 850 mgfree-form850 mgper 1 Capsule(s)DSLD:299060
- Pure EncapsulationsLiver-G.I. DetoxFree-Form225 mgper 2 Capsule(s)DSLD:294006
- Pure EncapsulationsLiver-G.I. DetoxFree-Form225 mgper 2 Capsule(s)DSLD:295526
- Pure EncapsulationsPureBi-Ome G.I.450 mgper 1 Capsule(s)DSLD:245992
- Pure EncapsulationsUltraDetox 10-Day Pure PackL-Glutamine Note: free form225 mgper 9 Capsule(s)DSLD:247322
- Pure Essence Real-ZymesKeto25 mgper 1 Capsule(s)DSLD:231141
- Pure Essence Real-ZymesKeto25 mgper 1 Capsule(s)DSLD:253156
- Pure Essence Real-ZymesOmnivore25 mgper 1 Capsule(s)DSLD:253180
- Pure Essence Real-ZymesOmnivore25 mgper 1 Capsule(s)DSLD:253183
- Pure Essence Real-ZymesVegan25 mgper 1 Capsule(s)DSLD:253202
- Pure Essence Real-ZymesVegan25 mgper 1 Capsule(s)DSLD:253203
- Pure Essence Real-ZymesVegetarian25 mgper 1 Capsule(s)DSLD:253201
- Pure TheraPro RxLeaky Gut Defense3 Gram(s)per 1.4 Gram(s)DSLD:305954
- Pure TheraPro RxLeaky Gut Defense3 Gram(s)per 5.6 Gram(s)DSLD:305955
- PureBulk.comL-Glutamine1,000 mgper 500 mgDSLD:23138
- PureBulk.comL-Glutamine Alpha-KetoglutarateL-Glutamine Alpha-Ketoglutarate · L-Glutamine (Form: as L-Glutamine Alpha Ketoglutarate)867 mgper 650 mgDSLD:23139
- PureFormulasGluthaSoothe1.5 Gram(s)per 8 Gram(s)DSLD:205604
- Puritan's PrideL-Glutamine 500 mgfree form2,000 mgper 4 Tablet(s)DSLD:286173
- RapidCBDSleep Shot Dreamberry380 mgper 1.93 fl. Oz.DSLD:247258
- RealDoseRealMeal GF Natural Chocolate FlavorTotal Glutamine Value3.9 Gram(s)per 31.4 Gram(s)DSLD:182109
- RealDoseRealMeal GF Natural Vanilla FlavorTotal Glutamine Value3.9 Gram(s)per 34.8 Gram(s)DSLD:182865
- Renew LifeDigestMore Enzymes50 mgper 1 Capsule(s)DSLD:250867
- Renew LifeFloraBEAR For Kids Orange Flavor100 mgper 1 Tablet(s)DSLD:242864
- Renew LifeFloraMORE80 mgper 1 Capsule(s)DSLD:247418
- Renew LifeHeartburn Stop Enzyme Formula Raspberry Flavor150 mgper 1 Tablet(s)DSLD:250894
- Renew LifeIntestiNew5,000 mgper 5 Gram(s)DSLD:250898
- Renew LifeIntestiNew835 mgper 2 Capsule(s)DSLD:250900
- Return HealthyGlutathione Symmetry100 mgper 2 Capsule(s)DSLD:313313
- Revolution Nutrition Pro SeriesBCAA Splash Blue Raspberry1.25 Gram(s)per 5.5 Gram(s)DSLD:232598
- REVSCIRegains300 mgper 2 Capsule(s)DSLD:289168
- REVSCIRegains Max Muscle Mango2,000 mgper 10.5 Gram(s)DSLD:288809
- Rise-N-ShineBedtime Weight Loss150 mgper 1 Capsule(s)DSLD:313437
- Rise-N-ShineSnooze & Lose150 mgper 1 Capsule(s)DSLD:297125
- RunFit NutritionRunner's Performance Mix Fruit Punch Flavor75 mgper 10 Gram(s)DSLD:286060
- RunFit NutritionRunner's Recovery Mix Cinnamon Vanilla Flavor2,500 mgper 65 Gram(s)DSLD:286061
- RunFit NutritionRunner's Sleep Recovery100 mgper 2 Capsule(s)DSLD:286063
- Ryno PowerHydration Fuel Fruit Punch2.5 Gram(s)per 45 Gram(s)DSLD:231292
- Ryno PowerHydration Fuel Fruit Punch2.5 Gram(s)per 45 Gram(s)DSLD:231309
- Ryno PowerHydration Fuel Lemon-Lime2.5 Gram(s)per 45 Gram(s)DSLD:231311
- Ryno PowerHydration Fuel Lemon-Lime2.5 Gram(s)per 45 Gram(s)DSLD:231313
- S SculptNight Kit150 mgper 1 Capsule(s)DSLD:236801
- S.O LabsAlpha X10ND Ultra420 mgper 2.6 Gram(s)DSLD:306508
- SakaraMetabolism1,000 mgper 20 Gram(s)DSLD:250440
- SCI-MX NutritionBCAA Orange Flavour2 Gram(s)per 100 Gram(s)DSLD:263969
- ScivationXTEND Lemon Lime Sour2,500 mgper 12.8 Gram(s)DSLD:13369
- Seeking HealthL-Glutamine PowderL-Glutamine Note: USP5 Gram(s)per 5 Gram(s)DSLD:174485
- Seeking HealthL-Glutamine Powder5 Gram(s)per 5.85 Gram(s)DSLD:210852
- Seeking HealthOptimal Amino Blend12 mgper 1 Capsule(s)DSLD:210883
- Seeking HealthOptimal GI Powder1.5 mgper 6.8 Gram(s)DSLD:210952
- Sierra FitBCAA & Electrolytes Fruit Punch Flavor2.5 Gram(s)per 14.5 Gram(s)DSLD:272448
- Sierra FitBCAA & Electrolytes Mango2.5 Gram(s)per 14.5 Gram(s)DSLD:273054
- Sierra FitBCAA & Electrolytes Watermelon2.5 Gram(s)per 14.5 Gram(s)DSLD:273057
- SimplyBestProstamex Gold10 mgper 1 Tablet(s)DSLD:22076
- SimplyBestVitaMen Plus96 mgper 1 Tablet(s)DSLD:22587
- SimplySupplementsProstaform Plus100 mgper 1 Capsule(s)DSLD:22464
- SNAC NutritionPro-Night Chocolate3,000 mgper 34 Gram(s)DSLD:258510
- SNAC NutritionPro-Night Vanilla3,000 mgper 35.5 Gram(s)DSLD:258511
- SNAC NutritionProglycosyn Orange Cream3 Gram(s)per 59 Gram(s)DSLD:211842
- SNAC NutritionProglycosyn Vanilla Cream3 Gram(s)per 59 Gram(s)DSLD:211849
- SnugellImmune Defense200 mgper 2 Capsule(s)DSLD:273281
- SolgarCreatine Complex1 Gram(s)per 6 Tablet(s)DSLD:214026
- SomaLifeYouth Formula250 mgper 6 Capsule(s)DSLD:16517
- SomaLife InternationalgHP Sport250 mgper 6 Capsule(s)DSLD:16512
- Sonora NutritionMultivitamin for Men100 mgper 3 Capsule(s)DSLD:247436
- Soto SupplementsGFC 200+amount not statedper 10 Drop(s)DSLD:209984
- Source NaturalsBCAA400 mgper 3 Capsule(s)DSLD:209439
- Source NaturalsBCAA400 mgper 3 Capsule(s)DSLD:210778
- Source NaturalsBCAA400 mgper 3 Capsule(s)DSLD:214428
- Source NaturalsDiet-Metabo-766 mgper 1 Tablet(s)DSLD:214126
- Source NaturalsDiet-Metabo-766 mgper 1 Tablet(s)DSLD:214139
- Source NaturalsGluco-Science66 mgper 1 Tablet(s)DSLD:214217
- Source NaturalsHGH Surge500 mgper 5 Tablet(s)DSLD:273332
- Source NaturalsHigher Mind500 mgper 1 Tablet(s)DSLD:274666
- Source NaturalsL-Glutamine2 Gram(s)per 0.25 Teaspoon(s)DSLD:295937
- Source NaturalsL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:274769
- Source NaturalsL-Glutamine 500 mgfree form500 mgper 1 Capsule(s)DSLD:295939
- Source NaturalsMegaMind500 mgper 1 Tablet(s)DSLD:296055
- Source NaturalsMental Edge500 mgper 4 Tablet(s)DSLD:296084
- Spring ValleyL-Glutamine600 mgper 1 Capsule(s)DSLD:178386
- Spring ValleyL-Glutamine600 mgper 1 Capsule(s)DSLD:178401
- Spring ValleyL-Glutamine 500 mg500 mgper 1 Tablet(s)DSLD:12129
- Spring ValleyL-Glutamine 500 mgL-Glutamine Note: 1,000 mg1 Gram(s)per 2 Tablet(s)DSLD:239764
- SteelADABolic Candy Bliss3 Gram(s)per 37 Gram(s)DSLD:277714
- Steel NutritionSteel Chain Amino Acids Fruit Punch2,000 mgper 9 Gram(s)DSLD:240329
- SuperSmartL-Glutamine3 Gram(s)per 3 Gram(s)DSLD:315578
- Supplement SpotHealthy Brain150 mgper 1 Capsule(s)DSLD:264594
- SwansonBrain Essentials100 mgper 1 Veggie Capsule(s)DSLD:308484
- SwansonGlutathione Precursor Complex100 mgper 1 Capsule(s)DSLD:308516
- SwansonL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:308643
- SwansonVitality Renewal Formula1.5 mcgper 12 Drop(s)DSLD:206865
- Swiss BioEnergeticsL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:284285
- SwolverineL-Glutamine Unflavored5,000 mgper 5 Gram(s)DSLD:242062
- SyntraxAmino-Tor Blue Raspberry3,000 mgper 11 Gram(s)DSLD:228545
- SyntraxAmino-Tor Juicy Watermelon3,000 mgper 11 Gram(s)DSLD:228547
- SyntraxAmino-Tor Orange Citrus3,000 mgper 11 Gram(s)DSLD:228550
- SyntraxAmino-Tor Pink Lemonade3,000 mgper 11 Gram(s)DSLD:228551
- SyntraxAmino-Tor Strawberry Kiwi3,000 mgper 11 Gram(s)DSLD:228552
- SyntraxAmino-Tor Tangy Mango3,000 mgper 11 Gram(s)DSLD:228553
- SyntraxMatrix 1.0 Milk ChocolateGlutamine Note: Important Nonessential Amino Acid8.4 Gram(s)per 31 Gram(s)DSLD:228586
- SyntraxSuperGluL-Glutamine Note: USP5 Gram(s)per 5 Gram(s)DSLD:228746
- SyntraxSuperGLUUSP5 Gram(s)per 5 Gram(s)DSLD:299080
- Systemic FormulasAccell Therapeutic550 mgper 30 Gram(s)DSLD:22284
- Systemic FormulaseNRG LQ Quantum Cellular ATP Energyamount not statedper 0.5 Dropper(s)DSLD:22506
- Systemic FormulasEventa LQamount not statedper 0.5 Dropper(s)DSLD:22400
- Tapout Sports NutritionGlutamine5 gper 5 Gram(s)DSLD:2125
- Tapout Sports NutritionRecover Post Workout1 gper 66 Gram(s)DSLD:2126
- Taylor MD FormulationsGreenMed Rx5 Gram(s)per 8.19 Gram(s)DSLD:295217
- TennesseeTennessee Pre Smokey Mountain Lemonade5 Gram(s)per 1 Scoop(s)DSLD:268909
- Terra OriginHealthy Gut Berry5 Gram(s)per 8.1 Gram(s)DSLD:313237
- Terra OriginHealthy Gut Fennel5 Gram(s)per 7.9 Gram(s)DSLD:247923
- Terra OriginHealthy Gut Matcha Green Tea5 Gram(s)per 7.58 Gram(s)DSLD:304880
- Terra OriginHealthy Gut Matcha Green Tea5 Gram(s)per 7.58 Gram(s)DSLD:313240
- Terra OriginHealthy Gut Mint1.5 Gram(s)per 5.06 Gram(s)DSLD:242098
- Terra OriginHealthy Gut Mint5 Gram(s)per 7.4 Gram(s)DSLD:247932
- Terra OriginHealthy Gut Peach Banana5 Gram(s)per 7.8 Gram(s)DSLD:247934
- Terra OriginHealthy Gut Peach Banana5 Gram(s)per 7.8 Gram(s)DSLD:313241
- Terra OriginHealthy Gut Vegan Formula5 Gram(s)per 8.22 Gram(s)DSLD:313243
- The Asylum Cabinet by Insane LabzGlutamine Unflavored5 Gram(s)per 5 Gram(s)DSLD:298694
- The Enclare NutritionA6Burn150 mgper 1 Capsule(s)DSLD:276196
- The Enclare NutritionEmergency Immune System Support200 mgper 2 Vegan Capsule(s)DSLD:266456
- The Genius BrandGenius BCAA Power Orange3 Gram(s)per 13.8 Gram(s)DSLD:263173
- The Vitamin ShoppeCritical Aminos XT Strawberry Lemonade2,500 mgper 10.1 Gram(s)DSLD:183879
- The Vitamin ShoppeL-Glutamine 500 mgL-Glutamine Note: a free form amino acid500 mgper 1 Vegetable Capsule(s)DSLD:245279
- The Vitamin ShoppeL-Glutamine 500 mgL-Glutamine Note: a free form amino acid500 mgper 1 Vegetable Capsule(s)DSLD:245282
- The Vitamin ShoppeL-Glutamine Powder 4.5 gL-Glutamine Note: a free form amino acid4.5 Gram(s)per 4.5 Gram(s)DSLD:183778
- The Vitamin ShoppeL-Glutamine Powder 4.5 gL-Glutamine Note: a free form amino acid4.5 Gram(s)per 4.5 Gram(s)DSLD:183782
- ThorneMediClear Orange Vanilla Flavoredadded amino acids500 mgper 41.2 Gram(s)DSLD:313913
- TimeFightersSharp Thinking Ultra50 mgper 1 Tablet(s)DSLD:28751
- Tokkyo NutritionBCAA Stack Watermelon2,500 mgper 12.5 Gram(s)DSLD:180485
- Totally ProductsHGH-Up Hormone SupportL-Glutamine Hydrochloride300 mgper 2 Capsule(s)DSLD:294183
- Totally ProductsL-Glutamine 1000 mg1,000 mgper 1 Tablet(s)DSLD:294251
- True AthleteGlutamine SportL-Glutamine Note: fermented4 Gram(s)per 6.1 Gram(s)DSLD:207940
- True AthleteGlutamine SportL-Glutamine Note: fermented4,000 mgper 6.1 Gram(s)DSLD:221531
- True AthleteNatural Recovery Mixed Berry2,500 mgper 10.25 Gram(s)DSLD:217915
- True HealthDr. Cutler's Ultimate Digestion Formula50 mgper 1 Capsule(s)DSLD:16770
- TwinlabL-Glutamine500 mgper 1 Capsule(s)DSLD:268468
- Ultra PlanUltimate-Plus100 mgper 3 Tablet(s)DSLD:12951
- UniversalAmino 1900260 mgper 4 Tablet(s)DSLD:246059
- UniversalAmino 1900260 mgper 4 Tablet(s)DSLD:274619
- UniversalGH Max100 mgper 6 Tablet(s)DSLD:275376
- UniversalUniversal Amino 2700260 mgper 3 Tablet(s)DSLD:247363
- Universal NutritionUniversal Amino 2700260 mgper 3 Tablet(s)DSLD:274726
- Vega SportPerformance Protein Chocolate5,000 mgper 1.3 Ounce(s)DSLD:14863
- Vega SportPerformance Protein Vanilla5,000 mgper 1.2 Ounce(s)DSLD:14868
- Vera's FormulationsUpLift Pro12.5 mgper 1 Capsule(s)DSLD:256597
- ViMultiAnti-Aging Complex300 mgper 2 Capsule(s)DSLD:231118
- ViMultiMind Support150 mgper 1 Capsule(s)DSLD:231099
- ViMultiP.M. Weight LossL-Glutamine Hydrochloride · L-Glutamine (Form: as L-Glutamine HCl)150 mgper 1 Capsule(s)DSLD:231010
- ViMulti Beautiful MeSkinny DreamsL-Glutamine Hydrochloride150 mgper 1 Capsule(s)DSLD:230866
- Vital NutrientsDetox Formula250 mgper 2 Veg Capsule(s)DSLD:207469
- Vital NutrientsDetox Formula250 mgper 2 Vegetarian Capsule(s)DSLD:304974
- Vital NutrientsGI Repair Nutrients900 mgper 3 Vegetarian Capsule(s)DSLD:304988
- Vital NutrientsGlutamine 3400 mgUSP3,400 mgper 1 Vegetarian Capsule(s)DSLD:304992
- Vital NutrientsGlutamine 850 mg3,400 mgper 1 Vegetarian Capsule(s)DSLD:208223
- Vital NutrientsGlutamine Powder9,600 mgper 1 Rounded Teaspoon(s)DSLD:182330
- Vital NutrientsGlutamine Powder9,600 mgper 1 Rounded Teaspoon(s)DSLD:305043
- Vital PerformanceRECOVER Guava Lime970 mgper 36 Gram(s)DSLD:245646
- Vital PerformanceRECOVER Lemon Grape970 mgper 38 Gram(s)DSLD:245640
- Vital PerformanceRECOVER Watermelon Blueberry970 mgper 38 Gram(s)DSLD:245630
- Vital PerformanceRECOVER Yuzu Clementine970 mgper 38 Gram(s)DSLD:245614
- Vital ProteinsVitality Immune Booster Clementine2 Gram(s)per 15 Gram(s)DSLD:254297
- Vital ProteinsVitality Immune Booster Clementine2 Gram(s)per 15 Gram(s)DSLD:302836
- Vital ProteinsVitality Immune Booster Grape Citrus2 Gram(s)per 13 Gram(s)DSLD:302874
- Vital Proteins PerformanceRecoveryWAVE Lemon Grape970 mgper 38 Gram(s)DSLD:302834
- Vital Proteins PerformanceRecoveryWAVE Watermelon Blueberry970 mgper 38 Gram(s)DSLD:302835
- Vitamer LaboratoriesShow Me The Whey Natural Chocolate Flavor75 mgper 24 Gram(s)DSLD:23854
- Vitamer LaboratoriesShow Me The Whey Natural Chocolate Flavor75 mgper 24 Gram(s)DSLD:23948
- Vitamer LaboratoriesShow Me The Whey Natural Vanilla Flavor75 mgper 21.5 Gram(s)DSLD:23946
- Vitamin WorldL-Glutamine 500 mgL-Glutamine Free Form500 mgper 1 Tablet(s)DSLD:20281
- Vitamin WorldL-Glutamine 500 mgL-Glutamine Free Form500 mgper 1 Tablet(s)DSLD:20295
- VitanicaEndocrine Disruptor Relief250 mgper 2 Capsule(s)DSLD:302788
- VitaScriptProtein Balance Natural Vanilla Flavored75 mgper 21 Gram(s)DSLD:283132
- Viva VitaminsCerebro Smart200 mgper 1 Tablet(s)DSLD:237114
- Viva VitaminsPMA Positive Mental Attitude100 mgper 1 Veggie Cap(s)DSLD:238864
- Viva VitaminsPMA Positive Mental Attitude100 mgper 1 Capsule(s)DSLD:238867
- Viva VitaminsVegiSource Multivitamin10 mgper 3 Tablet(s)DSLD:20021
- Whole FoodsThink Smart with Gingko Biloba150 mgper 1 Capsule(s)DSLD:12093
- Wholly LiquidHealthy Gut2,500 mgper 1.5 Teaspoon(s)DSLD:272102
- Wonder LaboratoriesEyeguard30 mgper 1 Capsule(s)DSLD:260556
- Wonder LaboratoriesEyeguard20 mgper 1 Capsule(s)DSLD:262312
- Wonder LaboratoriesEyeguard30 mgper 1 Capsule(s)DSLD:315178
- Wonder LaboratoriesL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:215318
- Wonder LaboratoriesL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:215319
- Wonder LaboratoriesL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:260607
- Wonder LaboratoriesL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:262692
- Wonder LaboratoriesL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:215322
- Wonder LaboratoriesL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:215328
- Wonder LaboratoriesL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:262764
- Wonder LaboratoriesL-Glutamine Powder4,500 mgper 1 Heaping Teaspoon(s)DSLD:263088
- Wonder LaboratoriesVision All60 mgper 2 Capsule(s)DSLD:262384
- Woodstock VitaminsGI Soothe3 Gram(s)per 5.5 Gram(s)DSLD:263474
- Woodstock VitaminsL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:263066
- Woodstock VitaminsL-Glutamine 500 mg500 mgper 1 Capsule(s)DSLD:263067
- XTENDElite Citrus Passionfruit2,500 mgper 18 Gram(s)DSLD:228992
- XTENDElite Citrus Passionfruit2,500 mgper 18 Gram(s)DSLD:229004
- XTENDElite Fraserade2,500 mgper 18.5 Gram(s)DSLD:229746
- XTENDElite Island Punch Fusion2,500 mgper 18 Gram(s)DSLD:228941
- XTENDElite Island Punch Fusion2,500 mgper 18 Gram(s)DSLD:228998
- XTENDElite Sour Gummy Flavor2,500 mgper 18 Gram(s)DSLD:228986
- XTENDElite Sour Gummy Flavor2,500 mgper 18 Gram(s)DSLD:229001
- XTENDRipped Blueberry Lemonade2,500 mgper 16.5 Gram(s)DSLD:228723
- XTENDRipped Strawberry Kiwi Splash2,500 mgper 16.5 Gram(s)DSLD:228782
- XTENDRipped Watermelon Lime2,500 mgper 16.5 Gram(s)DSLD:228772
- XTENDThe Original Black Cherry2,500 mgper 13.5 Gram(s)DSLD:240942
- XTENDThe Original Blue Raspberry Ice2,500 mgper 14 Gram(s)DSLD:228580
- XTENDThe Original Blue Raspberry Ice2,500 mgper 14 Gram(s)DSLD:229101
- XTENDThe Original Blue Raspberry Ice2,500 mgper 14 Gram(s)DSLD:254294
- XTENDThe Original Blue Raspberry Ice2,500 mgper 14 Gram(s)DSLD:292457
- XTENDThe Original Blueberry Lemonade2,500 mgper 14.7 Gram(s)DSLD:295112
- XTENDThe Original Freedom Ice2,500 mgper 14 Gram(s)DSLD:295113
- XTENDThe Original Glacial Grape2,500 mgper 13.5 Gram(s)DSLD:228587
- XTENDThe Original Glacial Grape2,500 mgper 13.5 Gram(s)DSLD:295110
- XTENDThe Original Italian Blood Orange2,500 mgper 14.5 Gram(s)DSLD:244190
- XTENDThe Original Italian Blood Orange2,500 mgper 14.5 Gram(s)DSLD:292458
- XTENDThe Original Knockout Fruit Punch2,500 mgper 13.5 Gram(s)DSLD:228681
- XTENDThe Original Knockout Fruit Punch2,500 mgper 13.5 Gram(s)DSLD:278240
- XTENDThe Original Lemon-Lime Squeeze2,500 mgper 14 Gram(s)DSLD:295111
- XTENDThe Original Lemon-Lime Squeeze2,500 mgper 14 Gram(s)DSLD:296441
- XTENDThe Original Mango Madness2,500 mgper 14 Gram(s)DSLD:229150
- XTENDThe Original Mango Madness2,500 mgper 14 Gram(s)DSLD:295114
- XTENDThe Original Mango Madness2,500 mgper 14 Gram(s)DSLD:295115
- XTENDThe Original Smash Apple2,500 mgper 14 Gram(s)DSLD:228709
- XTENDThe Original Smash Apple2,500 mgper 14 Gram(s)DSLD:292459
- XTENDThe Original Strawberry Kiwi Splash2,500 mgper 14 Gram(s)DSLD:228712
- XTENDThe Original Strawberry Kiwi Splash2,500 mgper 14 Gram(s)DSLD:229145
- XTENDThe Original Strawberry Kiwi Splash2,500 mgper 14 Gram(s)DSLD:292461
- XTENDThe Original Strawberry Kiwi Splash2,500 mgper 14.7 Gram(s)DSLD:295116
- XTENDThe Original Tropic Thunder2,500 mgper 14 Gram(s)DSLD:228719
- XTENDThe Original Tropic Thunder2,500 mgper 14 Gram(s)DSLD:292460
- XTENDThe Original Watermelon Explosion2,500 mgper 13 Gram(s)DSLD:228538
- XTENDThe Original Watermelon Explosion2,500 mgper 13 Gram(s)DSLD:229114
- XTENDThe Original Watermelon Explosion2,500 mgper 13 Gram(s)DSLD:292462
- XtendlifeKiwi-Klenz300 mgper 2 Capsule(s)DSLD:318016
- XtendlifeNeuro-Natural Memory149 mgper 2 Tablet(s)DSLD:17031
- XtendlifeTotal Balance Unisex Premium100 mgper 6 Tablet(s)DSLD:283408
- XYMOGENGI Balance Powder Natural Chai Flavor4 Gram(s)per 13.7 Gram(s)DSLD:294725
- XYMOGENGI Protect Natural Cherry Flavor1 Gram(s)per 10.4 Gram(s)DSLD:218580
- XYMOGENGI Protect Natural Peach Flavor1 Gram(s)per 10 Gram(s)DSLD:218576
- XYMOGENGI Protect Natural Peach Flavor Sugar- and Stevia-Free2.5 Gram(s)per 5.8 Gram(s)DSLD:303695
- XYMOGENGlutAloeMine3 Gram(s)per 5.8 Gram(s)DSLD:303696
- XYMOGENGlutAloeMine3 Gram(s)per 5.8 Gram(s)DSLD:303697
- XYMOGENMedCaps GI250 mgper 2 Capsule(s)DSLD:303745
- Zen NutrientsPodiVite25 mgper 2 Capsule(s)DSLD:277221
- Zen NutrientsWoundVite25 mgper 2 Capsule(s)DSLD:277222
- ZHOUMuscle BCAA Tropical Punch2,000 mgper 11 Gram(s)DSLD:313669
- Zongle TherapeuticsGI-Renew1.5 Gram(s)per 8 Gram(s)DSLD:276602
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- L-glutamine
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
141 trials
141 registered trials without posted results · Overdue (FDAAA 801): 112 · Showing 120 of 141
112 past the window8 within it, or no actual date
- NCT07507344completed2026-07-20a university or hospital
- NCT07466758completed2026-03-04a university or hospital
- NCT05753774terminated— The study was terminated early because recruitment of eligible children with refractory functional abdominal pain disorders was slower than anticipated, and enrollment of the planned 50 participants was not feasible within the approved study period.2026-01-05a university or hospital
- NCT07020754completed2026-01-01a university or hospital
- NCT05655819completed2025-12-31a university or hospital
- NCT03275974terminated— \<75% participation2025-12-23a university or hospital
- NCT07442084completed2025-11-01a university or hospital
- NCT06031012completed2025-10-31a university or hospital
- NCT07210450completed2025-05-22a university or hospitalpast the reporting window
- NCT06039384terminated— This was a strategic business decision. There were no safety concerns contributing to this decision.2025-04-11industrypast the reporting window
- NCT05322135terminated— PI Request2025-03-07a university or hospitalpast the reporting window
- NCT03119883completed2024-06-30a university or hospitalpast the reporting window
Show the remaining 129
- NCT06764420completed2024-06-20a university or hospitalpast the reporting window
- NCT03461354terminated— Interim analysis indicated study closure2024-04-01a university or hospitalpast the reporting window
- NCT04353869completed2024-01-10a university or hospitalpast the reporting window
- NCT05954923completed2023-12-20a university or hospitalpast the reporting window
- NCT05822518completed2023-11-30a university or hospitalpast the reporting window
- NCT05592951completed2023-07-14a university or hospitalpast the reporting window
- NCT04634539completed2023-07-06a university or hospitalpast the reporting window
- NCT06004375completed2023-05-30a university or hospitalpast the reporting window
- NCT04471415terminated— Company decision to closing study and discontinue further patient enrollment.2023-03-28industrypast the reporting window
- NCT03967795completed2023-03-27a university or hospitalpast the reporting window
- NCT05371184completed2023-01-03a university or hospitalpast the reporting window
- NCT05106101completed2022-12-30industrypast the reporting window
- NCT03878381completed2022-10-29a university or hospitalpast the reporting window
- NCT04152473completed2022-08-31a university or hospitalpast the reporting window
- NCT02124941completed2022-08-14a university or hospitalpast the reporting window
- NCT05152849completed2022-06-21industrypast the reporting window
- NCT03445221completed2022-03-31a university or hospitalpast the reporting window
- NCT04265534terminated— Lack of Clinical Benefit2021-11-05industrypast the reporting window
- NCT04698681terminated— Lack of Clinical Benefit2021-11-05industrypast the reporting window
- NCT04909905completed2021-10-25a university or hospitalpast the reporting window
- NCT05061797completed2021-10-11industrypast the reporting window
- NCT04948138completed2021-09-09a university or hospitalpast the reporting window
- NCT04814602completed2021-08-30a university or hospitalpast the reporting window
- NCT04388371completed2021-06-30a university or hospitalpast the reporting window
- NCT04684381completed2021-06-30industrypast the reporting window
- NCT02037035completed2021-06a university or hospitalpast the reporting window
- NCT04912947completed2021-04-15industrypast the reporting window
- NCT06065566completed2021-02-04a government bodypast the reporting window
- NCT03933410terminated— Kaleido Biosciences, Inc. closed the K020-218 trial due to business reasons, and not due to any safety concerns.2021-02-02industrypast the reporting window
- NCT04701463completed2020-11-03a university or hospitalpast the reporting window
- NCT03697681completed2020-08-12a university or hospitalpast the reporting window
- NCT04274114terminated— Inhability to recruit further participants due to SARS-CoV-2 pandemics.2020-05-12a university or hospitalpast the reporting window
- NCT02780219completed2020-03-06a university or hospitalpast the reporting window
- NCT06801951completed2020-02-27a university or hospitalpast the reporting window
- NCT04019184completed2020-02-13a university or hospitalpast the reporting window
- NCT03525184completed2019-12-10US federal agencypast the reporting window
- NCT03851354completed2019-11-01a university or hospitalpast the reporting window
- NCT04047095completed2019-09-01a university or hospitalpast the reporting window
- NCT03133169completed2019-08-25a university or hospitalpast the reporting window
- NCT04442633completed2019-08-01a university or hospitalpast the reporting window
- NCT05023499completed2019-06-30a university or hospitalpast the reporting window
- NCT02071862completed2019-03industrypast the reporting window
- NCT03265509completed2018-09a university or hospitalpast the reporting window
- NCT02998931completed2018-08-25a university or hospitalpast the reporting window
- NCT03730545completed2018-07-01a university or hospitalpast the reporting window
- NCT03382015completed2018-06-30industrypast the reporting window
- NCT01838915completed2018-06a university or hospitalpast the reporting window
- NCT01552291completed2018-02-10a university or hospitalpast the reporting window
- NCT02733120completed2017-10-30a university or hospitalpast the reporting window
- NCT03113240completed2017-10-01a university or hospitalpast the reporting window
- NCT03685552completed2017-09-13industrypast the reporting window
- NCT03720015completed2017-07-24a university or hospitalpast the reporting window
- NCT03743896completed2017-03-10industrypast the reporting window
- NCT02801240completed2016-12-16a university or hospitalpast the reporting window
- NCT03589495completed2016-10-15a university or hospitalpast the reporting window
- NCT02071927completed2016-10industrypast the reporting window
- NCT03015077completed2016-08a university or hospitalpast the reporting window
- NCT01704430completed2016-06-21a university or hospitalpast the reporting window
- NCT03123432completed2016-06-01a university or hospitalpast the reporting window
- NCT03011593completed2016-06industrypast the reporting window
- NCT02053506completed2016-05US federal agencypast the reporting window
- NCT02071888completed2016-04industrypast the reporting window
- NCT03933709completed2015-12-18a university or hospitalpast the reporting window
- NCT01832636completed2015-12a university or hospitalpast the reporting window
- NCT02283190completed2015-12a university or hospitalpast the reporting window
- NCT03236532completed2015-12a university or hospitalpast the reporting window
- NCT02444780completed2015-09a university or hospitalpast the reporting window
- NCT02520440completed2015-07a university or hospitalpast the reporting window
- NCT02026609terminated— Lack of patient accrual2015-01-27a university or hospitalpast the reporting window
- NCT02491931completed2014-12a government bodypast the reporting window
- NCT01503320completed2014-10a university or hospitalpast the reporting window
- NCT02310035completed2014-09a university or hospitalpast the reporting window
- NCT03166956completed2014-08-31a university or hospitalpast the reporting window
- NCT02351323completed2014-08a university or hospitalpast the reporting window
- NCT01063738completed2014-03a university or hospitalpast the reporting window
- NCT01794884completed2014-03a university or hospitalpast the reporting window
- NCT01263041completed2014-02a university or hospitalpast the reporting window
- NCT05054517completed2013-12a university or hospitalpast the reporting window
- NCT03048994completed2013-06a university or hospitalpast the reporting window
- NCT01087658completed2013-03industrypast the reporting window
- NCT01478126completed2012-12a research networkpast the reporting window
- NCT02048410completed2012-09a university or hospitalpast the reporting window
- NCT02575313terminated— Lack of participant recruitment.2012-09a university or hospitalpast the reporting window
- NCT02575391terminated— Lack of participant recruitment.2012-09a university or hospitalpast the reporting window
- NCT01367223completed2012-07a university or hospitalpast the reporting window
- NCT01798342completed2012-06a university or hospitalpast the reporting window
- NCT02772861completed2012-05a university or hospitalpast the reporting window
- NCT01353638terminated— Primary endpoint (HSP) could not be analyzed with the specified method in the planned interim analysis; a method of increased sensitivity had to be established.2012-03a university or hospitalpast the reporting window
- NCT00455247completed2012-01industrypast the reporting window
- NCT00647036completed2011-12a university or hospitalpast the reporting window
- NCT01057082completed2011-12a university or hospitalpast the reporting window
- NCT01219608completed2011-06a university or hospitalpast the reporting window
- NCT00828399completed2011-05a university or hospitalpast the reporting window
- NCT01255696completed2011-05industrypast the reporting window
- NCT01092039completed2011-03industrypast the reporting window
- NCT01051999completed2011-02a university or hospitalpast the reporting window
- NCT02130674completed2011-02a university or hospitalpast the reporting window
- NCT01254110completed2011-01a university or hospitalpast the reporting window
- NCT01215396completed2010-10a university or hospitalpast the reporting window
- NCT00959114completed2010-08industrypast the reporting window
- NCT01060813completed2010-06a university or hospitalpast the reporting window
- NCT00255229completed2010-01a university or hospitalpast the reporting window
- NCT00502372terminated— VA never granted approval following suspension of enrollment.2010-01US federal agencypast the reporting window
- NCT00772824completed2009-12a university or hospitalpast the reporting window
- NCT00943020completed2009-11a university or hospitalpast the reporting window
- NCT00645879completed2009-08a university or hospitalpast the reporting window
- NCT00838149completed2008-08a university or hospitalpast the reporting window
- NCT01250080completed2008-06a university or hospitalpast the reporting window
Where it reaches
10 systems, 28 regions, 224 tissues, 431 transporter routes — routes, not measurements: transporters known to carry L-glutamine are expressed there, and no source reports it arriving.
Loading the model…
Papers screened
2,801 papers
- Compound
- L-glutamine
- Screened
- 2,801
- Admitted
- 15
- Discarded
- 1,812
- Not read
- 974
- Showing
- 200 of 2,801
Produced a finding15 papers
and 15 more.
Read and discarded1,812 papers
- PMID:11213895cited by PMID:23564914; not about the subject it would be filed under2026-10-15
- PMID:12610053cited by PMID:23564914; not about the subject it would be filed under2026-10-15
- PMID:19542012cited by PMID:23564914; not about the subject it would be filed under2026-10-15
- PMID:8862300cited by PMID:23564914; not about the subject it would be filed under2026-10-15
- PMID:9614672cited by PMID:23564914; not about the subject it would be filed under2026-10-15
- PMID:7995220no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-15
- PMID:10102909cited by PMID:22249475; not about the subject it would be filed under2026-10-15
- PMID:10419990cited by PMID:22249475; not about the subject it would be filed under2026-10-15
- PMID:10462619cited by PMID:22249475; not about the subject it would be filed under2026-10-15
- PMID:10586898cited by PMID:22249475; not about the subject it would be filed under2026-10-15
- PMID:10688201cited by PMID:22249475; not about the subject it would be filed under2026-10-15
- PMID:11118825cited by PMID:22249475; not about the subject it would be filed under2026-10-15
and 1,800 more.
Not read yet974 papers
- PMID:104661442026-10-15
- PMID:78055882026-10-15
- PMID:19082212026-10-13
- PMID:86661592026-10-13
- PMID:162567362026-10-12
and 969 more.
Measured, not recorded
- Compound
- L-glutamine
- Endpoints measured
- 1,741 endpoints
- Recorded as a finding
- No
Show what was measured
positive blood cultures (one or more)
no effect, RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5)
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:10796267 · one of two readings recorded this
positive blood cultures, proportion of infants with one or more
no effect, RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5)
Not recorded as a finding: no single self-supporting sentence names both the endpoint and the estimate; the endpoint is named in the preceding sentence and not repeated in the sentence carrying the numbers
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:10796267 · one of two readings recorded this
proportion of infants with one or more positive blood cultures (pooled across three trials)
no effect, RR 0.73 (95% CI 0.44 to 1.23); RD -8.8% (95% CI -23.2 to 5.5)
Not recorded as a finding: the sentence carrying the RR/RD result does not itself name the endpoint (named only in a preceding sentence); a claim needs a single self-supporting sentence
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:10796267 · one of two readings recorded this
proportion of infants with one or more positive blood cultures
no effect, RR 0.73 (95% CI 0.44 to 1.23); RD -8.8% (95% CI -23.2 to 5.5)
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:10796267 · one of two readings recorded this
positive blood cultures (one or more)
no effect, RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5)
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:11687112 · one of two readings recorded this
positive blood cultures, proportion of infants with one or more
no effect, RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5)
Not recorded as a finding: no single self-supporting sentence names both the endpoint and the estimate; the endpoint is named in the preceding sentence and not repeated in the sentence carrying the numbers
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:11687112 · one of two readings recorded this
proportion of infants with one or more positive blood cultures (pooled across three trials)
no effect, RR 0.73 (95% CI 0.44 to 1.23); RD -8.8% (95% CI -23.2 to 5.5)
Not recorded as a finding: the sentence carrying the RR/RD result does not itself name the endpoint (named only in a preceding sentence); a claim needs a single self-supporting sentence
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:11687112 · one of two readings recorded this
proportion of infants with one or more positive blood cultures
no effect, RR 0.73 (95% CI 0.44 to 1.23); RD -8.8% (95% CI -23.2 to 5.5)
Meta-analysis showed no significant difference between glutamine-supplemented and non-supplemented babies; RR = 0.73 (95% CI 0.44, 1.23), RD = -8.8% (95% CI -23.2, 5.5).
PMID:11687112 · one of two readings recorded this
hospital length of stay by patient-type subgroup (surgical vs critically ill patients)
decreases, -3.5 days (95% CI, -5.3 to -1.7) surgical vs 0.9 days (95% CI, -4.9 to 6.8) critically ill
Not recorded as a finding: subgroup-only finding; the pooled overall hospital-stay estimate is recorded separately as a claim
With respect to hospital length of stay, all of the treatment benefit was observed in surgical patients (-3.5 days; 95% CI, -5.3 to -1.7) compared with critically ill patients (0.9 days; 95% CI, -4.9 to 6.8).
PMID:12352035 · one of two readings recorded this
hospital length of stay by patient-type subgroup
decreases, -3.5 days (95% CI, -5.3 to -1.7) surgical vs 0.9 days (95% CI, -4.9 to 6.8) critically ill
With respect to hospital length of stay, all of the treatment benefit was observed in surgical patients (-3.5 days; 95% CI, -5.3 to -1.7) compared with critically ill patients (0.9 days; 95% CI, -4.9 to 6.8).
PMID:12352035 · one of two readings recorded this
hospital length of stay, critically-ill-patient subgroup
0.9 days (95% CI -4.9 to 6.8)
With respect to hospital length of stay, all of the treatment benefit was observed in surgical patients (-3.5 days; 95% CI, -5.3 to -1.7) compared with critically ill patients (0.9 days; 95% CI, -4.9 to 6.8).
PMID:12352035 · one of two readings recorded this
hospital length of stay, surgical-patient subgroup
decreases, -3.5 days (95% CI -5.3 to -1.7)
With respect to hospital length of stay, all of the treatment benefit was observed in surgical patients (-3.5 days; 95% CI, -5.3 to -1.7) compared with critically ill patients (0.9 days; 95% CI, -4.9 to 6.8).
PMID:12352035 · one of two readings recorded this
mortality (aggregated across 14 trials)
risk ratio (RR) of 0.78 (95% confidence interval [CI], 0.58-1.04)
Not recorded as a finding: sentence reports a signed risk ratio with no direction word; direction is not inferable from a signed estimate alone
When the results of these trials were aggregated, with respect to mortality, glutamine supplementation was associated with a risk ratio (RR) of 0.78 (95% confidence interval [CI], 0.58-1.04).
PMID:12352035 · one of two readings recorded this
mortality (aggregated)
risk ratio (RR) of 0.78 (95% CI 0.58-1.04)
When the results of these trials were aggregated, with respect to mortality, glutamine supplementation was associated with a risk ratio (RR) of 0.78 (95% confidence interval [CI], 0.58-1.04).
PMID:12352035 · one of two readings recorded this
mortality, risk ratio (pooled overall)
risk ratio (RR) of 0.78 (95% confidence interval [CI], 0.58-1.04)
Not recorded as a finding: direction not stated in words for the overall pooled mortality estimate, only a bare risk ratio is given
When the results of these trials were aggregated, with respect to mortality, glutamine supplementation was associated with a risk ratio (RR) of 0.78 (95% confidence interval [CI], 0.58-1.04).
PMID:12352035 · one of two readings recorded this
mortality
risk ratio (RR) of 0.78 (95% CI, 0.58-1.04)
When the results of these trials were aggregated, with respect to mortality, glutamine supplementation was associated with a risk ratio (RR) of 0.78 (95% confidence interval [CI], 0.58-1.04).
PMID:12352035 · one of two readings recorded this
cost in critically ill patients
decreases
Glutamine-enriched diets showed good overall tolerance, improvement of immunologic aspects in multiple trauma patients, cost reduction in critically ill patients, and improvement of mucositis in post-chemotherapy patients (grade B recommendations).
PMID:12921894 · one of two readings recorded this
immunologic aspects in multiple trauma patients
increases
Glutamine-enriched diets showed good overall tolerance, improvement of immunologic aspects in multiple trauma patients, cost reduction in critically ill patients, and improvement of mucositis in post-chemotherapy patients (grade B recommendations).
PMID:12921894 · one of two readings recorded this
mucositis in post-chemotherapy patients
decreases
Glutamine-enriched diets showed good overall tolerance, improvement of immunologic aspects in multiple trauma patients, cost reduction in critically ill patients, and improvement of mucositis in post-chemotherapy patients (grade B recommendations).
PMID:12921894 · one of two readings recorded this
overall tolerance, immunologic aspects (multiple trauma), cost (critically ill), and mucositis (post-chemotherapy)
grade B recommendations
Glutamine-enriched diets showed good overall tolerance, improvement of immunologic aspects in multiple trauma patients, cost reduction in critically ill patients, and improvement of mucositis in post-chemotherapy patients (grade B recommendations).
PMID:12921894 · one of two readings recorded this
overall tolerance of glutamine-enriched diets
increases
Glutamine-enriched diets showed good overall tolerance, improvement of immunologic aspects in multiple trauma patients, cost reduction in critically ill patients, and improvement of mucositis in post-chemotherapy patients (grade B recommendations).
PMID:12921894 · one of two readings recorded this
neurodevelopmental outcomes including Bayley scales at 18 months corrected age, one trial (Poindexter 2004)
no effect
Not recorded as a finding: no matching outcome node for neurodevelopmental assessment; also a single-trial subgroup rather than the pooled population
The investigators reported that they did not find any statistically significant differences in various assessments of neurodevelopment (including Bayley scales) on follow up at 18 months corrected age.
PMID:15674878 · one of two readings recorded this
neurodevelopmental outcomes including Bayley scales at 18 months corrected age (single trial, Poindexter 2004)
no effect
Not recorded as a finding: no outcome node for composite neurodevelopmental assessment; single-trial result, not a whole-population estimate
The investigators reported that they did not find any statistically significant differences in various assessments of neurodevelopment (including Bayley scales) on follow up at 18 months corrected age.
PMID:15674878 · one of two readings recorded this
neurodevelopmental outcomes including Bayley scales at 18 months corrected age (single trial)
no effect
The investigators reported that they did not find any statistically significant differences in various assessments of neurodevelopment (including Bayley scales) on follow up at 18 months corrected age.
PMID:15674878 · one of two readings recorded this
neurodevelopmental outcomes including Bayley scales at 18 months corrected age
no effect
The investigators reported that they did not find any statistically significant differences in various assessments of neurodevelopment (including Bayley scales) on follow up at 18 months corrected age.
PMID:15674878 · one of two readings recorded this
fat mass
no effect, p = 0.14
fat mass (WMD = -1.50, 95%CI [-3.48, 0.48], P=0.14)
PMID:15734715 · one of two readings recorded this
lean body mass
increases, p = 0.0007
lean body mass (WMD = 2.16, 95%CI [0.91, 3.41], P=0.0007)
PMID:15734715 · one of two readings recorded this
absorption of carbohydrates
increases, p = 0.00001
absorption of carbohydrates (WMD = 6.21, 95%CI [5.27, 7.15], P< 0.00001)
PMID:15734715 · one of two readings recorded this
absorption of D-xylose
increases, p = 0.00001
absorption of D-xylose (WMD = 0.37, 95%CI [0.29, 0.44], P<0.00001)
PMID:15734715 · one of two readings recorded this
absorption of energy
no effect, p = 0.32
absorption of energy (WMD = 7.48, 95%CI [-7.22, 22.17], P=0.32)
PMID:15734715 · one of two readings recorded this
absorption of fat
no effect, p = 0.17
absorption of fat (WMD = 7.16, 95%CI [-2.95, 17.28], P=0.17)
PMID:15734715 · one of two readings recorded this
absorption of nitrogen
increases, p = 0.0002
absorption of nitrogen (WMD = 10.83, 95%CI [5.22, 16.44], P=0.0002)
PMID:15734715 · one of two readings recorded this
body weight
increases, p = 0.00001
body weight (weighted mean difference [WMD] = 2.44, 95%CI [1.62, 3.27], P<0.00001)
PMID:15734715 · one of two readings recorded this
off TPN (total parenteral nutrition)
increases, p = 0.00001
off TPN (total parenteral nutrition) (odds ratios [OR] = 64.63, 95%CI [15.51, 269.22], P<0.00001)
PMID:15734715 · one of two readings recorded this
stool output
decreases, p = 0.001
stool output (WMD = -376.49, 95%CI [-600.35, -152.63], P=0.001)
PMID:15734715 · one of two readings recorded this
brain glutamate+glutamine (Glu/Gln) combined resonance levels by proton magnetic resonance spectroscopy in adult bipolar disorder patients versus controls, across mood states
increases, Glu/Gln levels higher in bipolar patients across all mood states compared to controls
Not recorded as a finding: the compound is what was measured, not what was given
Glu/Gln levels in adult bipolar patients were higher in all mood states compared to controls.
PMID:16677749 · one of two readings recorded this
brain glutamate+glutamine (Glu/Gln) combined resonance levels by proton MRS
increases, higher in bipolar patients across all mood states versus controls
Glu/Gln levels in adult bipolar patients were higher in all mood states compared to controls.
PMID:16677749 · one of two readings recorded this
brain glutamate/glutamine (Glu/Gln) levels by proton magnetic resonance spectroscopy in adult bipolar disorder patients versus controls
increases
Not recorded as a finding: the compound is what was measured, not what was given
Glu/Gln levels in adult bipolar patients were higher in all mood states compared to controls.
PMID:16677749 · one of two readings recorded this
brain glutamate/glutamine (Glu/Gln) levels
increases
Glu/Gln levels in adult bipolar patients were higher in all mood states compared to controls.
PMID:16677749 · one of two readings recorded this
N-acetylaspartate (NAA) levels
decreases
NAA levels were lower in euthymic bipolar patients in the frontal lobe structures and hippocampus.
PMID:16677749 · one of two readings recorded this
development of infection in critical illness
decreases
The present systematic review has found trends to suggest that parenteral and enteral glutamine supplementation reduce mortality, the development of infection and organ failure in critical illness.
PMID:16923308 · one of two readings recorded this
infection in elective-surgery patients on parenteral nutrition
decreases
Trials of parenteral nutrition containing glutamine with patients after elective surgery also suggest reduction of infection, but it is unlikely that glutamine-containing parenteral nutrition would be used for such patients.
PMID:16923308 · one of two readings recorded this
infection in patients after elective surgery receiving glutamine-containing parenteral nutrition
decreases
Trials of parenteral nutrition containing glutamine with patients after elective surgery also suggest reduction of infection, but it is unlikely that glutamine-containing parenteral nutrition would be used for such patients.
PMID:16923308 · one of two readings recorded this
mortality in critical illness
decreases
The present systematic review has found trends to suggest that parenteral and enteral glutamine supplementation reduce mortality, the development of infection and organ failure in critical illness.
PMID:16923308 · one of two readings recorded this
mortality, infection, and organ failure in critical illness; infection in elective-surgery patients on parenteral nutrition
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
The present systematic review has found trends to suggest that parenteral and enteral glutamine supplementation reduce mortality, the development of infection and organ failure in critical illness.
PMID:16923308 · one of two readings recorded this
mortality, infection, and organ failure in critical illness
decreases
The present systematic review has found trends to suggest that parenteral and enteral glutamine supplementation reduce mortality, the development of infection and organ failure in critical illness.
PMID:16923308 · one of two readings recorded this
mortality, the development of infection and organ failure in critical illness
decreases
Not recorded as a finding: no estimate is reported anywhere
The present systematic review has found trends to suggest that parenteral and enteral glutamine supplementation reduce mortality, the development of infection and organ failure in critical illness.
PMID:16923308 · one of two readings recorded this
organ failure in critical illness
decreases
The present systematic review has found trends to suggest that parenteral and enteral glutamine supplementation reduce mortality, the development of infection and organ failure in critical illness.
PMID:16923308 · one of two readings recorded this
length of hospital stay
decreases, WMD -3.55 (95% CI -5.26 to -1.84), n = 373
shortening the length of hospital stay (WMD= -3.55, 95% CI [-5.26, -1.84], P < 0.00001)
PMID:17167847 · one of two readings recorded this
postoperative cumulative nitrogen balance
increases, WMD 8.35 (95% CI 2.98-13.71), p = 0.002, n = 373
The combined results showed that glutamine dipeptide has a positive effect in improving postoperative cumulative nitrogen balance (weighted mean difference (WMD = 8.35, 95% CI [2.98, 13.71], P = 0.002).
PMID:17167847 · one of two readings recorded this
postoperative infectious morbidity
decreases, OR 0.24 (95% CI 0.06-0.93), p = 0.04, n = 373
decreasing postoperative infectious morbidity (OR = 0.24, 95% CI [0.06, 0.93], P = 0.04)
PMID:17167847 · one of two readings recorded this
change in plasma reduced glutathione (GSH) from baseline to day 7
increases, p = 0.03
Gln-PN significantly improved the change in plasma levels of reduced GSH from baseline to day 7 in the non-pancreatic surgery patients (PN -0.27 microM versus Gln-PN +0.26 microM, P < 0.03)
PMID:18065204 · one of two readings recorded this
patients with below-normal baseline plasma alpha-tocopherol
n = 59
A smaller percentage of patients exhibited below-normal plasma alpha-tocopherol levels (21%)
PMID:18065204 · one of two readings recorded this
patients with below-normal baseline plasma glutathione
n = 59
a larger percentage of patients demonstrated below-normal baseline plasma concentrations of GSH (59%), vitamin C (59%), and zinc (68%), respectively
PMID:18065204 · one of two readings recorded this
patients with below-normal baseline plasma vitamin C
n = 59
a larger percentage of patients demonstrated below-normal baseline plasma concentrations of GSH (59%), vitamin C (59%), and zinc (68%), respectively
PMID:18065204 · one of two readings recorded this
patients with below-normal baseline plasma zinc
n = 59
a larger percentage of patients demonstrated below-normal baseline plasma concentrations of GSH (59%), vitamin C (59%), and zinc (68%), respectively
PMID:18065204 · one of two readings recorded this
plasma zinc
increases
Study PN significantly improved plasma zinc levels in the entire study group and in each surgical subgroup
PMID:18065204 · one of two readings recorded this
APACHE II score
decreases, p = 0.01
The 15-d APACHE II score was lower in the early treatment group than in the late treatment group (5.0 +/- 2.4 vs 8.6 +/- 3.6, P < 0.01)
PMID:18200673 · one of two readings recorded this
duration of acute hepatitis
decreases, p = 0.01
acute hepatitis (3.2 +/- 2.3 d vs 7.0 +/- 7.1 d, P < 0.01)
PMID:18200673 · one of two readings recorded this
duration of acute respiratory distress syndrome
decreases, p = 0.01
acute respiratory distress syndrome (2.7 +/- 3.3 d vs 12.7 +/- 21.0 d, P < 0.01)
PMID:18200673 · one of two readings recorded this
duration of encephalopathy
decreases, p = 0.01
encephalopathy (2.3 +/- 1.9 d vs 9.5 +/- 11.0 d, P < 0.01)
PMID:18200673 · one of two readings recorded this
duration of enteroparalysis
decreases, p = 0.01
enteroparalysis (2.2 +/- 1.4 d vs 3.5 +/- 2.2 d, P < 0.01)
PMID:18200673 · one of two readings recorded this
duration of renal failure
decreases, p = 0.01
renal failure (1.3 +/- 0.5 d vs 5.3 +/- 7.3 d, P < 0.01)
PMID:18200673 · one of two readings recorded this
duration of shock
decreases, p = 0.05
shock (1.7 +/- 0.4 d vs 4.8 +/- 3.1 d, P < 0.05)
PMID:18200673 · one of two readings recorded this
hospital stay
decreases, p = 0.01
hospital stay (28.8 +/- 9.4 d vs 45.2 +/- 27.1 d, P < 0.01)
PMID:18200673 · one of two readings recorded this
infection rate
decreases, p = 0.05
The infection rate (7.9% vs 26.3%, P < 0.05)
PMID:18200673 · one of two readings recorded this
mortality
decreases, p = 0.05
mortality (5.3% vs 21.1%, P < 0.05)
PMID:18200673 · one of two readings recorded this
operation rate
decreases, p = 0.05
operation rate (13.2% vs 34.2%, P < 0.05)
PMID:18200673 · one of two readings recorded this
all-cause mortality (horizon not stated)
no effect, typical relative risk 0.98 (95% CI 0.80 to 1.20); typical risk difference 0.00 (95% CI -0.03 to 0.02)
Glutamine supplementation does not have a statistically significant effect on mortality: typical relative risk 0.98 (95% confidence interval 0.80 to 1.20); typical risk difference 0.00 (95% confidence interval -0.03 to 0.02).
PMID:18253992 · one of two readings recorded this
all-cause mortality in very low birth weight preterm infants, pooled as typical relative risk and risk difference, with no follow-up horizon stated
no effect, typical relative risk 0.98 (95% CI 0.80 to 1.20); typical risk difference 0.00 (95% CI -0.03 to 0.02)
Not recorded as a finding: the paper never states the instrument the node requires
Glutamine supplementation does not have a statistically significant effect on mortality: typical relative risk 0.98 (95% confidence interval 0.80 to 1.20); typical risk difference 0.00 (95% confidence interval -0.03 to 0.02).
PMID:18253992 · one of two readings recorded this
all-cause mortality in very low birth weight preterm infants, pooled typical relative risk, meta-analysis of 7 RCTs (2365 infants)
no effect, typical relative risk 0.98 (95% confidence interval 0.80 to 1.20)
Not recorded as a finding: the paper never states the instrument the node requires
Glutamine supplementation does not have a statistically significant effect on mortality: typical relative risk 0.98 (95% confidence interval 0.80 to 1.20); typical risk difference 0.00 (95% confidence interval -0.03 to 0.02).
PMID:18253992 · one of two readings recorded this
invasive infection, necrotising enterocolitis, time to achieve full enteral nutrition, duration of hospital stay
no effect
Glutamine supplementation does not have a statistically significant effect on other neonatal morbidities including invasive infection, necrotising enterocolitis, time to achieve full enteral nutrition, or duration of hospital stay.
PMID:18253992 · both readings recorded this
mortality
no effect, typical relative risk 0.98 (95% confidence interval 0.80 to 1.20); typical risk difference 0.00 (95% confidence interval -0.03 to 0.02)
Glutamine supplementation does not have a statistically significant effect on mortality: typical relative risk 0.98 (95% confidence interval 0.80 to 1.20); typical risk difference 0.00 (95% confidence interval -0.03 to 0.02).
PMID:18253992 · one of two readings recorded this
neurodevelopment at 18 months corrected age (various assessments, instrument not specified)
no effect
The only trial that assessed long-term outcomes did not find any statistically significant differences in various assessments of neurodevelopment at 18 months corrected age.
PMID:18253992 · one of two readings recorded this
delivered AG dose
increases, p = 0.001
subjects in the i.v. AG group received a higher dose of AG (i.v. AG 0.50 versus e.n. AG 0.32+/-0.02 g/kg/day; p<0.001)
PMID:18258342 · one of two readings recorded this
intestinal permeability
no effect
There were no differences between groups for plasma concentrations of vitamin C, glutathione, malondialdehyde (MDA), T-lymphocyte subsets, intestinal permeability or nitrogen balance
PMID:18258342 · one of two readings recorded this
nitrogen balance
no effect
There were no differences between groups for plasma concentrations of vitamin C, glutathione, malondialdehyde (MDA), T-lymphocyte subsets, intestinal permeability or nitrogen balance
PMID:18258342 · one of two readings recorded this
plasma alpha-tocopherol over time
increases
E.n. AG subjects showed a significant increase in plasma alpha-tocopherol levels over time and maintained plasma gamma-tocopherol concentrations
PMID:18258342 · one of two readings recorded this
plasma gamma-tocopherol
no effect
E.n. AG subjects showed a significant increase in plasma alpha-tocopherol levels over time and maintained plasma gamma-tocopherol concentrations
PMID:18258342 · one of two readings recorded this
plasma glutamine
increases, p = 0.039
Plasma Gln was higher in the i.v. AG (565+/-119 microM, mean+/-SEM) vs the e.n. AG (411+/-27 microM) group by day 9 (p=0.039)
PMID:18258342 · one of two readings recorded this
plasma glutamine
increases, p = 0.039
Plasma Gln was higher in the i.v. AG (565+/-119 microM, mean+/-SEM) vs the e.n. AG (411+/-27 microM) group by day 9 (p=0.039)
PMID:18258342 · one of two readings recorded this
plasma glutathione
no effect
There were no differences between groups for plasma concentrations of vitamin C, glutathione, malondialdehyde (MDA), T-lymphocyte subsets, intestinal permeability or nitrogen balance
PMID:18258342 · one of two readings recorded this
plasma malondialdehyde
no effect
There were no differences between groups for plasma concentrations of vitamin C, glutathione, malondialdehyde (MDA), T-lymphocyte subsets, intestinal permeability or nitrogen balance
PMID:18258342 · one of two readings recorded this
plasma vitamin C
no effect
There were no differences between groups for plasma concentrations of vitamin C, glutathione, malondialdehyde (MDA), T-lymphocyte subsets, intestinal permeability or nitrogen balance
PMID:18258342 · one of two readings recorded this
T-lymphocyte subsets (CD-3, CD-4, CD-8)
no effect
There were no differences between groups for plasma concentrations of vitamin C, glutathione, malondialdehyde (MDA), T-lymphocyte subsets, intestinal permeability or nitrogen balance
PMID:18258342 · one of two readings recorded this
baseline children with rotavirus in faeces
no effect, p = 0.2, n = 147
Reporting rotavirus in faeces, no. (%) | 35 (47.3) | 27 (37.0) | 0.20 †
PMID:18330060 · one of two readings recorded this
baseline median age
no effect, p = 0.63, n = 147
Median age (months) (minimum-maximum) | 11 (1–39) | 10 (2–34) | 0.63 ∗
PMID:18330060 · one of two readings recorded this
baseline percentage of dehydration
no effect, p = 0.59, n = 147
Percentage of dehydration ‡, median (minimum-maximum) | 4.3 (1–10.8) | 4.2 (2–10.2) | 0.59 ∗
PMID:18330060 · one of two readings recorded this
baseline total number of stools in 24 hours before enrollment
no effect, p = 0.053, n = 147
Total number of stools 24 hours before enrollment, median (minimum-maximum) | 8 (1–27) | 10 (2–30) | 0.053 ∗
PMID:18330060 · one of two readings recorded this
correlation between ingested ORS volume and stool output
no effect, p = 0.2, n = 73
No association between the volume of ingested ORS and the stool output was found in any of the two treatment groups (Rs=0.30 in the WHO-ORS group and Rs=0.53 in the L-glutamine solution group; p=0.20)
PMID:18330060 · one of two readings recorded this
correlation between ingested ORS volume and stool output
no effect, p = 0.2, n = 74
No association between the volume of ingested ORS and the stool output was found in any of the two treatment groups (Rs=0.30 in the WHO-ORS group and Rs=0.53 in the L-glutamine solution group; p=0.20)
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 147
The cumulative probability of being rehydrated at 4, 6, and 10 hours in the WHO-ORS group was 26%, 64%, and 93% respectively, and in the L-glutamine-ORS group, these frequencies were 34%, 67%, and 97% respectively
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 147
The cumulative probability of being rehydrated at 4, 6, and 10 hours in the WHO-ORS group was 26%, 64%, and 93% respectively, and in the L-glutamine-ORS group, these frequencies were 34%, 67%, and 97% respectively
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 147
The cumulative probability of being rehydrated at 4, 6, and 10 hours in the WHO-ORS group was 26%, 64%, and 93% respectively, and in the L-glutamine-ORS group, these frequencies were 34%, 67%, and 97% respectively
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, p = 0.86, n = 85
was 28%, 59%, and 92% respectively, and in the L-glutamine-ORS group (46 children), these frequencies were 30%, 67%, and 80% respectively (Log-rank test, p=0.86)
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 85
was 28%, 59%, and 92% respectively, and in the L-glutamine-ORS group (46 children), these frequencies were 30%, 67%, and 80% respectively (Log-rank test, p=0.86)
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 85
was 28%, 59%, and 92% respectively, and in the L-glutamine-ORS group (46 children), these frequencies were 30%, 67%, and 80% respectively (Log-rank test, p=0.86)
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, p = 0.22, n = 62
was 23%, 69%, and 89% respectively, and in the L-glutamine-ORS group (27 children), these frequencies were 41%, 67%, and 100 % respectively (Log-rank test, p=0.22)
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 62
was 23%, 69%, and 89% respectively, and in the L-glutamine-ORS group (27 children), these frequencies were 41%, 67%, and 100 % respectively (Log-rank test, p=0.22)
PMID:18330060 · one of two readings recorded this
cumulative probability of rehydration
no effect, n = 62
was 23%, 69%, and 89% respectively, and in the L-glutamine-ORS group (27 children), these frequencies were 41%, 67%, and 100 % respectively (Log-rank test, p=0.22)
PMID:18330060 · one of two readings recorded this
diagnosis of osmotic diarrhoea
no effect, p = 0.16
Diagnosis of osmotic diarrhoea¶, no. (%) | 37 (52.0) | 24 (40.0) | 0.16 †
PMID:18330060 · one of two readings recorded this
end-of-rehydration serum glucose
no effect, p = 0.25
The median levels of serum sodium and glucose, at the end of rehydration period, showed not to be significantly different between the groups (p=0.84 and p=0.25)
PMID:18330060 · one of two readings recorded this
end-of-rehydration serum sodium
no effect, p = 0.84
The median levels of serum sodium and glucose, at the end of rehydration period, showed not to be significantly different between the groups (p=0.84 and p=0.25)
PMID:18330060 · one of two readings recorded this
end-of-study proportion with osmotic diarrhoea
no effect, p = 0.16
The median of serum creatinine, serum and urinary osmolality, and the proportion of patients with osmotic diarrhoea, at the end of the study, were not significantly different between both the groups (p=0.55, 0.53, 0.64, and 0.16 respectively)
PMID:18330060 · one of two readings recorded this
end-of-study serum creatinine
no effect, p = 0.55
The median of serum creatinine, serum and urinary osmolality, and the proportion of patients with osmotic diarrhoea, at the end of the study, were not significantly different between both the groups (p=0.55, 0.53, 0.64, and 0.16 respectively)
PMID:18330060 · one of two readings recorded this
end-of-study serum osmolality
no effect, p = 0.53
The median of serum creatinine, serum and urinary osmolality, and the proportion of patients with osmotic diarrhoea, at the end of the study, were not significantly different between both the groups (p=0.55, 0.53, 0.64, and 0.16 respectively)
PMID:18330060 · one of two readings recorded this
end-of-study urinary osmolality
no effect, p = 0.64
The median of serum creatinine, serum and urinary osmolality, and the proportion of patients with osmotic diarrhoea, at the end of the study, were not significantly different between both the groups (p=0.55, 0.53, 0.64, and 0.16 respectively)
PMID:18330060 · one of two readings recorded this
failure of the original ORS (switched to rice-powder ORS)
no effect, p = 0.53, n = 147
Six children (8%) in the WHO-ORS group and four children (5%) in the L-glutamine-ORS group showed failure to the original ORS, and this was changed to a rice-powder ORS (OR=0.66; 95% CI 0.15–2.79; p=0.53; with the WHO-ORS as the reference group)
PMID:18330060 · one of two readings recorded this
hourly stool output, stratified by rotavirus infection
no effect
both the ORS treatment groups had similar volumes of stool output during these same time periods within each stratum
PMID:18330060 · one of two readings recorded this
median number of vomits per hour (range row)
no effect, p = 0.08, n = 147
No./hour (minimum–maximum) | 0 (0–15) | 0 (0–1) | 0.08 ∗
PMID:18330060 · one of two readings recorded this
median of vomits per hour
no effect, p = 0.17, n = 147
Median of vomits/hour ‡ (minimum–maximum) | 0 (0–13.2) | 0 (0–9.1) | 0.17 ∗
PMID:18330060 · one of two readings recorded this
median stool output
no effect, n = 147
was 9.75, 8.45, 10.85, and 10.65 respectively in the WHO-ORS group and 11.90, 13.70, 10.70, and 10.00 respectively in the L-glutamine ORS group
PMID:18330060 · one of two readings recorded this
median stool output
no effect, n = 147
was 9.75, 8.45, 10.85, and 10.65 respectively in the WHO-ORS group and 11.90, 13.70, 10.70, and 10.00 respectively in the L-glutamine ORS group
PMID:18330060 · one of two readings recorded this
median stool output
no effect, n = 147
was 9.75, 8.45, 10.85, and 10.65 respectively in the WHO-ORS group and 11.90, 13.70, 10.70, and 10.00 respectively in the L-glutamine ORS group
PMID:18330060 · one of two readings recorded this
median stool output
no effect, n = 147
was 9.75, 8.45, 10.85, and 10.65 respectively in the WHO-ORS group and 11.90, 13.70, 10.70, and 10.00 respectively in the L-glutamine ORS group
PMID:18330060 · one of two readings recorded this
patients with vomits
no effect, p = 0.24, n = 147
Patients with vomits, no. (%); median of vomits | 17 (22.9) | 23 (31.5) | 0.24 †
PMID:18330060 · one of two readings recorded this
stool output during the time to rehydration
no effect, p = 0.8, n = 147
Stool output during the time to rehydration ‡, median (minimum–maximum) | 11.35 (0–28.7) | 11.8 (0.9–33.8) | 0.80 ∗
PMID:18330060 · one of two readings recorded this
time required for rehydration
no effect, p = 0.34, n = 147
Time (hours) required for rehydration, median (minimum–maximum) | 6 (3–12) | 5 (3–15) | 0.34 ∗
PMID:18330060 · one of two readings recorded this
time to successful rehydration, Cox regression
no effect, n = 147
the hazard ratio of the effect of the glutamine-based ORS, with the WHO-ORS as the reference, was calculated to be 1.06 (95% CI 0.76–1.46)
PMID:18330060 · one of two readings recorded this
time to successful rehydration, Cox regression
no effect, n = 85
The HR of the effect of the glutamine-based ORS, with the WHO-ORS as the reference, was calculated to be 0.97 (95% CI 0.63–1.49)
PMID:18330060 · one of two readings recorded this
time to successful rehydration, Cox regression
no effect, n = 62
The HR of the effect of the glutamine-based ORS, with the WHO-ORS as the reference, was calculated to be 1.31 (95% CI 0.78–2.19)
PMID:18330060 · one of two readings recorded this
time to successful rehydration in hours (Kaplan-Meier, Cox hazard ratio), stool output, ORS volume required, urinary output and vomiting in children with acute diarrhoea
HR 1.06 (95% CI 0.76-1.46) for L-glutamine ORS versus WHO-ORS
Not recorded as a finding: the comparison was against another active treatment
In the time to rehydrate analysis, the hazard ratio of the effect of the glutamine-based ORS, with the WHO-ORS as the reference, was calculated to be 1.06 (95% CI 0.76–1.46).
PMID:18330060 · one of two readings recorded this
time to successful rehydration (Kaplan-Meier, Cox hazard ratio) and stool output during rehydration with L-glutamine glucose-free ORS versus glucose-based WHO-ORS
HR 1.06 (95% CI 0.76-1.46), L-glutamine ORS vs WHO-ORS as reference, n = 147
Not recorded as a finding: the comparison was against another active treatment
In the time to rehydrate analysis, the hazard ratio of the effect of the glutamine-based ORS, with the WHO-ORS as the reference, was calculated to be 1.06 (95% CI 0.76–1.46).
PMID:18330060 · one of two readings recorded this
urinary output during the time to rehydration
no effect, p = 0.12, n = 147
Urinary output during the time to rehydration ‡, median (minimum–maximum) | 0.6 (0–4.9) | 0.8 (0–6.6) | 0.12 ∗
PMID:18330060 · one of two readings recorded this
volume of ORS required for rehydration
no effect, p = 0.72, n = 147
Volume of ORS required for rehydration ‡, median (minimum–maximum) | 24 (11–39) | 24 (15–44) | 0.72 ∗
PMID:18330060 · one of two readings recorded this
bloodstream infections
decreases, p = 0.01
bloodstream infections (7 vs 0, P < .01)
PMID:18596310 · one of two readings recorded this
infections attributed to fungi and enteric Gram-negative bacteria
decreases, p = 0.05
fungi, and enteric Gram-negative bacteria (each P < .05)
PMID:18596310 · one of two readings recorded this
infections attributed to Staphylococcus aureus
decreases, p = 0.01
infections attributed to Staphylococcus aureus (P < .01)
PMID:18596310 · one of two readings recorded this
nosocomial infection rates
no effect
GLN-PN did not alter infection rates after pancreatic necrosis surgery (17 STD-PN and 15 GLN-PN patients)
PMID:18596310 · one of two readings recorded this
plasma glutamine concentration
increases
Plasma glutamine concentrations were low in all groups and were increased by GLN-PN
PMID:18596310 · one of two readings recorded this
pneumonias
decreases, p = 0.05
pneumonias (16 vs 6, P < .05)
PMID:18596310 · one of two readings recorded this
total nosocomial infections
decreases, p = 0.03
total nosocomial infections (STD-PN 36 vs GLN-PN 13, P < .030)
PMID:18596310 · one of two readings recorded this
fasting plasma GLP-1 versus BMI
decreases, p = 0.003, n = 24
fasting GLP-1 levels were found to be inversely related to BMI (P = 0.003)
PMID:19056578 · one of two readings recorded this
fasting plasma glucagon versus BMI
increases, p = 0.016, n = 18
Fasting plasma glucagon levels were positively associated with BMI (P = 0.016)
PMID:19056578 · one of two readings recorded this
glutamine-induced incremental GLP-1 response versus age
no effect, p = 0.85, n = 24
It was also unrelated to the subject’s age (r = −0.04, P = 0.85), weight (r = −0.19, P = 0.36), BMI (r = −0.09, P = 0.67) and fasting plasma glucose concentration (r = −0.30, P = 0.15)
PMID:19056578 · one of two readings recorded this
glutamine-induced incremental GLP-1 response versus BMI
no effect, p = 0.67, n = 24
It was also unrelated to the subject’s age (r = −0.04, P = 0.85), weight (r = −0.19, P = 0.36), BMI (r = −0.09, P = 0.67) and fasting plasma glucose concentration (r = −0.30, P = 0.15)
PMID:19056578 · one of two readings recorded this
glutamine-induced incremental GLP-1 response versus fasting plasma glucose
no effect, p = 0.15, n = 24
It was also unrelated to the subject’s age (r = −0.04, P = 0.85), weight (r = −0.19, P = 0.36), BMI (r = −0.09, P = 0.67) and fasting plasma glucose concentration (r = −0.30, P = 0.15)
PMID:19056578 · one of two readings recorded this
glutamine-induced incremental GLP-1 response versus weight
no effect, p = 0.36, n = 24
It was also unrelated to the subject’s age (r = −0.04, P = 0.85), weight (r = −0.19, P = 0.36), BMI (r = −0.09, P = 0.67) and fasting plasma glucose concentration (r = −0.30, P = 0.15)
PMID:19056578 · one of two readings recorded this
incremental GLP-1 response to glutamine, OB-DIAB versus LEAN and OB-CON
no effect
Of note, the magnitude of the glutamine-induced incremental GLP-1 response in OB-DIAB subjects was not significantly different from that observed in LEAN and OB-CON subjects (Table 2)
PMID:19056578 · one of two readings recorded this
incremental plasma insulin area under the curve after glutamine, across groups
increases, p = 0.0013, n = 24
A similar result was found when comparing the incremental area under the curve for insulin (ANOVA P = 0.0013)
PMID:19056578 · one of two readings recorded this
incremental plasma insulin area under the curve, glutamine versus water
increases, p = 0.01, n = 8
the incremental area under the curve for insulin was greater following ingestion of glutamine than of water in all groups (LEAN, P = 0.01; OB-CON, P = 0.0002; OB-DIAB, P = 0.007)
PMID:19056578 · one of two readings recorded this
incremental plasma insulin area under the curve, glutamine versus water
increases, p = 0.0002, n = 8
the incremental area under the curve for insulin was greater following ingestion of glutamine than of water in all groups (LEAN, P = 0.01; OB-CON, P = 0.0002; OB-DIAB, P = 0.007)
PMID:19056578 · one of two readings recorded this
incremental plasma insulin area under the curve, glutamine versus water
increases, p = 0.007, n = 8
the incremental area under the curve for insulin was greater following ingestion of glutamine than of water in all groups (LEAN, P = 0.01; OB-CON, P = 0.0002; OB-DIAB, P = 0.007)
PMID:19056578 · one of two readings recorded this
plasma GIP area under the curve after glucose versus water
increases, p = 0.001
Glucose was a potent stimulus of GIP secretion (area under the curve: 2894 ± 276 vs 686 ± 133 pmol/L·90 min, glucose vs water, respectively, P < 0.001)
PMID:19056578 · one of two readings recorded this
plasma GIP area under the curve after glutamine versus water
increases, p = 0.001
but was markedly less effective than glucose (area under the curve: 1127 ± 216 vs 686 ± 133 pmol/L·90 min, glutamine vs water, respectively, P = 0.001)
PMID:19056578 · one of two readings recorded this
plasma GIP peak after glucose
increases
with elevated levels detected as early as 15 min and peak levels of 37.4 ± 4.0 pmol/L at 30 min
PMID:19056578 · one of two readings recorded this
plasma GIP peak after glutamine
increases
Glutamine also triggered GIP secretion (peak 16.3 ± 3.6 pmol/L at 30 min)
PMID:19056578 · one of two readings recorded this
plasma GLP-1 peak after glucose
increases, n = 8
mean peak levels observed at 30 min in LEAN subjects (31.9 ± 5.7 pmol/L) and OB-CON subjects (24.3 ± 2.1 pmol/L) and at 45 min in OB-DIAB subjects (19.5 ± 1.8 pmol/L)
PMID:19056578 · one of two readings recorded this
plasma GLP-1 peak after glucose
increases, n = 8
mean peak levels observed at 30 min in LEAN subjects (31.9 ± 5.7 pmol/L) and OB-CON subjects (24.3 ± 2.1 pmol/L) and at 45 min in OB-DIAB subjects (19.5 ± 1.8 pmol/L)
PMID:19056578 · one of two readings recorded this
plasma GLP-1 peak after glucose
increases, n = 8
mean peak levels observed at 30 min in LEAN subjects (31.9 ± 5.7 pmol/L) and OB-CON subjects (24.3 ± 2.1 pmol/L) and at 45 min in OB-DIAB subjects (19.5 ± 1.8 pmol/L)
PMID:19056578 · one of two readings recorded this
plasma GLP-1 peak after glutamine
increases, n = 8
with an initial peak at 30 min (22.5 ± 3.4 pmol/L, 17.9 ± 1.1 pmol/L and 17.3 ± 3.4 pmol/L in LEAN, OB-CON and OB-DIAB subjects, respectively)
PMID:19056578 · one of two readings recorded this
plasma GLP-1 peak after glutamine
increases, n = 8
with an initial peak at 30 min (22.5 ± 3.4 pmol/L, 17.9 ± 1.1 pmol/L and 17.3 ± 3.4 pmol/L in LEAN, OB-CON and OB-DIAB subjects, respectively)
PMID:19056578 · one of two readings recorded this
plasma GLP-1 peak after glutamine
increases, n = 8
with an initial peak at 30 min (22.5 ± 3.4 pmol/L, 17.9 ± 1.1 pmol/L and 17.3 ± 3.4 pmol/L in LEAN, OB-CON and OB-DIAB subjects, respectively)
PMID:19056578 · one of two readings recorded this
plasma glucagon area under the curve, glutamine versus water
increases, n = 18
Glutamine led to a marked early stimulation of glucagon release, with significant differences in area under the curve between the glutamine and water visits observed in all three groups
PMID:19056578 · one of two readings recorded this
plasma glucose after glutamine versus water
no effect, n = 24
Plasma glucose levels following glutamine ingestion were comparable to those following water alone in all study groups
PMID:19056578 · one of two readings recorded this
plasma glucose peak after oral glucose
increases, n = 8
peaking at 30 min in LEAN subjects (7.6 ± 0.5 mmol/L), 45 min in OB-CON subjects (9.8 ± 0.5 mmol/L) and 60 min in OB-DIAB subjects (14 ± 0.9 mmol/L)
PMID:19056578 · one of two readings recorded this
plasma glucose peak after oral glucose
increases, n = 8
peaking at 30 min in LEAN subjects (7.6 ± 0.5 mmol/L), 45 min in OB-CON subjects (9.8 ± 0.5 mmol/L) and 60 min in OB-DIAB subjects (14 ± 0.9 mmol/L)
PMID:19056578 · one of two readings recorded this
plasma glucose peak after oral glucose
increases, n = 8
peaking at 30 min in LEAN subjects (7.6 ± 0.5 mmol/L), 45 min in OB-CON subjects (9.8 ± 0.5 mmol/L) and 60 min in OB-DIAB subjects (14 ± 0.9 mmol/L)
PMID:19056578 · one of two readings recorded this
plasma insulin area under the curve after glutamine, across groups (log10)
increases, p = 0.0001, n = 24
The absolute glutamine-induced insulin response was greatest in OB-DIAB subjects, intermediate in OB-CON subjects and lowest in LEAN subjects (ANOVA P < 0.0001 for comparison of log10insulin area under the curve across the groups)
PMID:19056578 · one of two readings recorded this
plasma insulin area under the curve, glutamine versus water
increases, p = 0.0001, n = 24
Differences between the glutamine-induced and water-induced insulin responses (area under the curve) were significant when all subjects were considered together (P < 0.0001)
PMID:19056578 · one of two readings recorded this
plasma total GLP-1 (radioimmunoassay after ethanol extraction), total and incremental AUC over 120 min after oral 30 g glutamine versus water; also GIP, insulin, glucagon and glucose
increases, total and incremental GLP-1 responses to glutamine greater than water alone, whole group
Not recorded as a finding: a node exists but the paper states a different instrument or population
In the whole group, both total and incremental GLP-1 responses to glutamine were significantly greater than those observed following the ingestion of water alone (P < 0.0001).
PMID:19056578 · one of two readings recorded this
plasma total GLP-1 (total and incremental AUC, RIA after ethanol extraction) after 30 g oral glutamine in water vs water; also plasma GIP (ELISA), insulin, glucagon and glucose
increases, total and incremental GLP-1 responses to glutamine significantly greater than water in the whole group, n = 24
Not recorded as a finding: a node exists but the paper states a different instrument or population
In the whole group, both total and incremental GLP-1 responses to glutamine were significantly greater than those observed following the ingestion of water alone (P < 0.0001).
PMID:19056578 · one of two readings recorded this
total and incremental plasma GLP-1 response to glutamine versus water
increases, p = 0.0001, n = 24
In the whole group, both total and incremental GLP-1 responses to glutamine were significantly greater than those observed following the ingestion of water alone (P < 0.0001)
PMID:19056578 · one of two readings recorded this
endotoxin-induced changes in monocyte, lymphocyte and neutrophil concentrations
no effect
but these changes were unaffected by the infusion of glutamine
PMID:19173710 · one of two readings recorded this
endotoxin-induced drop in plasma glutamine
no effect
The endotoxin-induced drop in plasma glutamine – absolute as well as fractional – was comparable between treatments
PMID:19173710 · one of two readings recorded this
endotoxin-induced heart rate and temperature response
no effect
but were unaltered by glutamine infusion
PMID:19173710 · one of two readings recorded this
endotoxin-induced response of plasma TNF-α and IL-6
no effect
infusion with glutamine had no effect on the response of either cytokine to endotoxin injection
PMID:19173710 · one of two readings recorded this
heart rate and temperature after endotoxin
increases, p = 0.05
Heart rate and temperature both increased (P < 0.05) after endotoxin administration but were unaltered by glutamine infusion
PMID:19173710 · one of two readings recorded this
HSP70 protein in blood mononuclear cells
no effect
No significant changes were detected in BMNC HSP70 protein concentrations over time or between trials
PMID:19173710 · one of two readings recorded this
monocyte, lymphocyte and neutrophil concentrations after endotoxin
modulates, p = 0.05
Endotoxin injection induced characteristic changes (P < 0.05) in the concentration of monocytes, lymphocytes and neutrophils, but these changes were unaffected by the infusion of glutamine
PMID:19173710 · one of two readings recorded this
plasma cortisol after endotoxin
increases, p = 0.0001
After endotoxin administration, plasma cortisol increased (P < 0.0001)
PMID:19173710 · one of two readings recorded this
plasma cortisol during first 2 hours of infusion
decreases, p = 0.0001
The plasma concentration of cortisol decreased significantly during the first 2 hours of both glutamine and placebo infusions (P < 0.0001)
PMID:19173710 · one of two readings recorded this
plasma cortisol time course after endotoxin
no effect
but the time course was unaffected by glutamine
PMID:19173710 · one of two readings recorded this
plasma glutamine concentration, baseline to end of first 2 hours of infusion
increases
from 500 μmol/l [95% CI = 430 to 570 μmol/l] to 764 μmol/l [95% CI = 708 to 821 μmol/l]
PMID:19173710 · one of two readings recorded this
plasma glutamine concentration, endotoxin injection to 4 hours later
decreases
from 764 μmol/l (95% CI = 708 to 821 μmol/l) at the time of endotoxin injection to 601 μmol/l (95% CI = 523 to 679 μmol/l) 4 hours later
PMID:19173710 · one of two readings recorded this
plasma glutamine drop after endotoxin, placebo infusion
decreases, p = 0.0003
plasma levels also dropped significantly, from 484 μmol/l (95% CI = 427 to 541 μmol/l) to 369 μmol/l (95% CI = 333 to 406 μmol/l), corresponding to a fractional decrease of 23% (95% CI = 15% to 31%; P = 0.0003)
PMID:19173710 · one of two readings recorded this
plasma glutamine fractional drop after endotoxin
decreases, p = 0.0001
plasma levels dropped by 21% (95% CI = 16% to 27%; P < 0.0001)
PMID:19173710 · one of two readings recorded this
plasma glutamine increase above baseline during first 2 hours of infusion
increases, p = 0.0001
Plasma glutamine concentration increased by 55% (95% confidence interval [CI] = 42% to 68%; P < 0.0001) above baseline levels
PMID:19173710 · one of two readings recorded this
plasma IL-6 after endotoxin
increases, p = 0.05
TNF-α (P < 0.0001) and IL-6 (P < 0.05) plasma concentrations both increased after endotoxin administration
PMID:19173710 · one of two readings recorded this
plasma TNF-α after endotoxin
increases, p = 0.0001
TNF-α (P < 0.0001) and IL-6 (P < 0.05) plasma concentrations both increased after endotoxin administration
PMID:19173710 · one of two readings recorded this
plasma TNF-alpha and IL-6 (ELISA) after endotoxin challenge, HSP70 in blood mononuclear cells (Western blot), rectal temperature, heart rate, leukocyte subsets, plasma cortisol
no effect, infusion with glutamine had no effect on the response of either cytokine to endotoxin injection, n = 8
Not recorded as a finding: the trial gave a chemically different species
However, infusion with glutamine had no effect on the response of either cytokine to endotoxin injection.
PMID:19173710 · one of two readings recorded this
plasma TNF-alpha and IL-6 response to endotoxin by ELISA, HSP70 in blood mononuclear cells by Western blot, leucocyte subpopulations, cortisol, rectal temperature and heart rate
no effect
Not recorded as a finding: the trial gave a chemically different species
However, infusion with glutamine had no effect on the response of either cytokine to endotoxin injection.
PMID:19173710 · one of two readings recorded this
2-minute walk test, baseline (median)
Pre | 100.0 (86.0; 120.9) | 105.5 (89.9; 115.2)
PMID:19421321 · one of two readings recorded this
2-minute walk test, endpoint (median)
no effect
Endpoint (4 mo) | 101.0 (81.6; 113.4) | 101.5 (87.0; 109.0)
PMID:19421321 · one of two readings recorded this
2-minute walk test over 9-month study, all subjects
no effect, p = 0.39
the 2-MWT did not differ from baseline (103.9 m (±20.4)) to the end of study, at 9 months (98.9 m (±28.1)) (p = 0.39; paired samples t test)
PMID:19421321 · one of two readings recorded this
24 h urinary 3-methyl-histidine excretion
no effect, p = 0.25
the 24 h excretion of 3 methyl-histidine in urine was not affected by 4 months Gln treatment (p = 0.25)
PMID:19421321 · one of two readings recorded this
change in 2-minute walk test (median)
no effect
Change at 4 mo | 2.0 (−16.2; 13.3) | −2.8 (−10.0; 2.3)
PMID:19421321 · one of two readings recorded this
change in fat free mass (median)
decreases
Change at 4 mo ** | 0.7 (0.2; 1.2) | 0.4 (−0.2; 0.7)
PMID:19421321 · one of two readings recorded this
change in fat mass percentage (median)
increases
Change at 4 mo * | 1.2 (−1.6; 2.3) | 1.9 (−0.8; 4.9)
PMID:19421321 · one of two readings recorded this
change in muscle mass (24 h urinary creatinine) (median)
no effect
Change at 4 mo | −0.3 (−1.5; 0.3) | −0.7 (−1.1; −0.1)
PMID:19421321 · one of two readings recorded this
change in power (median)
no effect
Change at 4 mo | 11 (−13; 23) | 10 (−17; 20)
PMID:19421321 · one of two readings recorded this
change in serum CPK (median)
no effect
Change at 4 mo | −795 (−3402; 3332) | −2010 (−4984; 1340)
PMID:19421321 · one of two readings recorded this
change in urinary 3-methyl-histidine/creatinine (median)
no effect
Change at 4 mo | −0.7 (−7.2; 8.0) | −4.8 (−16.7; 8.8)
PMID:19421321 · one of two readings recorded this
change in walking speed (median)
no effect
Change at 4 mo | 0.0 (−0.1; 0.1) | 0.0 (−0.1; 0.1)
PMID:19421321 · one of two readings recorded this
change in work (median)
no effect
Change at 4 mo | −1.1 (−7.1; 6.3) | 0.7 (−5.1; 2.0)
PMID:19421321 · one of two readings recorded this
families considering the child's condition improved
unclear
The families of 15 subjects (50%) considered the child's condition improved during the 4 months Gln treatment, whereas 12 families (40%) found that their child's condition improved during the placebo phase
PMID:19421321 · one of two readings recorded this
fat free mass, baseline (median)
Pre | 15.9 (14.0; 19.3) | 16.2 (14.6; 20.1)
PMID:19421321 · one of two readings recorded this
fat free mass, endpoint (median)
Endpoint (4 mo) | 17.4 (14.9; 19.0) | 16.6 (14.7; 19.6)
PMID:19421321 · one of two readings recorded this
fat free mass order effect
p = 0.001
The increase in fat free mass was significantly less with 4 months Gln treatment versus placebo (Table 2) and an order effect was observed (p = 0.001)
PMID:19421321 · one of two readings recorded this
fat free mass over 9-month study (BIA), all subjects
increases, p = 0.0001
Median (Q1; Q3) fat free mass increased from 16.2 kg (14.4; 19.2) at baseline to 17.4 kg (15.0; 19.5) at 9 months (p<0.0001; Wilcoxon's signed rank test)
PMID:19421321 · one of two readings recorded this
Sources cited
28 papers
- Subject
- L-glutamine
- Findings
- 47
- Papers
- 28
Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis.record2025PMID:405461371 finding
Enteral glutamine supplements for patients with severe burns: A systematic review and meta-analysis.record2024PMID:374603471 finding
Glutamine enteral therapy for critically ill adult patients: An updated meta-analysis of randomized controlled trials and trial sequential analysis.record2024PMID:380419381 finding
Glutamine Supplementation on Burn Patients: A Systematic Review and Meta-analysis.record2024PMID:382435791 finding
Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.record2024PMID:388088901 finding
Comparative Effects of Different Nutritional Supplements on Inflammation, Nutritional Status, and Clinical Outcomes in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis.record2023PMID:373756761 finding
The Efficacy of Glutamine Supplementation in Severe Adult Burn Patients: A Systematic Review With Trial Sequential Meta-Analysis.record2023PMID:371149122 findings
Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients' Survival: A Randomized Controlled Trial.record2022PMID:353345701 finding
Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.record2022PMID:357745406 findings
Glutamine relieves the hypermetabolic response and reduces organ damage in severe burn patients: A multicenter, randomized controlled clinical trial.record2022PMID:349738531 finding
Glutamine supplementation can reduce some atherosclerosis markers after exhaustive exercise in young healthy males.record2022PMID:348441563 findings
Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis.record2021PMID:338653132 findings
Glutamine on critical-ill patients: a systematic review and meta-analysis.record2021PMID:332224641 finding
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.record2020PMID:323865214 findings
Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.record2019PMID:301081631 finding
Effects of Carbohydrate and Glutamine Supplementation on Oral Mucosa Immunity after Strenuous Exercise at High Altitude: A Double-Blind Randomized Trial.record2017PMID:286716261 finding
Effect of glutamine dipeptide supplementation on primary outcomes for elective major surgery: systematic review and meta-analysis.record2015PMID:255849661 finding
Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.record2015PMID:255915701 finding
Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.record2015PMID:262832171 finding
L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.record2015PMID:253514531 finding
Immunonutrition as an adjuvant therapy for burns.record2014PMID:255361832 findings
Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.record2014PMID:253899594 findings
The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials.record2014PMID:244016362 findings
A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn.record2013PMID:233130171 finding
The impact of perioperative glutamine-supplemented parenteral nutrition on outcomes of patients undergoing abdominal surgery: a meta-analysis of randomized clinical trials.record2013PMID:236355871 finding
Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.record2009PMID:194213211 finding
Glutamine supplementation to prevent morbidity and mortality in preterm infants.record2005PMID:156748782 findings
Glutamine supplementation in serious illness: a systematic review of the evidence.record2002PMID:123520352 findings
Other names
11 names
Resolves to: L-glutamine
- Also called
- (2S)-2-amino-4-carbamoylbutanoic acid(2S)-2,5-diamino-5-oxopentanoic acid(S)-2,5-diamino-5-oxopentanoic acidGlutamic acid 5-amideGlutamic acid amideGLUTAMINEL-(+)-glutamineL-2-aminoglutaramic acidL-glutamic acid gamma-amideL-glutamic acid γ-amideLevoglutamide